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Synopsis
The purpose of this work was to study the effects of reactive oxygen species (ROS) on DNA and to 
investigate the relevance of ROS-induced DNA damage in systemic lupus erythematosus (SLE).
Using model systems of ROS generation, it was found that DNA was damaged by ROS at all levels of 
its structure, causing strand breaks, base modifications and conformational changes. Hydrogen 
peroxide, a ROS generated during inflammation in vivo, produced a characteristic type of site-specific 
damage dependent on the DNA-bound metal ion catalysis of its degradation.
8-hydroxydeoxyguanosine (80HDG), a modified DNA base, was used as a marker of oxidative damage 
to investigate the role of DNA damage in the aetiopathogenesis of SLE.
Excretion of this adduct was detected in normal urine and is believed to arise from normal oxidative 
metabolic processes. In patients with active rheumatoid arthritis, this level of 80HDG excretion was 
significantly elevated. In contrast, in SLE patients with inflammatory activity, 80HDG was 
undetectable in the urine.
Investigation of the mechanism responsible for this showed that SLE cells had aberrant removal of 
80HDG from DNA following oxidative stress in vitro compared to normal cells, and that ROS- 
denatured DNA accumulated in circulating immune complexes associated with the disease.
SLE is also characterised by circulating anti-DNA antibodies. These antibodies were found to bind 
better to ROS-DNA than to native double-stranded DNA. Furthermore, ROS-DNA was able to 
stimulate lymphocytes to produce anti-DNA antibodies.
The pattern of DNA damage seen in SLE patients was typical of that induced by hydrogen peroxide in 
vitro. This suggests that inflammation generates ROS which cause DNA damage. As a result of 
defective repair within cells, ROS-DNA is released into the circulation following cell death which can 
form complexes with anti-DNA antibodies. In addition, the ROS-DNA can stimulate further anti-DNA 
antibody production by acting directly on cells thus perpetuating the disease process and contributing to 
immune complex deposition, a deleterious manifestation of the disease process.
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SECTION 1
GENERAL INTRODUCTION
CHAPTER 1,1: THE BIOCHEMISTRY OF REACTIVE OXYGEN SPECIES 
1.1,1: Reactive Oxygen Species
Reactive oxygen species (ROS) are molecules derived from oxygen by univalent reduction reactions. 
They are formed during normal oxidative metabolism and have a high chemical reactivity.
Oxygen itself is essential for the maintenance of aerobic metabolism and comprises the terminal electron 
acceptor in mitochondrial respiration. In this metabolic process, water and carbon dioxide are formed 
from the tetravalent reduction of oxygen by the efficient mitochondrial enzyme cytochrome oxidase, 
with the concomitant production of ATP. However, oxygen can also react with single electrons that 
may leak from the respiratory chain and undergo univalent reduction by virtue of the electronic 
configuration conferred on the oxygen molecule. This produces superoxide anion radical (0^-‘), 
hydrogen peroxide and hydroxyl radical (OH ) from the 1-, 2- and 3-electron reductions of
oxygen respectively. It has been estimated that during normal metabolism 5% of oxygen is converted to 
Oj"' by this alternative reduction mechanism (Fridovich, 1978; Fridovich, 1984).
Most biological molecules have paired electrons in their outer shell ( t I ) and react with each other in 
thermodynamically favourable reactions. However, oxygen is a diradical with two unpaired electrons 
with unidirectional spin in its outer shell {t f ), one of which must undergo spin inversion before it 
can react with molecules with paired electrons. The length of time for spin inversion to occur is long 
compared with molecular interactions and therefore oxygen will react more readily with other molecules 
with parallel spin electrons or with free radicals rather than undergoing spin inversion.
A free radical is an atom or molecule that has one or more unpaired electrons in its outer orbital. Free 
radicals can have cationic (H ,0 ‘*'), anionic (0  • ) or neutral characteristics (O ) and are extremely 
reactive, with rate constants of the order of 10  ^ - 10’° M * s * (Wardman, 1978; Halliwell and 
Gutteridge, 1985).
Free radicals may be generated either from the unimolecular homolytic fission of a covalent bond 
between two atoms as shown below:
1 X - Y  ---- ► X- + Y-
or from oxidation or reduction reactions in which electrons are transferred directly from one redox 
intermediate to another, producing bound or free radicals.
The first mechanism, requiring bond scission, generates two neutral species and can be induced by high 
energy radiation if the energy input is greater than the bond dissociation energy. Ultraviolet (UV) 
irradiation of producing two molecules of OH- provides a typical example of this (see section 
2.4.2).
The second mechanism is frequently mediated by transition metal ions, many of which have unpaired 
electrons in their outer orbital. This allows them to accept and donate single electrons and they are 
found at the active site of many enzymes catalysing redox reactions (Hill, 1981).
1.1.2; Reactions of ROS
1.1.2.1: Superoxide Radical Anion
The acceptance of electrons by oxygen, one at a time, overcomes the spin restriction of the native 
molecule and produces O^-' as the first electron product of O^. This anion has only one unpaired 
electron ( t  lO ^ t)  and is an energetically stable intermediate in the reduction of oxygen. As a result of 
this, chemical and physicochemical studies have suggested that it is not a very reactive radical, causing 
damage only indirectly by giving rise to more powerful oxidants (Bielski and Richter, 1977; Sawyer and 
Valentine, 1981) such as OH-. However, this view is not held by Fridovich (1986), who documents that 
Oj-‘ finds critical targets in living cells, inactivating catalase and glutathione peroxidase, and mobilising 
iron from ferritin (section 1.1.3).
At physiological pH, O^-' is a relatively strong reducing agent, weak oxidising agent and nucleophile. 
These features facilitate the reaction between two molecules of O^-' in a dismutation reaction, one 
molecule being reduced, the other oxidised, to form H O and O :
O, 2 2
2 2 2 
+ o.
The reaction proceeds most rapidly at acidic pH, whereby O •' becomes protonated to form the
perhydroxyl radical, 
3 HO. H'" O.'2 ** ■ 2 
The pKa for the equilibrium of reaction 3 is «4 .8  (Bielski and Allen, 1977).
At physiological pH the overall rate of dismutation is relatively slow (» 5  x 10  ^M * s"‘). This allows 
to react not only with itself but also with other biological material.
One important competing reaction of O^*' is its reaction with trivalent ferric ions of the metalloprotein 
ferritin, to release the divalent ferrous form (Biemond et al., 1984; Biemond et al., 1988). Ferrous ions 
play an integral part in the generation of further ROS from O^-' as described in section 1.1.2.2.
The reactions of O^-' need not be confined to the cell in which the anion is produced. The protonated 
form of O^-’ (HOj-‘), is lipophilic and can diffuse through the lipid bilayer. It is also more reactive than 
O^-' and will attack the fatty acid components of membranes (Bielski, Arudi and Sutherland, 1983). In 
addition to this, O^*' may be transported across the cell membrane via an anion channel although the 
only example of this is in the red cell membrane (Lynch and Fridovich, 1978). With its relatively long 
half life this may allow O^-' to diffuse away from its site of production and extend the area of ROS- 
induced damage.
The dismutation of O^-' can also be catalysed by superoxide dismutase (SOD) (McCord and Fridovich, 
1969). The SODs are a family of metalloenzymes that is widely distributed in mammalian tissue and
increases the rate of dismutation of O^-' from 5 x 10  ^M s to 2 x 10 M ' s'L
1.1.2.2: Hydrogen Peroxide
Dismutation of Oj' > occurring either spontaneously or catalysed by SOD, results in the generation of 
H^O .^ This is a two electron reduction product of oxygen but has no unpaired electrons (H t IO^ t 1H): 
it is not a free radical and is more appropriately referred to as a reactive oxygen species.
The mechanism of H^O^ reduction to produce further reactive metabolites of oxygen has been the
subject of many studies and is still controversial. Shortly after the discovery of SOD, O •' was
suggested to react with via the Haber-Weiss reaction to produce OH- (Beauchamp and Fridovich, 
1970):
+ H O , 2 2 °2 + OH‘ OH-
Although this is thermodynamically feasible (Koppenol, 1976), O^-' dismutates faster than formation of 
OH- in this reaction (Halliwell, 1976; Weinstein and Bielski, 1979). It has now been shown that the 
rate constant for the Haber-Weiss reaction is less than 10"^  M'* s'* (Rigo and Stevanato, 1977) and 
cannot occur at the low steady-state concentrations of O^-' and H^O^ found in biological systems 
(Halliwell, 1976). The stoichiometry of the Haber-Weiss reaction can be achieved in the presence of 
catalytic metal ions (McCord and Day, 1978; Halliwell, 1978a; Halliwell, 1978b):
Fe(III) -I- O, Fe(II) -f O.5
6 Fe(II) -(• H^Oj ---- ► Fe(III) -t- OH' +  OH-
Reaction 6 is referred to as the Fenton reaction. It does not require high concentrations of Fe(II) and 
proceeds at a rate of 1-10“* M'* s'* (Simic, Bergtold and Karam, 1989). The role of Fe(II) is to catalyse 
the homolytic fission of H^O^, and the sum of reactions 5 and 6 gives rise to an iron-catalysed Haber- 
Weiss reaction. The role of O^-' would appear to be to reduce Fe(III) to its catalytic form of Fe(II). 
However, if alternative reducing agents, such as ascorbic acid (AA), are available to react with Fe(III), 
HjO^ can give rise to OH- in a reaction which cannot be inhibited by SOD (Winterboum, 1981; Rowley 
and Halliwell, 1983a). Despite this, the O^-' catalysed release of Fe(II) from iron complexes is 
important, because physiological iron complexes such as peroxidases and ferritin cannot catalyse the 
Haber-Weiss reaction (Halliwell, 1978a).
In vitro, Fe-EDTA can provide catalytic iron in its complexed form. It is, therefore, frequently used to 
study the reaction of iron in Fenton chemistry since it provides a soluble redox active form of iron 
(Walling, Kurz and Schuger, 1970; McCord and Day, 1978). Using this model system, Gutteridge 
(1990) has recently suggested that whilst classical Fenton chemistry describes H^Oj as both a reductant 
(7) and oxidant (8) of iron salts and their complexes:
7 H ,0 , + -----► HO,- -I- H'*' -t- Fe'
2 2 2
8 H ,0 , -I- Fe^ '*' -----► OH- -H OH' + Fe
2+
3 +
iron bound to EDTA is unlikely to be reduced by H^O  ^ (Gutteridge, Maidt and Foyer, 1990); it is O -^' 
that predominates in the reduction of ferric-EDTA and other iron complexes to the ferrous state 
(reaction 5), providing H^O^, essential for OH- formation (as above).
In the iron catalysed Haber-Weiss reaction (reactions 5 and 6), ultimately gives rise to the 
hydroxyl radical (OH-). The identification of the radical species as OH- has been the subject of 
controversy, predominantly because OH-, once generated, will react immediately with surrounding 
biomolecules at a diffusion-controlled rate within a few atomic collisions of where it is formed (Anbar 
and Neta, 1967). It is therefore difficult to detect and measure directly. Alternatives to OH- have been 
suggested as major contributors to oxidative damage in biological systems. These include the ferryl 
radical (FeO^"'’), in which iron has an oxidation number of four and the ROS does not dissociate from it 
(Walling, 1982; Rush and Koppenol, 1985). However, whilst the ferryl radical may be the reactive 
species at the active sites of horseradish peroxidase compounds I and II (Dunford, 1982) and is 
important in haemoglobin / myoglobin reactions (Harel and Kanner, 1988; Peterson, Symons and 
Taiwo, 1989), there is no clear evidence for its involvement in other systems.
Further evidence against the production of OH- is the apparent inability of OH- scavengers to protect in 
the Fenton reaction (Borg and Schaich, 1984; Czapski, 1984). This may be explained by production of 
an alternative radical species such as ferryl (FeO '^*') (Winterboum, 1987), perferryl (FeO"^) or a crypto 
OH- radical (Youngman, 1984) in which the radical species does not dissociate from the catalytic metal 
ion producing it. However, if the Fenton reaction is catalysed by a bound metal ion, the OH- produced 
may react preferentially with the biomolecule at the metal binding site in a site-specific manner, rather 
than with the scavenger molecule. Further support for OH- as the product of the Fenton reaction comes 
from recent work of Gutteridge (1990). This work shows that for an iron catalysed reaction, only when 
an iron complex or iron ion reacting with H^O^ does not release OH- into free solution, or cause site- 
specific damage, does the formation and oxidative damage by species other than OH- become more 
important in biological situations (Gutteridge, 1990). With this in mind OH- will be described as the 
main product of the Fenton reaction.
1.1.2.3: Hydroxyl Radical
OH- is a highly reactive radical species with a half-life of 10”* seconds (Roots and Okada, 1975) and has 
been shown to diffuse only 1.5 nm before reacting with a surrounding molecule. This distance was 
determined by measuring the rates of reaction of OH- with DNA and increasing concentrations of 
scavenger in a system where it was assumed that all OH- could be scavenged (Ward, Blakely and Joner, 
1985). It is thus the diffusion potential of H^O  ^and O^-' that will limit the area damaged by OH-.
H^O^, Oj-' and OH- arise from successive one electron reductions of oxygen. An alternative way to 
increase the reactivity o f oxygen is to move one of the unpaired electrons in a way that alleviates the 
spin restriction. This requires an input of energy and generates singlet oxygen ( t 1 Op referred to as 
*0 .^ This has no unpaired electrons and is not a radical. 'O^ is formed when photosensitive compounds 
are illuminated in the presence of oxygen eg. retinal pigments in the eye (Kirschfeld, 1982). There is 
however no conclusive evidence for the formation of 'O^ in O^-'-generating systems or by phagocytic 
cells (Arudi, Bielski and Allen, 1984; Halliwell and Gutteridge, 1985).
1.1.2.5: Hypochlorous Acid
Hypochlorous acid (HOCl) is not a radical species and is formed when myeloperoxidase (MP), the most 
abundant neutrophil protein, catalyses the conversion of and Cl' to HOCl (Harrison and Schultz, 
1976). Although HOCl is potently microbicidal and cytotoxic, it is unclear how efficiently it is formed 
within the phagosome and how much it contributes to bacterial killing and other inflammatory reactions 
of neutrophils.
1.1.2.4: Singlet Oxygen
MP reacts with H ,0 ,: 2 2
9 MP^+ -f H O , 2 2 ---- ► MP^+HjOj
10 MP^'^H^O^ -i- c r  — ► MP^ "^
and O^-’:
11 MP^"  ^ -t- °2-‘ ---- ► MP^'^Oj
+ HOCl +OH'
acting as a combined SOD/catalase enzyme (see section 1.1.6).
Although the rate o f reaction of with O^-’ is ten times slower than that with H^O^, there is
evidence that O^-' enhances the activity of myeloperoxidase and optimises production of HOCl by 
stimulated neutrophils (Kettle et al., 1988). This implies that O^-' may potentiate inflammatory tissue 
damage by enhancing the production of HOCl (Kettle and Winterbourn, 1988) and that the anti­
inflammatory effect of SOD (Niwa et al., 1985) may, in part, be due to the inhibition of this reaction. 
In view of this Kettle and Winterboum (1990) have suggested that HOCl, rather than OH- may be the 
principle agent responsible for tissue damage in inflammation.
1.1.3: Availability of Catalytic Iron
It has been demonstrated that production of OH- through the Haber-Weiss reaction (reactions 5 and 6)
can be effectively catalysed with ferrous ion, Fe(II) (section 1.1.2.2). The majority of iron stored in the 
body is complexed to haemoglobin and myoglobin (Harrison and Hoare, 1980); a small amount is found 
in iron-containing enzymes and the transport protein transferrin (Aisen and Listowsky, 1980), and the 
rest is complexed to the intracellular storage proteins ferritin (Harrison, 1977) and haemosiderin (Ozaki, 
Kawabata and Awai, 1988). This leaves little free iron to drive the Haber-Weiss reaction.
In spite of this, can reduce ferritin-bound iron to stimulate the formation of OH- from 0^-‘ and 
(Bannister, Bannister and Thomally, 1984). This is not true for release of iron from lactoferrin 
and transferrin, which are not thought to be major physiological catalysts of OH- production (Halliwell 
and Gutteridge, 1985). In view of the reactivity of OH-, even the ferritin catalysed production of OH- 
is only likely to cause extensive tissue damage close to ferritin deposits.
There is also a small transit pool of low molecular weight iron chelates present in cells. These are 
either attached to phosphate esters eg. ATP (Floyd, 1983), polar heads of membrane lipids (Halliwell 
and Gutteridge, 1984), proteins (Gutteridge and Stocks, 1981) and DNA (Floyd, 1981; Gutteridge and 
Toeg, 1982), or move as an Fe-citrate complex between transferrin, the cell cytoplasm, mitochondria 
and ferritin. This can provide iron to catalyse the Fenton reaction (Halliwell and Gutteridge, 1989 pp 
22-85) but as part of the defence against ROS-induced damage, is kept to a minimum. Where the iron is 
bound to a particular region of a biomolecule, the generation of OH- will be targeted to that residue, 
rendering the molecule susceptible to site-specific damage. This occurs with iron boimd to DNA and is 
discussed further in section 1.1.5.4.
1.1.4: Production of ROS in vivo
In the preceding sections, the production of ROS has been described in mechanistic terms; the following 
sections describe the biochemical reactions that generate these products in vivo. Particular attention will 
be paid to mechanisms relating to inflammation.
1.1.4.1: Arachidonic Acid Metabolism
When phagocytic cells are activated, phospholipase A  ^cleaves enzymatically arachidonic acid from 
membrane phospholipids allowing it to be subsequently oxidised by either of two metabolic processes: 
dioxygenation catalysed by the haem enzyme cyclooxygenase, to produce prostaglandin metabolites, or
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mono-oxygenation catalysed by the non-haem iron enzyme lipoxygenase to produce mono-hydroxy- 
eicosa-tetraenoic acids (HETES) and hydroperoxy-eicosa-tetraenoic acids (HPETES). Both pathways 
give rise to free radical intermediates, one of which, possibly OH-, may oxidatively deactivate 
cyclooxygenase, thereby modulating the inflammatory process by negative feedback (Ogino et al., 
1978).
1.1.4.2; Peroxisomes
These detoxifying organelles contain many oxidases (eg. glycolate oxidase, D-amino acid oxidase, fatty 
acyl oxidase), all of which produce Of this, 40-80% is destroyed by intracellular catalase, and
the remaining 20-60% diffuses easily through the peroxisome membrane and accounts for 35% of 
produced in the liver (Boveris, Oshino and Chance, 1972).
1.1.4.3: Endoplasmic Reticulum and Nuclear Membranes
Cytochrome P450/P450 reductase and cytochrome b^  reductase are present in the endoplasmic reticulum 
and nuclear membranes and catalyse desaturation, demethylation and hydroxylation reactions of 
endogenous substrates or foreign substances, such as drugs. They normally require NADPH and 
NADH as electron donors but may become uncoupled during the catalytic cycle to produce H^O .^ The 
mechanism for this uncoupling is not understood (Freeman and Crapo, 1982).
1.1.4.4: Mitochondria
In aerobic conditions, mitochondria are responsible for production of the major intracellular sources of 
O^-' and (Loschen et al., 1974). The 4 electron reduction of to H^O on the inner mitochondrial 
membrane, through the respiratory assemblies does not generate ROS. However, when the electron 
transport chain is highly reduced and the respiratory rate is dependent on ADP availability (eg. in 
ischaemic tissue) then leakage of electrons occurs to produce O^-’ and (Boveris and Chance, 
1973).
1.1.4.5; Autoxidation of Small Molecules
Small molecules such as hydroquinones, catecholamines, reduced ferredoxins and thiols autoxidise to 
produce O^-'. They can also reduce chelated iron to catalyse the Fenton reaction eg. the NADPH- 
supported enzymatic reduction of molecular oxygen by ferredoxin-ferredoxin; NADP'*’ oxidoreductase
produces free OH- (Morehouse and Mason, 1988).
The reaction of haemoglobin with low concentrations of gives rise to ROS but it is generally
accepted that the less reactive ferryl radical (FeO '^*’) and not OH- is the main oxidant in this system 
(Puppo and Halliwell, 1988).
This autoxidation process is also responsible for the toxicity of some drugs, including paracetamol and 
metronidazole (Clark, Cowden and Hunt, 1985), and for the anti-tumour activity of bleomycin (Lown 
and Sim, 1977). Drugs that contain the hydralazine moiety, eg. hydralazine and isoniazid can also be 
enzymatically activated to form free radical derivatives (Sinha, 1983); those derived from hydralazine 
metabolism having been shown to cause DNA strand breaks (Sinha and Patterson, 1983).
1.1.4.6: Cytosolic Sources
Many cytosolic oxidases and oxygena.ses have transition metal ions at their active site and generate free 
radicals during redox cycling. Free radicals can also be produced when the metabolic status of a tissue 
changes, influencing an enzyme substrate. This is illustrated by xanthine oxidase, a cytosolic enzyme 
normally present in its dehydrogenase form which uses NAD'*’ as its electron acceptor and converts 
xanthine or hypoxanthine to uric acid:
12 Hypoxanthine -t- H^O + NAD''  ^ ----Xanthine + H^ + NADH
13 Xanthine -I- H^O +  NAD"^ Uric acid -I- H"^  -f NADH
However, during ischaemia, reversible sulphydryl oxidation or irreversible proteolytic modification 
converts the enzyme to an oxidase form in a Ca '^ '^-dependent process (Della Corte and Stirpe, 1972). In 
the reperfusion stage, following ischaemia, the oxidase uses molecular oxygen (Op as its electron 
acceptor to break down the accumulated xanthine. This produces O -^’:
14 Xanthine -i- H^O -I- Uric acid + 20^-' -4- 2H’*’
This exchange o f electron acceptors with subsequent generation of O^-' has been suggested to be 
important in ischaemia/reperfusion injury (McCord, 1985) (section 1.1.7).
1.1.4.7: Plasma Membranes
The plasma membrane is a primary target of oxygen radicals owing to its vulnerable interfacial position 
between intra- and extra-cellular sources of radicals and because of its high content of peroxidisable
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lipids and proteins (see sections 1.1.5.1 and 1.1.5.2). However, one of these proteins, the NADPH 
oxidase enzyme, is a source of ROS believed to be important in the defence of phagocytes against 
invading pathogens (Babior, Kipnes and Cumutte, 1973).
The NADPH oxidase consists of an electron transport chain containing cytochrome b (Segal and 
Jones, 1978) (which becomes reduced on stimulation of neutrophils), and a 44-45 KD flavoprotein 
which has non-covalently bound FAD as a prosthetic group (Cross and Jones, 1982). Cytochrome b^^ 
is an unusual cytochrome with a very negative redox potential and is localised both in the plasma 
membrane and in the membrane of the specific secretory granules that fuse with the phagocytic vesicle 
soon after ingestion of bacteria (Michell, 1983).
Before phagocytosis can occur, the invading pathogen must be coated with host-derived proteins. Once 
in the vesicle, bacteria are destroyed by exposure to proteases released from cytoplasmic granules and 
from exposure to ROS generated by the phagocyte (Babior, 1978).
The generation of ROS by phagocytes (neutrophils, sensitised monocytes, macrophages and eosinophils) 
is achieved by a resp irato ry  burst. During th is, oxygen uptake is increased and the hexose 
monophosphate shunt metabolises glucose to produce NADPH. Membrane bound NADPH oxidase is 
activated to produce O^-' and H^O^ using NADPH as an electron donor and regenerating NADP* for 
further glucose oxidation (Segal, 1984).
Release of ROS plays a fundamental role in microbial killing and is triggered by perturbations in the 
phagocyte plasma membrane mediated by the Fc region of immunoglobulins (Ig) within immune 
complexes (Weiss and Ward, 1982; Ryan et al., 1990), complement (C) component C5a (Goldstein et 
al., 1975), aggregated IgG (Messner and Jelinek, 1970), the cytokines interleukin (IL) 1 and 6 and 
tumour necrosis factor alpha (TNFof) (Ward, Warren and Johnson, 1988).
Root and Metcalfe (1977), have suggested that 80% of the O^-' generated is converted to H^O  ^by 
dismutation. This can then react to generate the more reactive OH*, but may also diffuse into the 
surrounding environment before doing so.
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Qironic granulomatous disease (CGD), a condition inherited as an autosomal recessive or X-linked trait, 
provides strong evidence for the direct role of oxygen radicals in bacteriocidal and cytotoxic activities of 
phagocytic cells in vivo. The genetic lesion in CGD leads to a failure to phosphorylate the 44-45 KD 
flavoprotein (Segal et al., 1985) or a lack of the cytochrome b (Segal et al., 1983). As a result, 
neutrophils fail to have a respiratory burst following bacterial stimulation and patients suffer from 
recurrent bacterial infections (Johnston and Newman, 1977).
1.1.4.8: Ultra-Violet Irradiation
UV radiation, with a wavelength of 260nm, generates ROS and is strongly absorbed by DNA bases 
(Deering, 1962). This can cause the formation of hydroxylated residues such as thymine glycol 
(Leadon, 1987; Leadon, 1990) or the photochemical fusion of two adjacent pyrimidines into non-pairing 
dimeric structures (Hart, Hall and Daniel, 1978) which have the potential to cause mutations (Lehmaim 
et al., 1977). The DNA of an epithelial skin cell exposed to normal daylight would acquire thousands of 
dimers and base adducts per day were these not removed by repair enzymes (D'Ambrosio et al., 1981; 
Freeman et al., 1987).
Xeroderma pigmentosum, a human skin disease, is caused by a genetic defect in the enzymes that 
remove dimers and other UV-induced lesions (Cleaver, 1968) (see section 1.1.5.4.7). Some patients 
with systemic lupus erythematosus (SLE) also show enhanced sensitivity to UV light demonstrated by a 
characteristic erythematosus butterfly rash on the face, or by a more generalised maculo-papular rash on 
all light-exposed skin (Kochevar, 1985). However, the genetic and/or biochemical lesion responsible 
for this response remains to be identified (see sections 1.2.2.1 and 1.2.6).
These observations suggest that it is as important to repair ROS-induced lesions as it is to restrict their 
formation.
1.1.5: Reaction of ROS with Biomolecules
Reactions of ROS with biomolecules are generally of three types: a) abstraction of a hydrogen or halide 
ion, b) addition to unsaturated bonds (eg. purine and pyrimidine bases and unsaturated lipids) or c) 
electron transfer which may result in production of a secondary radical.
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1.1.5.1: ROS and Lipids
Polyunsaturated fatty acids (PUFA) of membrane lipids are particularly susceptible to oxidative damage 
because their double bonds are usually unconjugated and separated by methylene groups. This leads to a 
lower bond dissociation energy of the methylene C-H bonds and makes the hydrogen more susceptible to 
abstraction by any species that has sufficient reactivity to cleave this bond.
The process of lipid peroxidation can be divided into three phases: initiation, propagation and 
termination (Aust and Svingen, 1982). Initiation involves abstraction of a hydrogen atom resulting in 
formation of a carbon radical.
Initiation: LH + Fe(III) ---- ► L- + Feai) +
In PUFA this tends to be stabilised by a molecular rearrangement producing a conjugated diene which 
reacts rapidly with oxygen to give a hydroperoxy radical.
Propagation: L- + LOO-
LOO- + LH — -► LOOH -I- L-
Propagation of lipid peroxidation may also arise from LOO- reacting with another divinyl methane of 
the same molecule or a different molecule to generate LOOH and L-.
Alternatively transition metal ions can cleave LOOH to reactive LOO-; this can then react with LH, 
thereby exacerbating the reaction by increasing the rate of decomposition of hydroperoxide into the 
chain initiators.
Once initial hydrogen abstraction has occurred, lipid peroxidation is essentially autocatalytic (Logani and 
Davies, 1980) and continues until an antioxidant intervenes eg. vitamin E, or the substrate has been used 
up, ie. no further radical species remain to react (Slater, 1984).
Termination: L- + L- ---- LL
L- +  LOO- ---- ► LOOL
LOO- LOO- LOOL + O.
Lipid peroxidation can be initiated by OH-, alkoxy radicals (RO-) and peroxy radicals (ROO-) but not 
H^O  ^or Oj-' (reviewed by Halliwell and Gutteridge, 1984). The protonated form of O^-', HO^-', whose 
formation is favoured by the environment of non polar membrane interiors, may also attack fatty acids
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directly (Bielski, Arudi and Sutherland, 1983). The role of OH- as an initiator has been questioned due 
to poor inhibition by OH- scavengers. However, it is possible that either membrane-bound metal ions 
generate site-specific radicals inaccessible to scavengers (Czapski, 1984), or that only very small 
amoimts of OH- are needed to initiate lipid peroxidation before other radicals predominate.
Lipid peroxidation may cause decreased fluidity and membrane p>otential, increased permeability to ions 
or in the case of extensive damage, membrane rupture (Fong et al., 1973). Released lipid peroxides 
may be cytotoxic, block macrophage action, inhibit protein synthesis, inactivate enzymes and kill 
bacteria (Slater, 1984). They can also cause site-specific cleavage of double stranded DNA (dsDNA) 
(Inouye, 1984), and production of clastogenic material which reacts with DNA to form chromosome 
aberrations and sister chromatid exchanges (Khan and Emerit, 1985). Recently, evidence for a role of 
circulating lipid hydroperoxides in atherogenesis has been suggested (Carew, Schwenke and Steinberg, 
1987). The process of lipid peroxidation increases both the uptake of low density lipoproteins by 
macrophages, and deposition of these lipid laden foam cells in the arterial intima (Frei, Stocker and 
Ames, 1988). Mechanisms that act to degrade lipid hydroperoxides in human plasma could therefore be 
helpful in the prevention of atherosclerosis.
1.1.5.2; ROS and Proteins
Proteins are major components of both the intracellular and extracellular matrix and are important 
targets for ROS. All levels of the protein structure may be attacked by ROS resulting in fragmentation, 
aggregation, cross-linking and modification of individual amino acid residues.
Cysteine, and the aromatic amino acids tryptophan and tyrosine, with their unsaturated structures, are 
the most sensitive to oxidative attack but other amino acid residues may be altered (Adams et al., 1972). 
For example, histidine residues are often located at metal binding sites of proteins, the metal ions 
(copper in particular) catalysing the production of OH- (Kleinveld et al., 1989).
The biological consequences of amino acid modification are illustrated by ck- I  antitrypsin. Oxidation of a 
critical methionine residue modifies the enzymic activity and biological function of this protein 
(Matheson, Wong and Travis, 1979; Gee, Kittridge and Willson, 1985). Proline is also susceptible to 
attack by ROS and causes fragmentation of proteins such as collagen, following spontaneous hydrolysis
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of these residues after OH- attack (Wolff, Gamer and Dean, 1986).
Aggregation of proteins following ROS attack has been shown in the acute phase protein caeruloplasmin 
(Winyard et a l., 1984), and IgG (Griffiths et a l., 1988a), and is due partly to disulphide bond 
rearrangements and partly to uncharacterised amino acid interactions. Histidine (Verweij, Dubbelman 
and Van Steveninck, 1981), lysine and tyrosine have all been suggested to contribute to protein cross- 
linking.
Oxidation of proteins may cause gross conformational changes and may also affect their hydrophobicity. 
In addition, many proteins are rendered more susceptible to en2ymic hydrolysis (Davies and Lin, 1988) 
and this is likely to be due to structural deformation facilitating access of degradative proteases.
1.1.5.3: ROS and Carbohydrates
Simple monosaccharides can autoxidise under physiological conditions to produce O^-' (Wolff, Crabbe 
and Thoraalley, 1984) and ROS can react with carbohydrate polymers such as hyaluronic acid to cause 
fragmentation (McCord, 1974; Halliwell, 1978b).
Irradiation of carbohydrates (Bucknall et al., 1984) or exposure to Fenton systems (Gutteridge, 1981) 
liberates carbonyl compounds from opening of the ring structure which can react with thiobarbituric acid 
(TEA). Deoxyribose, the sugar in the repeating unit of the DNA backbone, reacts with OH-, and if 
treated under acidic conditions produces malondialdehyde, a mutagenic product which may be detected 
by its ability to react with TEA to form a pink chromogen (Gutteridge, 1981; Gutteridge 1987). The 
anti-tumour antibiotic, bleomycin, also attacks deoxyribose through production of a reactive oxygen 
intermediate (Wu, Kozarich and Stubbe, 1983) and both these processes result in DNA strand breakage.
The distribution o f sugars within a cell, as part of the DNA molecule or as integral components of 
glycoproteins as well as free sugar monomers or polymers is such, that damage to carbohydrate residues 
affects not one but many cellular biomolecules.
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1.1.5.4: ROS and DNA 
1.1.5.4.1; General Aspects
Modifications to DNA by ROS are particularly important in cell development because DNA contains the 
genetic material which encodes for constitutive proteins. Any ROS-induced modifications not deleted 
from the genetic material may become incorporated into germ-line genes and cause mutation, which in 
turn may form proteins with abnormal functions.
DNA is made up of deoxyribonucleotides linked together by phosphodiester bridges. The base moieties 
form an inner core of the molecule surrounded by phosphate and deoxyribose units. Damage to DNA 
by ROS can occur: a) directly as a result of chemical reaction of exogenous or endogenous agents or 
their metabolites with DNA (eg. production of OH- from radiation-induced ionisation of water 
molecules - section 2.4.1) or b) indirectly by secondary intermediates upon interaction with non-DNA 
targets such as interactions of lipid peroxides with DNA (section 1.1.5.1).
Much of the characterisation of DNA damage by ROS has been done by radiation biologists and 
although the doses used do not usually reflect those that are physiologically relevant, identification of 
ROS-induced products by these methods may be used to identify evidence of ROS-induced damage in 
disease situations by modification of sensitivity levels.
1,1.5.4.2: DNA Strand Breaks
Irradiation of DNA in aqueous solution causes single-strand breaks (Rhaese and Freese, 1968), double­
strand breaks, base liberation (Rhaese and Freese, 1968), base damage (Massie, Samis and Baird, 1972) 
and intra- and inter-strand cross-links (Lesko, Drocourt and Yang, 1982), all mediated by the actions of 
ROS.
These changes are mediated predominantly by ionising radiation producing OH- in solution: this reacts 
directly with DNA by hydrogen abstraction from deoxyribose to form a carbon centred radical and a 
direct strand break. Alternatively, OH- can react by addition to the pyrimidine bases forming a base 
adduct which may also result in a strand break. Damage formed by ionising radiation is likely to be 
randomly distributed throughout the DNA structure (Ward, 1981).
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Reaction of with DNA can also produce DNA damage. This reaction requires metal ion catalysis. 
If the metal ions are bound to DNA, the OH- produced will only diffuse a maximum of 1.5 nm before 
reacting (Ward, Blakely and Joner, 1985). This is less than the DNA helix diameter and therefore, the 
majority of OH- produced will react with the DNA in a site-specific manner.
Iron binds firmly to DNA (Mello Filho, Hoffmann and Meneghini, 1984) and copper has an important 
role in stabilising the association between DNA supercoils and the non-histone nuclear matrix 
(Minchenkova and Ivanov, 1967). Several classes of proteins involved in DNA binding or gene 
regulation also contain metal-binding domains (Berg, 1986). H^O^ can react with these metal ions to 
generate OH- (Mello Filho, Hoffmann and Meneghini, 1984) or can reduce the metal ions back to their 
original state (Halliwell and Gutteridge, 1984). The replenished metal ions can then generate further 
radical species, including O^-’ and the perhydroxy radical which also plays a role in DNA nicking.
In the case of Cu'*' complexing with DNA, the interaction is so strong (Ka *  10* M'*) that OH-, 
generated in a Fenton reaction at the copper binding site (possibly G-C base pair regions), reacts site- 
specifically with the DNA, in a reaction not significantly affected by the presence of OH- scavengers 
(Stoewe and Prutz, 1987; Dizdaroglu, Aruoma and Halliwell, 1990).
1.1.5.4.3: Base Damage
Reaction of ROS with DNA, as well as producing strand breaks, can also cause base changes and base 
release. Deoxyguanosine is particularly susceptible to attack by several radical producing drugs. These 
include bleomycin (Halliwell and Gutteridge, 1989 pp 416-508), and cis-platinum which forms an intra- 
strand cross-link between N-7 atoms of adjacent guanosine residues (Pinto and Lippard, 1985). Regions 
of polydeoxyguanosines have also been shown to exert some specificity to the production of OH- by 
H^O  ^and metal ions (Sagripanti and Kraemer, 1989). This has been attributed to the electronegativity 
of deoxyguanosine (Mattes, Hartley and Kohn, 1986) and its ability to bind metal ions (Zimmer and 
Venner, 1970).
One important oxidative product of deoxyguanosine is 8-hydroxydeoxyguanosine (80HDG), formed by 
the addition of OH- to C-8 of the native base (Kasai and Nishimura, 1984a). Other important oxidative 
products of DNA bases include 5-hydroxymethyluracil (Teebor, Frenkel and Goldstein, 1984; Lewis
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and Adams, 1985), thymine dimers (Freeman et al., 1987), thymine glycol (Leadon, 1987; Leadon 
1990), 8-hydroxyadenine (80HA) (Hissung et al., 1981) and 5-hydroxymethylcytosine (Childs, Ellison 
and Pilon, 1983).
1.1.5.4.4: DNA Cross-links
A further type of DNA damage is the production of cross-links. These can be between DNA and 
protein such as the linkages of thymine and lysine induced by OH- (Dizdaroglu and Gajewski, 1989). 
Lysine constitutes a high proportion of the amino acids in histones and helps binding to chromatin. 
Cross-links can also be formed between lipid peroxidation products and DNA (Fujimoto, Neff and 
Frankel, 1984). The nuclear membrane is particularly susceptible since lipid peroxidation products react 
predominantly within the membrane structure. DNA may act to quench the peroxidation reaction by 
reacting with peroxy radicals which in turn generate guanyl radicals, resulting in site-specific cleavage 
of DNA at guanine residues (Inouye, 1984). In addition, reaction of malondialdehyde, a lipid 
peroxidation product, with DNA causes inter-strand cross-links with guanine, cytosine and adenine 
(Brooks and Klamerth, 1968) and DNA-protein cross-links (Summerfield and Tappel, 1984).
1.1.5.4.5: DNA Repair
Although ROS are capable of inducing all these modifications studying the rates of reaction with any one 
species, Massie, Samis and Baird (1972) showed that damage to DNA is inflicted as: base destruction > 
single strand breaks >  double strand breaks >  cross-links. This is related to the half-lives of the 
damage: thymine glycol has a half-life of 7 minutes (Mattera, Hariharan and Cerutti, 1975) when 
compared to 4 minutes for a single strand break (Ward, Blakely and Moberly, 1983) and it is thus more 
likely that a second radical species produced in the vicinity of the first will react with the site of base 
damage.
Any change in DNA induced by ROS has the potential to be mutagenic if it is not correctly repaired. 
The ability of cells to recover from ROS-induced damage to DNA has provided information regarding 
the lethality of certain DNA lesions. Singly damaged sites are unlikely to affect the cell if efficient 
repair can take place (Cantoni, Murray and Meyn, 1986). With the undamaged strand of the double- 
stranded DNA acting as a template if base insertion is needed, the fidelity of the genetic code can be 
maintained. However, lesions present on both DNA strands in a local region cause more problems for
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cellular repair. In addition, all double strand breaks are not equally lethal. Those with constituent 
single strand breaks directly opposite are more lethal than those which are offset (Ward, 1988).
A key enzyme in the repair of DNA strand breaks is ADP ribosyl transferase (ADPRT) (Purnell, Stone 
and Whish, 1980). Strand breaks are a cofactor for ADPRT (Benjamin and Gill, 1980) which has a role 
in excision repair, especially at the ligation step. ADPRT uses NAD'*' to catalyse the repair of strand 
breaks. If there are sufficient strand breaks to deplete the cell of its supplies of NAD^ (which at the 
same time depletes ATP stores), the cell dies (Schraufstitter et al., 1985; Schraufstatter et al., 1986).
Modified bases are removed from DNA by repair enzymes if they are recognised by the cell as foreign. 
Specific glycosylases have been identified which remove 5-hydroxymethyluraciI (Hollstein et al., 1984; 
Boorstein, Levy and Teebor, 1987) and 5- hydroxymethylcytosine (Cannon, Cummings and Teebor, 
1988) from DNA.
Any damage to DNA induced by ROS is strongly influenced by the surrounding environment. 
Irradiation of DNA initially produces thymine T-' and guanine G-"*^  radicals which are the precursors to 
single and double strand breaks. However, localised protein, contained in complexed histones, can 
increase the production of T-' by electron transfer and thus enhances the production of strand breaks 
(Cullisetal., 1987).
1,1.5.4.6: Cellular DNA Damage
Cellular DNA is packaged into the nucleus and is separated from extracellularly produced ROS by 
plasma and nuclear membranes. H^O^ is lipophilic and can diffuse through lipid bilayers and can react 
with DNA (Allan et al., 1988). However, it can also react with the membrane components to produce 
secondary products. This mechanism is proposed to explain the generation of clastogenic factors 
(Emerit and Michelson, 1980). Clastogenic factors are produced during chronic inflammation and are 
also observed as an indirect effect of ionising radiation (Hollowell and Littlefield, 1968). They are 
characterised as low molecular weight peroxidation products (<10,000 Da) and their appearance in cells 
correlates with increased DNA damage (Emerit and Cerutti, 1982). Several lipid peroxidation products 
have been characterised and malondialdehyde is known to be both clastogenic and mutagenic (Petkau, 
1980).
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DNA from normal cells incubated with clastogenic factors in vitro undergoes chromosome breakage and 
rearrangements, such as sister chromatid exchanges (Emerit and Michelson, 1980); this transferable 
property of clastogenic factors rules out a short lived radical species and may contribute to both the 
persistence of DNA damaging agents and to the distance over which the damage is done. Inhibition of 
arachidonic acid metabolism reduces the effects of clastogenic factors and is further evidence for the 
involvement of lipid peroxidation products in DNA damage {Emerit, Levy and Cerutti, 1983).
1.1.5.4.7: DNA Damage in Disease
The importance of DNA damage and more importantly its repair is illustrated in several disease states. 
Patients with xeroderma pigmentosum have increased sensitivity to UV light correlated with an inability 
to excise UV-induced DNA damage or to seal daughter strand gaps left after DNA synthesis on a 
damaged template (Cleaver, 1968). Cockayne syndrome is also characterised by severe photosensitivity 
as well as skeletal and retinal abnormalities; patients have an increased sensitivity to UV irradiation and 
increased levels of sister chromatid exchanges (Guzzetta, 1972). The defect identified in these patients 
is not an inability to remove pyrimidine dimers but an inability to repair transcriptionally active DNA at 
a rate faster than other DNA (Venema et al., 1990). Bloom's syndrome is associated with a high 
incidence of cancer (Bloom, 1966; German and Passarge, 1989) and cells show an elevated frequency of 
sister chromatid exchanges (Latt et al., 1983) and genomic instability (German, 1983). An elevated 
level of O^-' has been shown to produce increased DNA damage and lipid peroxidation, and this 
increased oxidative stress is a likely explanation for the cancer prone phenotype of Bloom's syndrome 
(Emerit and Cerutti, 1981).
Fanconi's anaemia is another disease associated with an increased rate of spontaneous mutation arising 
from chromosomal instability and may be due to a defect in the DNA repair enzyme DNA ligase 
(Hirsch-Kauffmann et al., 1978; Schroeder, 1982). However, Porfirio et al., (1989) have shown that 
desferrioxamine can exert a partial correction of chromosome instability which suggests that free radical 
formation and processing in the cells are crucial events in the development of Fanconi's anaemia.
Repair of DNA damage has also been investigated in autoimmune diseases which appear to associate 
with a higher incidence of malignancy than normal age and sex matched controls (Louie and Schwartz, 
1978). In SLE it was found that there is defective repair of the adduct 0®-methylguanine (Harris et al.,
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1982) , a potent premutagenic DNA base, resulting in its accumulation in lymphocytes. This defective 
repair mechanism could account for the associated malignancy in this disease (see section 4.2.1).
1.1.6: Defence Against ROS-Induced Damage
Several defence mechanisms have evolved to protect the cell against ROS produced during normal 
oxidative metabolism. These mechanisms rely on either enzymatic breakdown of the reactive species or 
non-specific scavenging to limit their deleterious effects.
The ability of SOD to degrade O^-' enzymatically has been described in section 1.1.2.1, and this enzyme 
is very effective at physiological pH. This is exemplified by the maintenance of intracellular O ^  '  
concentrations at 10"“  M (Freeman and Crapo, 1982). Two different SOD enzymes are found in the 
cell: the cytosolic enzyme has binding sites for copper and zinc (CuZn SOD) whilst the mitochondrial 
enzyme contains manganese (Mn SOD). Extracellular concentrations of SOD are very low (McCord, 
1974) but it has been suggested that extracellularly generated O ^  '  may enter cells via an anion channel 
and become inactivated intracellularly (Lynch and Fridovich, 1978). Red blood cells, which contain 10' 
 ^M SOD, may act in this way to limit the damage caused by ROS released by activated neutrophils, 
plasma having little SOD activity (McCord, 1974). Whilst SOD acts to protect the cell against the 
actions of O^-', SOD itself becomes inactivated by the product of its reaction, H^O  ^(Blech and Borders,
1983) . Oxidative inactivation of SOD by H^O  ^ generates a modified protein, which is recognised and 
selectively degraded by an intracellular proteolytic pathway, and free OH-, which may account for the 
biological damage associated with elevated intracellular SOD activity (Yim, Chock and Stadtman, 
1990). The mechanism of inactivation comprises oxidative modification of a histidine residue important 
in copper binding (Salo et al., 1990).
SOD is constitutively expressed in leukocytes and other tissues and levels vary little with increasing age 
(Niwa, et a l., 1989). However, the significant induction of SOD activity by agents increasing 
intracellular 0^-‘ concentrations is reduced in the elderly and may play a role in development of 
malignancy (Niwa, Ishimoto and Kanoh, 1990).
Catalase, a ferriprotoporphyrin enzyme catalyses the breakdown of H^O^. This enzyme is only effective 
at removing H^O^ when its levels are elevated by endogenous or exogenous metabolites. Removal of
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low concentrations of produced during normal metabolism, and maintenance of an intracellular 
concentration of of 10’*-10'*M (Boveris and Chance, 1973) is regulated by glutathione peroxidase. 
This enzyme is found in both the cytoplasm and mitochondria (Freeman and Crapo, 1982) whilst 
catalase is found predominantly in peroxisomes (Boveris and Chance, 1973). As for SOD, extracellular 
levels of catalase are very low.
Glutathione peroxidase also catalyses the degradation of lipid hydroperoxides and DNA hydroperoxides:
15 2GSH + ---- ► GSSG + 2H^O
16 2GSH + LOOK ---- ► GSSG + LOH + H O
2
Glutathione peroxidase is found in low concentration in the nucleus. In this organelle glutathione 
transferases may be important alternatives in the degradation of organic hydroperoxides (Ketterer and 
Meyer, 1989), having been shown to reduce the level of peroxidised lipids in vitro (Tan et al., 1984) 
and peroxidised DNA in the nucleus (Tan et al., 1988). Glutathione (GSH) is the most important non­
protein thiol in mammalian cells and becomes oxidised to replenish SH groups on functional proteins 
that have themselves become oxidised. Glutathione reductase converts oxidised glutathione (GSSG) 
back to its reduced form at the expense of NADPH. Thus, glutathione peroxidase activity shifts the 
major, soluble redox active cofactors from a predominantly reduced state to a predominantly oxidised 
state, GSH to GSSG and NAD(P)H to NADfP)''’. An increase in GSSG is also paralleled by an increase 
in oxidised protein-bound thiols, largely because GSSG can react with protein-bound thiols to form 
glutathione mixed disulphides (Farber, Kyle and Coleman, 1990). These changes in both soluble and 
protein-bound thiols are accompanied by a release into the cytosol of sequestered stores of calcium 
(Bellomo, Thor and Orrenius, 1984) which may also cause oxidation of pyrimidine nucleotides and 
changes in cell regulation thus mediating cell injury associated with acute oxidative stress (Bellomo and 
Orrenius, 1985).
The high reactivity of OH- precludes enzymic removal; prevention of damage by OH- occurs by 
scavenging the radical itself. Thiols of high (albumin) and low (cysteine) molecular weight scavenge 
OH-. Albumin also binds Cu '^*' and decreases the formation of OH- in free solution at the expense of 
ROS damage to the protein site-specifically (Rowley and Halliwell, 1983b; Marx and Chevion, 1985). 
Thiol compounds also have an important protective role as donators of H-. When reacting with DNA, 
OH- reacts with both sugar and base molecules, the reaction with the sugar involving hydrogen
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abstraction. Donation of H- from a thiol results in true regeneration of the original molecule. 
However, the reaction of OH- with DNA bases is predominantly by addition, so H- donation by a thiol 
does not restore the original base (Ward, 1983). Since it is damage to the sugar rather than damage to a 
base that is most likely to result in the formation of a strand break (Ward, 1975), thiols appear to protect 
DNA predominantly from strand breaks.
Ascorbic acid scavenges both OH- and O^-’ when it is present at high concentrations (>  O.SmM) 
forming an ascorbate free radical which disproportionates to form AA and dehydroascorbic acid (Rose, 
1990). AA scavenges O^-' at 1/3 the rate of SOD (Blake et al., 1984). However, AA can also act as a 
pro-oxidant when present at concentrations < 20/iM (Johnson, 1979) reducing iron to the ferrous form 
for participation in the Fenton reaction.
Caeruloplasmin can also scavenge O -^’ but is only 1/3000 as effective as SOD (Goldstein et al., 1979). 
It is a major serum anti-oxidant and as an acute phase protein its concentration is increased during 
inflammation when there is an increase in radical production. It is also important for its ability to 
oxidise Fe '^*' to Fe^"'' reducing the availability of iron to participate in the Fenton reaction and favouring 
the storage of Fe^ '*’ by ferritin (Gutteridge and Stocks, 1981).
Uric acid, the end product of purine metabolism in mammals, is also a free-radical scavenger and 
important biological antioxidant. It has high reactivity with ROS and exists in high concentrations in 
biological fluids. Further, it can also complex iron and therefore inhibit the Fenton reaction (reaction 6) 
(Hochstein, Hatch and Sevanian, 1984).
Vitamin E is the major lipid soluble anti-oxidant reacting with O^-', OH- and lipid peroxides (Packer, 
Slater and W illson, 1979). As a membrane soluble vitamin it can inhibit lipid peroxidation by 
scavenging peroxy and alkoxy radicals so breaking the chain reaction (Redpath and Willson, 1973).
These reactions aim to minimise the damage caused by ROS under normal metabolic conditions. 
However, during p>eriods of increased oxidative stress or when defence mechanisms are impaired these 
processes may become overwhelmed and damage to cellular molecules will occur.
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1.1.7: ROS and Tissue Damage
Most if not all tissues may suffer damage from ischaemia/reperfusion events. During ischaemia (ie. 
poor oxygenation of tissue) ATP levels fall, xanthine accumulates and calcium activates the protease, 
calpain, to cleave a bond in the enzyme xanthine dehydrogenase forming xanthine oxidase (McCord, 
1985). Upon reperfusion of this ischaemic tissue, damage occurs when xanthine oxidase degrades the 
accumulated xanthine thus producing high levels of O^*'. The levels of O^-' produced are sufficient to 
inactivate enzym es and follow ing injury to the brain for example, glutamine synthetase is 
inactivated causing increased levels of L-glutamate, which may be important in the inflicted 
neurotoxicity following ischaemia/reperfusion events (Oliver et al., 1990).
Inflammation is also associated with considerable tissue injury. Phagocytic cells can be stimulated by 
bacterial or immunological stimuli, and the NADPH oxidase activated, to produce ROS (see section 
1.1.4.7). Bacterial stimulation of macrophages releases ILl and TNF, cytokines that act on many cells 
and have a variety of pro-inflammatory effects (Ward, Warren and Johnson, 1988). For example ILl 
and TNF both directly initiate oxidant production by phagocytes and prime macrophages (Warren et al., 
1988) and neutrophils (Berkow et al., 1987) for enhanced O^-' responses in the presence of IgG immune 
complexes. They also cause non-cytotoxic modification of endothelial cells on contact, enhancing the 
susceptibility of these cells to ROS-mediated damage (Pober et al., 1986).
Immune complexes also stimulate neutrophils to release ROS and proteases in a complement mediated 
process (Weiss and Ward, 1982; Ryan et al., 1990). Deposition of immune complexes causes 
complement activation and the generation of C5a, a chemotactic factor needed for recruitment of 
neutrophils from the vascular compartment. ROS released from activated neutrophils subsequently 
causes the release of epithelial and endothelial cells from basement membranes which contributes to 
tissue injury (Ward PA et al., 1987). For example, in nephritis, immune complex-mediated tissue 
injury causes release o f these cells from the glomerular basement membrane which results in 
permeability defects in the kidney (Harlan et al., 1981).
During the inflammatory response many cell types can contribute to tissue injury and platelets 
accumulating in the vascular lumen also accentuate the response of neutrophils to produce O^ -" (Ward 
PA etal., 1987).
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The effects of tissue damage may, however, result in cells increasing their defence against oxidative 
stress (Brown et al., 1990). Pretreatment of cells with ILl can induce mRNA for SOD (Wong and 
Goeddel, 1988), and TNF primes granulocytes, enhancing O^-' released by a second stimulus (Berkow 
et al., 1987) such that an early oxidant stress may decrease the effects of a subsequent oxidant insult by 
increasing the levels of endogenous antioxidants and perhaps influencing other defence mechanisms also.
ROS have not only been associated with tissue injury but also in the pathogenesis of certain disease 
processes. A well studied example is the chronic inflammatory disorder, rheumatoid arthritis (RA).
ROS, thought to originate from activated phagocytes in the inflamed joint, can cause destruction of 
cartilage (Dean, Roberts and Fomi, 1984), decrease the de novo synthesis of cartilage-proteoglycan 
(SchaUcwijk et al., 1985), peroxidise cell membranes (Lunec et al., 1981), depolymerise hyaluronic acid 
(Greenwald and Moy, 1980) and attack proteins (Blake et al., 1986). Protein modification by ROS in 
RA may have particular relevance since most patients possess serum antibodies directed against their 
own IgG (known as rheumatoid factors). It has been suggested that the IgG has been altered, possibly 
by ROS, thus acquiring antigenicity (Lunec, Griffiths and Brailsford, 1988).
In vitro, ROS can modify IgG, inducing fluorescent changes (Wickens et al., 1983), an increased thiol 
group content (Kleinveld et al., 1986), and changes in constituent amino acids (Griffiths et al., 1988b). 
Further, ROS-altered IgG has been shown to have an increased binding to serum rheumatoid factors 
(Lunec et al., 1986; Griffiths and Lunec, 1988; Swaak et al., 1989).
Although the role of ROS in the pathogenesis of RA is not definitive, the tissue damage caused by 
increased ROS production highlights the need to control carefully reactions involving or producing ROS.
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CHAPTER 1.2; SYSTENHC LUPUS ERYTHEMATOSUS 
1.2.1: General Aspects
Systemic lupus erythematosus (SLE) is a chronic inflammatory connective tissue disorder which affects 
many organs of the body and is characterised by the presence of antibodies against nuclear components 
(anti-nuclear antibodies - ANAs), particularly against dsDNA.
It affects approximately 0.1% of the population and is more common in coloured races, with an overall 
prevalence of approximately 1 in 700 women increasing to 1 in 250 amongst black women in the USA. 
It is about nine times more common in young women than men with a peak incidence between 20 and 40 
years of age.
SLE is extremely variable in its clinical manifestations, many of which appear to be due to the 
consequences of a widespread vasculitis affecting capillaries, arterioles and venules. There are general 
features such as fever and malaise which are very common, particularly during exacerbations of the 
disease. Rashes occur in »80%  of patients, the characteristic erythematosus butterfly rash being 
evident in =50% . Skin lesions have a predilection for sun exposed areas and there is marked 
photosensitivity in one third of patients. Polyarthralgia is one of the commonest features occurring in 
= 90% of patients and is frequently the first manifestation of the disease. Although the joints are 
painful, radiological erosions typical of RA are rarely seen. An important manifestation of SLE is 
nephritis, which occurrs in =  50 % of patients and contributes to most of the deaths due to SLE (Dubois 
et al., 1974; Rosner et al., 1982). Mild to moderate proteinuria is the most common presenting feature 
of lupus nephritis and is usually associated with serological abnormalities indicative of immune complex 
formation such as low serum complement levels. The glomerular damage typical of SLE is associated 
with granular deposits of immunoglobulin and complement which accumulate in the capillary walls. 
Other manifestations of this multisystem disease include involvement of the lungs (50% - pleural 
effusion, pneumonitis), the heart (40% - pericarditis, myocarditis, endocarditis), the central nervous 
system (60 %) and the blood (75 % - anaemia, leucopenia and thrombocytopenia)
The systemic nature of SLE was first described by Kaposi in 1872 and the disease was thought of as a 
frequently fulminating, progressive and fatal condition. Today, sensitive serological techniques allow
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diagnosis of milder forms of the disease displaying a broader clinical spectrum than was once thought. 
In most cases the disease pursues a chronic unpredictable course in which episodes of activity are 
interrupted by periods of clinical remission (Dieppe et al., 1985).
1.2.2: Aetiology
The aetiology of SLE is unknown. It is thought that a combination of environmental, genetic and 
immunological factors are involved predisposing to polyclonal B cell activation, production of anti­
nuclear and other autoantibodies and impaired T cell regulation.
1.2.2.1: Environmental Factors
Environmental factors which contribute to the development of SLE include infection, exposure to 
sunlight and drugs.
The hypothesis that SLE may be due to a defective host response to an exogenous infectious agent (eg. 
viral) has been suggested. The mechanism of action of viruses may involve: selective inactivation of 
suppressor lymphocytes thereby allowing proliferation of autoreactive B cell clones, selective infection 
of autoreactive B cells thereby stimulating their continued proliferation or transformation of B cells 
already reacting with an unrelated antigen (Denman, 1981). In addition, retroviruses have been 
implicated in mouse models of lupus (Mountz and Steinberg, 1989). However, there is no conclusive 
evidence for persistent viral infection, and attempts to isolate type C virus from human SLE tissues have 
been unsuccessful.
Despite this, a correlation between autoimmune diseases and the expression of cellular oncogenes 
(Mountz et al., 1984) and retroviral genes (Krieg, Khan and Steinberg, 1988) has been shown but it is 
again not clear whether abnormal expression of these genes leads to autoimmune disease or predi.sposes 
to it.
SLE is exacerbated by exposure to sunlight in 30% of cases (reviewed by Kochevar, 1985). UV light 
causes specific denaturation of DNA with the formation of antigenic thymine dimers, the implications of 
which are discussed in section 1.2.6.
Certain drugs, notably hydralazine and procainamide can cause drug-induced SLE (Hess, 1988). Drug
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induced lupus occurs more readily in slow acetylators, and hydralazine-induced lupus shows a close 
association with the major histocompatibility complex (MHC)-related antigen, HLA DR4 (see section 
1.2.2.2). It is more common in the elderly and the clinical picture is very similar to idiopathic SLE in 
this age group, with manifestations involving predominantly the joints, heart and lungs but rarely renal 
complications. ANAs are present in high titres and react predominantly with histones. Anti-dsDNA 
antibodies common in idiopathic SLE are rarely seen in drug-induced lupus and serum complement 
levels usually remain normal. In addition, withdrawal of the drug usually results in rapid recovery 
although ANAs may persist for several months (Dieppe et al., 1985).
1.2.2.2: Genetic Factors
About 10% of patients with SLE have one or more first or second degree relatives with the same disease 
but data from studies on identical twins shows that only 15% of monozygotic twins are concordant for 
SLE (Fessel, 1988). Susceptibility to SLE is determined in part by genes located within the MHC and 
associations between disease and polymorphic markers of HLA DR and C-4 loci in particular have been 
shown.
In Caucasians there is an increased frequency of SLE patients possessing either HLA DR2 or HLA DR3 
compared to healthy controls (Reinertsen et al., 1978). There is also an association between SLE and a 
deficiency of complement components suggesting that the complement deficiency state might predispose 
to SLE (reviewed by Steinberg and Klinman, 1988).
C4a binds to immune complexes (Law, Dodds and Porter, 1984) to prevent their precipitation in 
membranes and the deficiency of C4a found in 11 % of SLE patients may interfere with normal 
clearance of immune complexes and their solubilisation (Schifferli et al., 1986). Further abnormalities 
in immune complex clearance arise from a deficiency of the CRl receptor (Theofilopoulos and Dixon, 
1981) found on erythrocytes that binds C3b and C4b. CRl binds to immune complexes consisting of 
antigen-antibody-complement and transports them to the reticuloendothelial system of the liver and 
spleen where they are eliminated. Decreased levels of CRl receptor have been found to correlate 
closely with disease activity (Ross et al., 1985).
A lupus-like disease also occurs in 40% of patients with an inherited homozygous deficiency of the
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complement component C2 (Fessel, 1988). The disease has a lower incidence of renal complications 
and a low prevalence of antibodies to native dsDNA.
However, despite the close association of complement defects with SLE, most individuals with 
complement deficiencies do not develop SLE. This suggests that complement deficiencies are likely to 
be just one aspect of a multifactorial disorder.
The production of particular autoantibodies in SLE has also been suggested to be associated with MHC 
antigens. Autoantibodies to native DNA, especially those found in SLE patients with renal involvement, 
have been suggested to be associated with DR2 and DQwl (Alvarellos et al., 1983), or DQw6 (Fronek 
e ta l., 1988), but this has been disputed by other investigators (Reveille et al., 1989). The role of the 
MHC in the autoantibody response in SLE is still unclear.
1.2.2.3: Immunological Factors
Patients with SLE have several abnormalities of the immune system. It is thought that some are inherent 
to the disease process whilst others may occur as a consequence of the disease and therefore are found 
esp>ecially or entirely during periods of disease exacerbations.
The overproduction of antibodies reactive with nuclear determinants (eg. DNA), cytoplasmic proteins 
and cell membrane molecules is characteristic of SLE (Stollar, 1981). These autoantibodies are 
involved in several pathogenic processes including the development of glomerulonephritis and vasculitis. 
During periods of active disease, patients have increased numbers of activated B cells (Tan et al., 1980) 
resulting in increased immunoglobulin secretion (Blaese, Grayson and Steinberg, 1980).
Not all patients develop high levels of the same autoantibodies; some have increased anti-DNA 
antibodies, others increased anti-cardiolipin antibodies while still others develop a generalised 
hypergammaglobulinaemia without apparent antigenic bias (Harley and Gaither, 1988). The 
hypergammaglobulinaemia seen in SLE is characterised predominantly by antibodies of theIgG class 
(Talal, 1976).
The increase in activated B cells in SLE is accompanied by an absolute reduction in the number of
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circulating T cells (Messner, Lindstrom and Williams, 1973). This may be partly due to the presence of 
anti-lymphocyte antibodies, including autoantibodies directed against various T cell subsets (Litvin, 
Cohen and Winfield, 1983). There appears to be a specific reduction in the numbers and activity of 
suppressor T cells which is suggested to be an important mechanism underlying B-cell hyperactivity and 
the production of multiple autoantibodies (Talal, 1976). However, suppressor cell defects are not found 
in all patients (Theofilopoulos and Dixon, 1985) whilst they are found in some clinically healthy family 
members o f  SLE patients (M iller and Schwartz, 1979). This suggests that suppressor T cell 
abnormalities are not sufficient to induce SLE.
Helper T cells and T helper cell-derived lymphokines also appear to play a central role in the 
pathogenesis o f SLE possibly through their regulatory role on B cell function (Wofsy, 1986). In mice 
models o f the disease, treatment with antibodies to helper T cells can reverse established renal disease 
and extend survival (Wofsy and Seaman, 1987).
1.2.3: Autoantibodies
Whilst the diagnosis of SLE is associated with a variety of autoantibodies, the connection between these 
and the clinical manifestations of the disease remains unclear. For example, anti-dsDNA antibodies are 
highly specific for SLE and are detected at a high frequency (75-95 % )  in untreated patients with active 
disease (Levine and Stollar, 1968). They are generally claimed to correlate with disease activity, 
especially in patients with renal involvement (Stollar, 1981). This may associate with their ability to 
form immune complexes with DNA which play an important role in the pathogenesis of lupus nephritis 
(see section 1.2.5).
The detection of IgG anticardiolipin antibodies also seems to be associated with particular disease 
manifestations, particularly thrombosis, recurrent foetal loss and thrombocytopaenia (Harris et al., 
1986). Patients with these antibodies tend to have a mild form of SLE. They do not have high levels of 
circulating anti-dsDNA antibodies or the associated renal complications (Ishii et al., 1990).
Antibodies to histone proteins are also found in patients with SLE and drug-induced lupus, and have 
been shown to correlate with severity of disease, particularly lupus nephritis (Kohda et al., 1989; 
Gompertz, Isenberg and Turner, 1990).
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In addition to anti-dsDNA, anti-histone and anti-cardiolipin antibodies other antibodies commonly found 
in SLE patients bind single stranded DNA (ssDNA), RNA, other nuclear antigens such as Sm, RNP, 
and the non-histone chromatin proteins, phospholipids, cell surface antigens and cytoskeletal proteins.
1.2.4: Anti-DNA Antibodies
Antibodies to DNA are the best studied of all the autoantibodies found in SLE (Casperson and Voss, 
1983; Stollar and Schwartz, 1986; Isenberg and Shoenfeld, 1987). Anti-DNA antibodies are generally 
classified as either specific for ssDNA, reactive with both ssDNA and dsDNA or specific for dsDNA 
(Arana and Seligmann, 1967; Stollar, 1979). Anti-dsDNA antibodies are a characteristic feature of SLE 
whilst anti-ssDNA antibodies are found in many rheumatic disorders (Harley and Gaither, 1988).
Whilst anti-dsDNA antibodies are known to participate in immune complex formation, their relevance to 
the clinical expression of SLE is perplexing because of the clinical diversity among patients who share 
identical autoantibody profiles.
Antibodies reacting with native dsDNA recognise specific determinants on the deoxyribose-phosphate 
backbone not expressed on ssDNA (Steinman, Deesomchok and Spiera, 1976; Stollar and Papalian, 
1980); the native helical DNA structure has its bases inaccessibly directed inward, surrounded by this 
protective deoxyribose-phosphate backbone. The repeating units of nucleosides and the regular turns of 
the helix increase the binding avidity of the antibodies due to the repeating nature of the antigenic 
determinants (Eilat, 1986).
Antibodies recognising purine or pyrimidine bases, or base sequences react only with denatured DNA 
(Stollar, 1973). This is because the anti-DNA antibodies can only react with DNA when the base-paired 
double helical structure has been disrupted by heat or by chemical denaturants which expose the base 
residues.
Antibodies which react with helical regions of ssDNA as well as dsDNA determinants (Stollar and 
Papalian, 1980) also show remarkable cross-reactivity with molecules other than polynucleotides, 
presumably by virtue of the antigenic determinant being expressed on the sugar-phosphate backbone.
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The phospholipid cardiolipin, has a backbone containing phosphate esters, separated by three carbon 
atoms, that may mimic the DNA backbone (Schwartz and Stollar, 1985). It has been suggested that 
several other compounds such as vimentin (Geisler and Weber, 1982) and platelets (Shoenfeld et al., 
1983) can function as antigenic targets for anti-DNA antibodies, their structures containing repeating 
negatively charged groups.
Antibodies to DNA found in the circulation are, themselves, very heterogeneous in their 
immunoglobulin class, complement fixing ability, functional activity and the tendency to bind bivalently 
to one antigen molecule (Sontheimer and Gilliam, 1978). They also appear to differ in their 
pathogenicity (Hahn, 1982). High levels of IgG antibodies are more specific for SLE and are more 
closely related to renal complications than IgM antibodies (Rothfield and Stollar, 1967). Antibodies of 
the IgA class may also associate with active nephritis (Gripenberg and Helve, 1986). Antibodies 
reacting with dsDNA are thought to be more pathogenic than those reacting with ssDNA (common in 
other autoimmune diseases). This is based on the observations that there is a relative specificity for anti- 
dsDNA antibodies in SLE nephritis (Stollar, 1981), a slow dissociation rate between anti-DNA 
antibodies and dsDNA (Taylor et al., 1979) and a preferential reaction of IgG anti-DNA antibodies, 
eluted from glomeruli of SLE patients, with dsDNA (Mmiter, Stollar and Agnello, 1979).
The mechanism underlying the production of antibodies reactive with DNA is unclear. One theory 
proposes that autoantibody production in SLE is induced and perpetuated by immunisation with an 
autoantigen or an antigen cross-reactive with self (Eilat, 1985). DNA is inherently a very poor 
immunogen in its native state although it becomes more immunogenic after modification (Schwartz and 
Stollar, 1985). Nucleic acids altered during cell disintegration or by chemical or physical factors may 
induce an antigenic response. However, it has not been possible to induce SLE-like disease in animal 
models by immunisation with native DNA (Madaio et al., 1984). Furthermore, whilst modified DNA 
is more immunogenic, the altered nucleic acids tend only to induce antibodies that are highly specific for 
the particular modification rather than antibodies with polyreactivity to native dsDNA (Stollar, 1975). 
Tan and Stoughton (1969) were able to show that native DNA irradiated with UV light was 
immunogenic and although producing antibodies primarily against the modified UV-irradiated DNA, 
low concentrations of antibodies with specificity for native DNA could be induced.
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In view of the little evidence supporting DNA as the eliciting antigen in the production of anti-DNA 
antibodies (Schwartz and Stollar, 1985; Isenberg and Shoenfeld, 1987), attention has been diverted to 
the possibility that other factors are responsible for driving their production. Diamond and Scharff 
(1984) showed that a mutation in the gene of the myeloma protein S107 (glutamine 35 replaced by 
alanine), led to a loss of the antibody's phosphorylcholine-binding activity and a gain in its ability to 
bind to DNA and cardiolipin, and have suggested that autoantibodies may arise by mutation of genes 
that encode antibodies against bacterial antigens. Alternatively, Naparsteket al., (1986) hypothesised 
that autoantibodies characteristic of SLE might be a subset of antibodies encoded by unmutated germ­
line genes.
Another theory proposes that autoantibodies in SLE arise from polyclonal B cell activation (Klinman and 
Steinberg, 1987). Epitopes on non-nucleic acid structures can activate a large family of B cells, some of 
which form antibodies that can cross-react with nucleic acids. It is thought that the disordered immune 
regulation described previously (section 1.2.2.3) allows the spontaneous activation of B cells.
Although the mechanism for the production of autoantibodies remains to be elucidated, it is now thought 
that both antigen-driven and polyclonal B cell activation mechanisms contribute to anti-DNA antibody 
production in SLE. Low affinity IgM autoantibodies appear to arise as a consequence of polyclonal B 
cell activation (Levinson et al., 1987; Sanz and Capra, 1988) whilst high affinity IgG autoantibodies 
appear to be antigen-driven (Nakamura et al., 1988; Shlomchik et al., 1990).
However, for DNA to participate in an antigen-driven response the DNA must be not only immunogenic 
in nature but must also be available as an antigen for presentation to antibody producing cells.
1.2.5: Immune Complexes
Circulating immune complexes represent a normal and effective immunological effector mechanism for 
antigenic clearance (Contreras et al., 1982). Complement facilitates the solubilisation of these 
complexes by contributing the fragments C3b and C3d to the complex. These bind to receptors on 
phagocytic cells and facilitate antigen degradation.
There is abundant evidence that circulating DNA/anti-DNA antibody complexes are detectable in the
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serum or plasma of patients with SLE (Bruneau and Benveniste, 1979; Adu, Dobson and Williams, 
1981), and in those with associated nephritis DNA has been found in the diseased glomeruli (Koffler, 
Schur and Kunkel, 1967). IgG antibodies to DNA have also been eluted from kidneys of patients with 
SLE implying that DNA/anti-DNA complexes are present in these organs (Winfield, Faiferman and 
Koffler, 1977).
Attempts to isolate DNA from circulating immune complexes have led to differences in the sizes of 
fragments obtained. Adu, Dobson and Williams (1981) showed that both DNA and anti-DNA antibodies 
could be found in some but not all immune complexes in patients with SLE nephritis and demonstrated 
the ability of these complexes to activate complement in vitro. Activation of complement in vivo by 
such immune complexes may contribute to the tissue damage seen in SLE (Adu and Williams, 1984). 
Bruneau and Benveniste (1979) characterised the DNA isolated from immune complexes as being of low 
molecular weight and the corresponding antibodies of the IgG isotype were specific for native DNA. 
Ikebe, Gupta and Tan (1983) also isolated dsDNA from immune complexes of four different sizes in 
both normal and SLE sera, the larger fragments of 150-240 bp and 370-470 bp most notable in the SLE 
patients. Sano and Morimoto (1981) confirmed the presence of low molecular weight fragments but 
Contreras et al., (1987) showed that DNA of 17-20 kb could be detected in immune complexes isolated 
by cryoprecipitation. The DNA was found to have significant homology with human genomic DNA, 
supporting the work of Steinman (1984), and suggesting that the circulating DNA is derived from, and 
composed of, sequences repeated in the human genome. The view that plasma derived DNA has a 
cellular origin was confirmed by Rumore and Steinman (1990) who characterised the DNA as largely 
double-stranded but with single-stranded regions containing nucleotide base sequences, present in the 
human genome and sim ilar to oligonucleosomes, the structural units of chromatin. Further 
characterisation of the DNA by these workers showed that it formed a series of multimeric complexes, 
at least a portion of which are bound noncovalently to histone and thus protected from nuclease 
degradation.
One explanation for the differences in size of DNA isolated from the serum or plasma of SLE patients is 
that the smaller fragments of DNA isolated may in fact be degradation products of an immunogenic 
form of DNA generated during clearance of the molecule.
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Injection of experimental animals with high molecular weight DNA leads to its rapid elimination from 
the circulation either via liver-mediated clearance of ssDNA or via degradation by serum and/or tissue 
nucleases (Emlen and Mannik, 1984). Persistence of DNA in the circulation of patients with SLE may 
arise because the DNA is predominantly complexed to antibodies and associated DNA binding proteins, 
and thus protected from the action of nucleases such as DNase. Emlen, Ansari and Burdick (1984) 
demonstrated protection of DNA from DNase digestion but found that the DNA was most effectively 
protected by bivalent F(ab')j fragments and was only 35-45 bp in size. These small lattice immune 
complexes would be unlikely to fix complement or deposit in tissues (Haakenstad and Mannik, 1974). 
However, experim ents were not done in antibody excess, which would lead to larger, more 
pathogenically relevant immune complexes in vivo. The size and strandedness of the circulating DNA 
does alter the clearance kinetics and mechanisms (Emlen and Mannik, 1984). dsDNA remains in the 
circulation longer than ssDNA and its clearance is therefore more susceptible to variations in serum 
nuclease levels and has an increased chance of binding to circulating antibodies and specific tissues such 
as the glomerular basement membrane (Izui, Lambert and Miescher, 1976). The competition of anti- 
DNA antibodies with nucleases may inhibit enzymic digestion of the DNA and cause its persistence in 
the circulation. In addition it has been shown that there is decreased activity of circulating nucleases in 
SLE patients which would also contribute to a prolonged presence of DNA, particularly dsDNA in the 
circulation (Frost and Lachmann, 1968; Chitrabamrung, Rubin and Tan, 1981). The amount of DNA in 
the plasma has been positively correlated with disease activity, especially vasculitic symptoms and has 
an elevated level of nicks, hairpins, dG-dC content (61 % compared with 38% in bulk human DNA), and 
other uncommon structures that may serve as targets for antibodies in SLE serum (Krapf et al., 1989).
The interactions between anti-DNA antibodies and the glomerular basement membrane may be mediated 
by charge. Antibodies which bind to the kidney have a high proportion of positively charged amino 
acids at physiological pH suggesting the presence of subpopulations of anti-dsDNA antibodies which 
preferentially bind to glomeruli at negatively charged sites in the basement membrane (Dang and 
Harbeck, 1984). Therefore, the deposition of immune complexes in the kidney may occur by trapping 
of circulating DNA / anti-DNA immune complexes or the initial binding of free DNA to the renal 
glomerulus followed by subsequent interaction with anti-DNA antibodies in situ (Izui, Lambert and 
Miescher, 1976).
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Histones also have a high affinity for the glomerular basement membrane, related to charge (pl>  8.5) 
(Schmiedeke et al., 1989), and Brinkman et al., (1990) have suggested that anti-DNA antibodies might 
bind to DNA linked to histone proteins in the circulation to form immune complexes. These may then 
adhere to the glomerular basement membrane through the favourable charge interaction of histones with 
heparan sulphate (Brinkman et al., 1990).
A further source of DNA may arise from the polyclonal activation of B cells; human peripheral blood 
lymphocytes can both excrete DNA (Distelhorst, Cramer and Roger, 1978) and have DNA associated 
with their cell surface (Moyer, 1979). Thxis, the circulating source of DNA may be from dying cells or 
be produced by activated lymphocytes. DNA has been shown to be associated with a cell surface 
receptor, the role of which is to scavenge and degrade exogenous DNA, possibly constituting a 
nucleotide salvage pathway (Bennett, Gabor and Merritt, 1985). There is defective binding of DNA to 
peripheral blood mononuclear cells from patients with SLE and autoantibodies to this receptor, which 
may also contribute to the elevated levels of circulating DNA in SLE (Hefeneider et al., 1990).
1.2.6: SLE and ROS
Although there is an increasing amount of evidence to suggest that ROS produced during cell 
metabolism (eg. during phagocytosis), may play an important role in the pathogenesis of RA (see section 
1.1.7), there has been little extrapolation of these findings to the investigation of the role of ROS in 
other chronic inflammatory disorders.
Several experimental findings, however, do suggest that ROS are involved in SLE. Immunisation of 
female rats with a DNA molecule modified by the O^-' generating system, xanthine/xanthine oxidase 
elicited the production of antibodies that could react with both native and the modified DNA whilst 
native dsDNA did not induce the production of anti-DNA antibodies (Jansson, 1985). This suggests that 
ROS modification of DNA renders it more antigenic than the native form.
If ROS modification of DNA is important in altering the antigenic state of the molecule SLE patients are 
likely to be more susceptible to these effects for several reasons. It has already been discussed that 
DNA entering the circulation of SLE patients persists longer than in normal controls (see section 1.2.5). 
Furthermore, Harris et al., (1982) have shown that DNA damage in SLE is not repaired as efficiently as
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in norm als. This results in accumulating concentrations of altered base residues such as O*- 
methylguanine thus exacerbating any effects that may be due to the formation of a ROS-denatured DNA.
Further evidence for involvement of ROS in SLE is based on the ability of hydralazine, a drug forming 
free radical derivatives, to induce a lupus-like syndrome (section 1.1.4.5 and 1.2.2.1) and the role of 
UV light exacerbating the disease manifestations. An altered form of DNA containing thymine dimers 
is formed following exposure of the molecule to UV light (Deering, 1962) and rabbits immunised with 
UV-irradiated DNA produce antibodies against this denatured DNA (Natali and Tan, 1971). Its 
antigenic determinant is the conformational distortion produced by the formation of the dimer residues. 
Sensitivity to UV is a prominent feature of SLE and Golan and Borel (1984) showed an increased 
sensitivity to near UV in the NZB/NZW mouse model of SLE. In this mouse model there is defective 
endonuclease activity and inefficient repair of the damaged DNA. Studies in SLE patients by Beighlie 
and Teplitz (1975) have demonstrated a much lower excision repair in lymphocytes from SLE patients 
compared to normals whilst D'Ambrosio et ah, (1983) found levels of repair of UV-induced damage to 
be only similar or slightly lower in skin from patients with SLE compared to normal skin. Although the 
evidence is conflicting, it again appears that a ROS-modified DNA persists longer in the cells of SLE 
patients than in the cells of normals.
Emerit and Michelson (1980) have proposed that the photosensitivity to UV seen in SLE is manifested 
not by a repair enzyme deficiency but by a clastogenic factor formed from the action of free radicals on 
lipids. SLE serum contains this chromosome-breaking agent of low molecular weight which produces 
chromosomal breakage and rearrangement of DNA (Emerit et al., 1980). The breakage factor is 
released from SLE lymphocytes and the aberration rate induced by this clastogenic agent is reduced to 
normal values if  SOD is added to the culture medium. Emerit and Michelson (1981) have also 
suggested that the clastogenic factor is itself photosensitive and reacts with UV light to produce O^-’ 
which can then react with more clastogenic factor and DNA, causing excessive damage.
Whichever mechanism, if either, is responsible for the U V photosensitivity, the data from both sets of 
experiments suggest that there is increased susceptibility to ROS, produced by UV light. In addition to 
this, the chronic inflammatory component of SLE will generate greater concentrations of ROS during 
neutrophil activation than during normal oxidative metabolism, and result in tissue damage.
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Furthermore, a factor present in the serum of SLE patients causes neutrophils to generate significantly 
increased levels of ROS which are cytotoxic to endothelial cells (Hashimoto, Ziff & Hurd, 1982). This 
enhanced damage to endothelial cells, which may result in vascular injury, is inhibited by SOD and 
catalase (Niwa et al., 1985).
Increased ROS production may be involved in the pathogenesis of SLE.
ROS-denatured DNA is thought to be more antigenic than native DNA and since DNA is a component 
of the circulating immune complexes in SLE sera, the exposure of this modified antigen may be relevant 
to the process of anti-DNA antibody production.
The general aim of this thesis was to investigate the potential role of ROS-damaged DNA in the 
aetiopathogenesis of SLE.
The following specific questions were addressed:
Can damage to DNA by biologically relevant levels of ROS provide characteristic, measurable products 
in vivo?
Can this damage be ascribed to a specific radical species?
Can ROS-induced DNA products be detected in human biological material, and thus used as an indicator 
of both excreted and accumulated damage?
Can ROS-DNA act as a mediator of anti-DNA antibody production?
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SECTION 2:
MATERIALS AND METHODS
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CHAPTER 2.1: REAGENTS AND SUPPLIERS 
2.1.1: Enzymes
Phosphodiesterase 1 (EC 3.1.4.1): from crotalus atrox venom with a specific activity of 0.13 units/mg, 
Endonuclease (EC 3.1.30.1): from Neurospora crassa with a specific activity of 420 units/mg,
Alkaline phosphatase (EC 3.1.3.1): from Escherichia coli with a specific activity of 2.5 units/mg. 
Superoxide dismutase (EC 1.15.1.1): from bovine erythrocytes with a specific activity of 3,000 
units/mg.
Catalase (EC 1.11.1.6): from bovine liver with a specific activity of 11,000 units/mg,
SI nuclease (EC 3.1.30.1): from Aspergillus oryzae with a specific activity of 31,250 units/mg. 
Proteinase K (EC 3.4.21.14): from Tritirachium album with a specific activity of 10.7 units/mg. 
Deoxyribonuclease 1 - DNase (EC 1.11.1.7): from bovine pancreas,
Ribonuclease A - RNase (EC 3.1.27.5),
were all supplied by Sigma Chemical Company; Poole, Dorset, UK.
To inactivate any contaminating DNase in the RNase preparation, RNase at a concentration of lOmg/ml 
in lOmM Tris-HCl (pH 7.5) and 15mM NaCl was heated to 100°C for 15 minutes and allowed to cool 
slowly to room temperature. The enzyme was then aliquoted at Img/ml and stored at -20°C.
2.1.2: Immunochemicals
Goat anti-human IgG (gamma chain specific), goat anti-human IgM {jx. chain specific) and goat anti­
human IgA (a chain specific) were from Sigma.
Peroxidase conjugated goat anti-mouse polyvalent immunoglobulin and peroxidase conjugated goat anti­
human IgG (gamma chain specific), goat anti-human IgM ( j x  chain specific) and goat anti-human IgA (a 
chain specific) were also from Sigma.
IgA from human colostrum and polyclonal human IgG were from Sigma, and polyclonal human IgM 
was from Calbiochem, Cambridge, UK.
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Monoclonal antibodies were a gift from Professor Norman Staines; Kings College, London. The 
antigenic determinants recognised by each of the antibodies listed below, and their optimum working 
dilutions are shown in table 3.5 (chapter 3):
Group Monoclonal Antibody
1 402, 410
2 212, 405
3 152
4 233, 228
5 223
Autoantibody control sera, positive and negative for the presence of anti-DNA antibodies were from 
Sigma.
2.1.3: Disposables
Ninety-six well Nunc-Immuno plates were from Gibco; Dennaark, 24 well sterile plates and 6cm petri 
dishes were from Sterilin; Hounslow, UK; all other tissue culture disposables were from Flow 
Laboratories; Irvine, Scotland. Three ml glass disposable tubes were from Laboratory Sales (UK) Ltd., 
Rochdale; acrylic cuvettes were from Sarstedt Ltd.; Leicester, UK and poly tetrafluoroethylene capped 
hypovials were from Pierce Chemical Co.; Rockford Illinois, USA.
2.1.4: HPLC Apparatus
For reverse phase chromatography a 25cm C-18 ODS 5/rm column with a guard column of 10cm was 
used, both from Technicol; Stockport, Cheshire, UK.
SEP-PAK C-18 1ml cartridges were obtained from Waters (Millipore); Watford, UK.
2.1.5: Miscellaneous
Ficoll-Paque for isolation of PBMC was from Pharmacia; Uppsala, Sweden, Ficoll-Hypaque mono-poly 
re.solving medium with a density of 1.114 ± 0.002 for isolation of polymorphonuclear leucocytes was 
from Flow.
Desferal (referred to in the text as desferrioxamine) was a gift from Ciba; Horsham, Sussex, UK.
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Poly-L-lysine hydrobrotnide was from British Drug Houses (BDH) Ltd.; Dorset, UK.
Hoechst 33258 dye was from Hoechst; Frankfurt, West Germany.
Isoamyl alcohol was from Fisons Scientific Equipment, Loughborough, Leicestershire, UK.
RPMI 1640, foetal calf serum and L-glutamine were from Flow.
Penicillin was from Glaxo; Greenford, M iddx., UK and Streptomycin was from Evans Med.; 
Greenford, Middx., UK.
8-hydroxyguanine (80HG) was from Chemical Dynamics Corp.; South Plainfield, NJ, USA.
DNA from human placenta, agarose, sodium dodecyl sulphate (SDS), hydrogen peroxide (30% solution 
with stabilisers), bis(trimethylsilyl)trifluoroacetamide (BSTFA) containing 1 % trimethylchlorosilane, 
bovine serum  album in (BSA ), cy tochrom e C from horse heart, th iourea, m annitol, 
orthophenylenediamine (OPD) lOmg tablets, trypan blue, ethidium bromide, phenol, protein A crude 
cell suspension from Staphylococcus Aureus (SPA), sigmacote, 2'deoxy D-ribose, 2'deoxynucleosides 
and 2 'd e o x y  5 'n u c le o tid e s , 8-azaadenine (8A ZA ), 5-hydroxyuracil and 4,6-diam ino-5- 
formamidopyrimidine (FAPY Adenine) were of the highest grade available and obtained from Sigma.
Solvents used for HPLC buffers were of Spectrosol grade and, with all other general laboratory reagents 
(of Analar grade) were from BDH.
2.1.6: Buffers
The principal buffers used include: lOmM Tris, ImM EDTA (pH 8.0) (TE), 89mM Tris Borate (pH 
8.0) (TBE), phosphate buffered saline (O.OIM; pH 7.4) (PBS) and complete culture medium: RPMI 
1640 containing 10% heal inactivated foetal calf serum - HIFCS, penicillin (5 units), streptomycin (5 
units) and L-glutamine (0 .15mg) - GPS
Wherever possible, buffers were made up in chelex treated water and autoclaved prior to use.
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2.1.7: Clinical Samples
Samples used throughout this study were obtained from patients with:
RA (classical or definite - according to American Rheumatism Association criteria)
SLE (satisfying the revised criteria for the diagnosis of SLE - Tan et al., (1982), and receiving 
conventional non-steroidal anti-inflammatory drugs and steroids)
scleroderma and primary Raynauds as diagnosed by standard clinical and serological criteria 
attending rheumatology clinics at the Rheumatism Research Wing, University of Birmingham.
Young normal control samples were obtained from healthy laboratory staff and elderly normal control 
samples were from informed volunteers attending out-patient clinics at the Queen Elizabeth Hospital, 
Birmingham.
CHAPTER 2.2: EQUIPMENT
For all HPLC analysis a model 510 solvent delivery system and WISP 710B autosampler were 
connected to a 490 m ultiw avelength detector (all from Waters) and an LC-4B amperometric 
electrochemical detector from Biotech Instruments Ltd., Luton, Beds, UK. Data collection was 
facilitated using two Waters 740 data modules.
Analysis of samples by gas-chromatography mass spectroscopy (GCMS) employed a mass selective 
detector, controlled by a computer work station, interfaced to a gas chromatograph (all instruments from 
Hewlett Packard Co., Bracknell, Berkshire, UK, with model numbers S970B, S970C and S890A 
respectively).
A Model LS-5 Scanning Fluorescence Spectrophotometer from Perkin-Elmer Ltd.; Beaconsfield, 
Bucks., UK, was used for determination of DNA concentration using Hoechst 33258 dye and also for 
the fluorometric analysis of DNA unwinding (FADU) assay.
The mini-gel apparatus was from BioRad Laboratories Ltd.; Hemel Hemstead, Herts., UK.
A cobalt 60 source in the Department of Radiation Physics, University of Birmingham, was used for 
gamma radiolysis experiments.
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The UV lamp was from Andermann and Company Ltd.; Surrey, UK and emitted light at wavelengths of 
366nm and 254nm corresponding to average light intensities of 17/iW/cm^ and 10.5^tW/cm^ respectively 
at Im, according to the manufacturers specification.
Enzyme linked immunosorbent assay (ELISA) plates were washed using a Wellwash 4 platewasher from 
Denley Instruments Ltd.; Billingshurst, Surrey, UK and read on a Titertek Multiscan spectrophotometer, 
from Flow.
A Mistral 3000 refrigerated centrifuge (MSE Scientific Instruments; Crawley, Sussex, UK) was used for 
cell isolation procedures and a microfuge from Beckman; High Wycombe, Bucks., UK was used in 
DNA preparation.
For maintenance of lymphocytes in culture a Leec Mkll Proportional Temperature Controllers incubator 
from Leec; UK was used and sterile separation of cells was done in a Gelaire BSB4 hood from Flow.
The Fluorescence Activated Cell Sorter - FACS 440 was from Becton Dickinson, Cowley, Oxford, UK.
CHAPTER 2.3: GENERAL METHODS
The work described in this thesis uses a variety of methods. Some were developed specifically for the 
purpose; others were from existing methods with minor modifications for performing particular 
experiments. Consequently, several specific techniques are described in separate "methods sections" in 
the first relevant chapter in which they are used. The methodology described below reflects basic 
experimental techniques common to the thesis as a whole.
2.3.1: DNA Processing Techniques
2.3.1.1: Isolation of Genomic DNA from Cells
Isolation of DNA from cells was based on the method described by Maniatis, Frisch and Sambrook 
(1982), pp 280-281 and pp 458-462. Cells were washed twice in ice-cold PBS by centrifugation at 300 
X  g for 10 minutes at 4®C and resuspended in fresh buffer. After the final wash the cell pellet was 
resuspended at a concentration of 10* cells/ml in ice-cold TE. To this was added 10 volumes of 0.5M 
EDTA (pH 8.0), 100/ig/ml proteinase K, and 0.5% Sarcosyl as a detergent. The suspension of lysed 
cells was incubated at 50°C for 3 hours with periodic swirling.
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To extract the DNA, an equal volume of phenol was added to the viscous solution and the two mixed 
until an emulsion formed. After centrifuging for 15 seconds in an Eppendorph centrifuge at room 
temperature, and good separation of the two layers, the upper aqueous phase was transferred to a fresh 
f)olypropylene tube. The aqueous phase was extracted a second time with phenol, then incubated with 
lOO/ig/ml of DNase-free RNase at 37 ®C for 3 hours. Further extraction, as for the phenol, was 
performed with: firstly, an equal volume of a 1:1 mixture of phenol and chloroform, and secondly, an 
equal volume of chloroform. DNA was recovered by precipitation with two volumes of ice-cold ethanol 
and incubation at -20°C for up to 24 hours. After centrifugation of the DNA at 0°C for 10 minutes in 
an Eppendorph centrifuge, the ethanol supernatant was discarded and remaining traces of supernatant 
were removed by vacuum desiccation. Finally, the DNA was dissolved in the minimum volume of TE.
2.3.1.2: Determination of DNA Concentration
DNA concentration was accurately determined fluorimetrically using the DNA binding dye Hoechst 
33258. The assay was based on that described by Labarca and Paigen (1980), showing no significant 
interference by RNA and protein in the range used. The binding of Hoechst 33258 to DNA was linear 
over the range of concentrations used in this thesis and is shown in the calibration curve constructed 
using human placental DNA from 0-100/ig/ml (Figure 2.1a) and 0-1000/rg/ml (Figure 2.1b).
To determine DNA concentration, Hoechst 33258 was diluted to l;ig/ml in a buffer consisting of 0.05M 
sodium phosphate, 2M NaCl and ImM EDTA, pH 7.4. Two microlitres of human placental DNA of 
known concentration diluted in TE (for the calibration curve) or 2/xl of extracted DNA, also in TE, were 
added to 2mls of dye-containing buffer and the fluorescence measured at excitation 356nm and emission 
458nm using acrylic cuvettes.
2.3.1.3: Agarose Gel Electrophoresis
Agarose gel electrophoresis of DNA was used in conjunction with the data obtained from the 
fluorescence assay described in 2.3.1.2 to determine the purity of isolated DNA and also to estimate its 
size. Using a mini-gel apparatus 0.2g agarose was dissolved in 20mls TBE to give a gel concentration 
of 1 %. Ethidium bromide was added to a final concentration of 0.75;rg/ml. Twenty microlitres of 
DNA mixed with 5/il loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol and 40% w/v
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Figure 2.1
Fluorometric determination of DNA concentration by Hoechst dye binding. The calibration curve shows the linear increase in fluorescence
from Hoechst dye binding to a) 0-100/xg/ml and b) 0-1000/ig/ml human placental DNA obtained from the means ± ISD of three separate
experiments.
sucrose in water) was loaded onto the gel and electrophoresis was carried out at 70V for 30 minutes in 
TBE. DNA bands were identified using UV-illumination and the gels photographed.
2.3.1.4: Enzymic Digestion of DNA
Digestion of DNA to its nucleoside components was carried out according to the method of Beland, 
Dooley and Casciano (1979). DNA, dissolved in TE, pH 7.4 at a concentration of « Img/ml was made 
lOmM in magnesium chloride, heated for 3 minutes in boiling water and rapidly cooled with ice. 
DNase 1 (O.lmg/mg DNA) and endonuclease (6 units/mg DNA) were added and the solution incubated 
overnight at 37°C. The pH was then adjusted to 8.0 using IM Tris base, and the enzymes 
phosphodiesterase 1 (0.04 units/mg DNA) and alkaline phosphatase (1 unit/mg DNA) were added. The 
incubation was continued overnight at 37°C, after which the pH was re-adjusted to 7.0 with IM HCl 
and the solution stored at -20°C prior to analysis. This method was found to give the highest yield of 
80HDG from DNA when compared to other digestion procedures described in Floyd et al., (1990).
2.3.1.5: DNA Preparations
All glass and plastic surfaces used for storage or incubation of DNA samples were coated with 
Sigmacote to prevent sticking of the DNA to the tube surfaces. All surfaces were briefly immersed in 
Sigmacote, drained and incubated at 37 °C for 1 hour to complete evaporation of the solution, prior to 
use in DNA experiments.
Phenol: Highly purified phenol was purchased from Sigma and used without further distillation. The 
phenol was melted at 68°C and 8-hydroxyquinolone was added to a final concentration of 1 %. The 
phenol was then extracted several times with an equal volume of buffer; l.OM Tris, pH 8.0, followed by 
O.IM Tris, pH 8.0 until the pH of the aqueous phase was >7.6. The phenol was stored under the final 
equilibration buffer at 4°C using the hydroxyquinolone dye as an indicator of oxidation.
Chloroform: A mixture of chloroform and isoamyl alcohol (24:1 v/v) was prepared and stored in a 
closed bottle at room temperature. This solution is referred to as "chloroform".
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2.3.2: ELISA Assays
2.3.2.1: Direct Binding ELISA
In the direct binding ELISA, the interaction between an immobilised ligand and its antibody was 
measured colorimetrically. All incubations were for 1 hour at 37°C in a humidified environment, 
volumes pipetted into wells were consistently 50;rl and between each stage in the assay the plates were 
washed 3 times in PBS containing 0.05% tween 20 (PBST).
Ligand was coated onto 96 well plates in 0.05M carbonate/bicarbonate buffer (pH 9.6) to achieve 
maximum immobilisation to the positively charged plastic plates. BSA (1 %) was used to block 
remaining sites on the plate thus avoiding non-specific binding of the antibody to the plate. Antibody 
diluted in PBST was then added in triplicate leaving the first row of each plate blank to control for any 
interaction between the conjugated antibody and the coating ligand. Determination o f antibody, 
complexed to the bound ligand, was achieved using peroxidase-conjugated antibodies directed against 
the primary antibody. The reaction of bound peroxidase with and OPD at room temperature
produced a characteristic yellow colour. The reaction was stopped with 4M H^SO  ^ and the optical 
density (OD) read at 492nm on a Titertek Multiscan.
2.3.2.2: Competition ELISA
In a direct binding ELISA, immobilisation of ligand to the plate may sterically hinder interaction of the 
complexing antibody with certain epitopes on the ligand. To overcome this problem a competition 
ELISA can be used. In this assay, increasing concentrations of ligand are available in free solution to 
compete with immobilised ligand for the specific antibody. In a similar way, a comparison of affinity of 
an antibody for two different ligands can be determined using this assay (sections 3.6 and 5.1).
The direct binding assays u.sed in this thesis were found not to give significantly different results from 
those of a competition ELISA (section 5.2.3.2) and therefore the direct binding assays alone were used.
2.3,3: Cell Isolation Techniques
2.3.3.1: Isolation of Peripheral Blood Mononuclear Cells (PBMC) (after Boyum, 1968).
Whole venous blood was collected into plastic universals containing lOO/il of preservative free heparin, 
then diluted to 50% with RPMI 1640. Diluted blood (7.5mls) was layered gently onto 2.5mls of Ficoll-
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Paque, in sterile 10ml round bottomed disposable plastic tubes. Tubes were centrifuged at 300 x g for 
30 minutes. Mononuclear cells collected at the interface were removed using a pasteur pipette and 
washed three times in RPMI 1640, by centrifugation at 300 x g for 10 minutes, in 10ml V-bottomed 
plastic tubes. Cells were pelleted and resuspended in the appropriate medium required for culture or 
further processing. Mononuclear cell preparations were consistently greater than 97% viable and 
contained 10-20% monocytes.
2.3.3.2: Isolation of Polymorphonuclear Leucocytes (PMN)
Whole venous blood was collected into EDTA and layered onto Mono-Poly Resolving Medium. 
Separation and washing of cells was as described for mononuclear cells in section 2.3.3.1.
2.3.3.3: Viable Cell Counts
Cells were resuspended to 5 x 10* per ml. The cell suspension was diluted 1:1 with 1% trypan blue in 
PBS and incubated at room temperature for 5 minutes before counting. Dead cells were stained dark 
blue. Both unstained (viable) and stained (dead) cells were enumerated separately to obtain a percentage 
as well as absolute viable cell counts.
CHAPTER 2.4: GENERATION OF REACTIVE OXYGEN SPECIES
The role of ROS in normal metabolism has been discussed at length in chapter 1, and in particular the 
role of ROS in inflammation. To characterise the modifications caused by ROS-mediated damage to 
DNA in an in vivo situation it is first necessary to establish the changes occurring, and to develop 
and/or evaluate reliable assays to determine these end points.
Investigation of the effects of ROS on DNA in an in vitro situation was simplified by using several 
model systems to generate ROS. These models, and the ROS they produce, have been well 
characterised: they also have the advantage of being chemically manipulated to produce one species 
predominantly as illustrated in the following sections.
2.4.1: Gamma Radiolysis
Exposure of aqueous solutions to high energy ionising radiation, from a Cobalt 60 gamma source,
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ionises the water molecules as described in the equation:
—► OH- +2HjO -t-
The yields (G values: number of molecules formed per 100 eV of energy absorbed) are: e'^, 2.7; OH-, 
2.7; H, 0.5 and 2.76 (Singh & Singh, 1982).
The reducing aqueous electron and oxidising free radical will react further with themselves or other 
solutes and in the presence of oxygen, the additional reactive species formed include peroxy radicals 
(RO^-), superoxide anions (O^-') and singlet oxygen (Singh & Singh, 1982).
The mechanism of pure superoxide radical generation in an oxygenated solution of lOOmM formate has
by B ielski (1978) as shown below:
2HjO OH- + H3O+ + e'
“S
e’ + —
HjO+ + o HO,- HaO
H O,- H^ + Oa-'
OH- + HCO^' — COa-- + H ,0
co^-- + o . Oa‘ -t- COa
To produce peroxy radicals in solution, a UV absorbing compound (eg. lOmM phenylalanine) is added 
to scavenge both OH- and O^-' producing R(OH-) and R(0H)0^' respectively as shown below (Gee 
Kittridge and Willson, 1985; Willson, 1985):
OH- + R ----- ► R(OH-)
R(OH-) + O -^- ---- ► R (0H )0;
2.4.1,1: Gamma irradiation ofDNA
DNA at 0.5mg/ml in 40mM sodium phosphate buffer, pH 7.4, was irradiated in glass tubes in the 
presence or absence of either lOOmM formate or lOmM phenylalanine. A dose of up to 1000 Gray (Gy) 
was given at a dose rate of «  10 Gy per minute: tubes were shaken at regular intervals to reoxygenate 
the solutions.
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2'deoxyguanosine (dG) at 2.5mM in 40mM sodium phosphate buffer, pH 7.4, was irradiated as for 
DNA.
2.4.1.3: Gamma irradiation of RPMI-1640
RPMI-1640 was irradiated as for DNA. Formate and phenylalanine were found to reduce cell viability 
above that found in control cells and therefore were not included in these experiments.
2.4.1.4: Gamma irradiation of PBMC
For some experiments cells were irradiated directly. PBMC at a concentration of 2 x 10* cells/ml in an 
aerated solution of 2mls RPMI-1640 were irradiated in sterile glass tubes at 0°C at a dose of »25 Gy 
per minute up to 200 Gy.
2.4.2: UV Radiation
It has been established that the U V region most potent in its effects on living cells is near 260nm 
(Deering, 1962). DNA absorbs most strongly in this region, the UV light being predominantly absorbed 
by the bases. Cytosine and thymine, the pyrimidines, are far more sensitive to the effects of UV than 
the purines, adenine and guanine. A characteristic change induced by UV light is the photochemical 
fusion of two adjacent pyrimidines into non-pairing structures like the cyclobutane-containing thymine 
dimer (Deering, 1962).
2.4.1.2: Gamma irradiation of 2'deoxyguanosine
UV light can photoionise water molecules to produce a source of protons and hydroxyl radicals and in 
aerated solutions, hydrogen atoms can react with oxygen to produce OH- (McCord and Fridovich, 
1973):
H- HO, H'"
H-
UV
HO^- 20H-
The subsequent action of UV light on pure is one of the most efficient ways of producing OH- in 
solution.
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2.4.2.1: UV irradiation of DNA
DNA at 0.5mg/ml in PBS was irradiated in the presence or absence of 1.3niM Fe(NH^)^(SO^)j in a 6cm 
petri dish at a distance of 6cm from the source. Irradiations were done on ice to minimise evaporation 
and aliquots were removed at 15 minute intervals.
2.4.2.2: UV irradiation of 2 'deoxyguanosine
dG at 2.5mM in 0. IM sodium phosphate buffer, pH 6.8 was irradiated in the presence or absence of 
1.3mM Fe(NHp^(SO^)^ as for DNA.
2.4.2.3: UV irradiation of RPM l 1640
For exposure of PBMC to UV irradiation, RPMI 1640 was irradiated as for DNA, sterile filtered 
through a 0 . 2 / x . m  syringe, and 0.9ml added to the lymphocytes resuspended in 0.1ml of HIFCS 
containing 10/xl GPS to give a final concentration of 2 x 10® cells/ml.
2.4.2.4: UV irradiation of PBMC
PBMC were irradiated on ice in a sterile plastic petri dish as for DNA at a concentration of 2 x 10® 
cells/ml for a maximum of 60 minutes. Aliquots were removed every 15 minutes.
2.4.3: Fenton Reaction
In the presence of a reducing agent and a transition metal ion catalyst [such as Fe(II), Cu(I) and Co, 
and the more recently described Cr(VI) (Shi and Dalai, 1990)], reacts to produce OH- (the Fenton 
reaction). With Fe^ '*’ as a metal ion catalyst the reaction proceeds:
H ,0 , + Fe'
2 2
Traces of Fe^ "*^  can react further with H ,0,:2 2
2 +
F e ^ "* "  - f H2O,
Fe^+ +
Fe '^  ^ +
OH- -I- OH’
+ 2H-
to replenish Fe^ '*' in the absence of a reducing agent (Halliwell and Gutteridge, 1984).
Although the availability of metal ions in biological fluids to catalyse the Fenton reaction has been 
questioned (section 1.1.3) there is substantial evidence that H^O  ^induces DNA damage by interacting 
with DNA-bound iron to generate OH- radicals (Floyd, 1981; Mello-Filho, Hoffmann and Meneghini, 
1984).
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DNA at 0.5mg/ml in PBS was incubated at 37°C for 1 hour with increasing concentrations of np 
to 200^M, in the presence of lOmM ascorbic acid (AA) as a reducing agent. All reagents were made up 
in chelex-treated water and DNA-bound metal ions alone were available to catalyse the Fenton reaction.
2.4.3.2; and 2'deoxyguanosine
Incubation o f dG with was used as model system to generate 80HDG; levels of were not
required to be physiological and in this system 2.5mM dG was incubated with 50mM in O.IM
sodium phosphate buffer, pH 6.8.
2.4.3.3: and RPMI-1640
Increasing concentrations of ^ 2 ^ 2  200/xM were made up in RPMI-1640 and added to HIFCS and
GPS as for UV irradiation of RPMI-1640 (section 2.4.2.3) to give a final cell concentration of 2 x 10* 
cells/ml.
2.4.4: Activation of PAIN
PMN release ROS following activation of the membrane bound NADPH oxidase. In an in vivo situation 
activation at an inflammatory site is caused by stimuli such as immune complexes, complement or 
bacteria, but in vitro the stimulation of PMN can be mimicked using the tumour promoter, phorbol 
myristate acetate (PMA). To determine the effect of PMA-derived ROS on DNA the cellular DNA of 
PMN was studied directly, rather than adding further DNA to the system since it would not have been 
possible to differentiate between the cellular and naked DNA.
Isolated PMNs were incubated at a concentration of 2 x 10* cells/ml at 37°C for 15 minutes prior to 
activation with PMA at lOng/ml in RPMI 1640 for 30 minutes at 37°C. DNA was then isolated from 
stimulated or non-stimulated PMNs, incubated as for the stimulated cells but with the omission of PMA, 
as described in section 2.3.1.1.
Superoxide radical generation was measured spectrophotometrically by the SOD-inhibitable reduction of 
160/xM cytochrome C at 550nm over a 30 minute period at 37®C. Superoxide release was calculated in
2.4.3.1: HjOj and DNA
53
nmoles/10* cells using the molar extinction coefficient of 21 x 10^  M''cm"' for cytochrome C.
All reagents were diluted in RPMI 1640 (without phenol red, to prevent interference in the colorimetric 
assay) to maintain an isotonic solution.
CHAPTER 2.5: SCAVENGERS OF REACTIVE OXYGEN SPECIES
As described in section 2.4, the use of model systems to generate ROS predominantly results in the 
production of more than one reactive molecule. Identification of the ROS responsible for causing 
degradative changes to DNA in any one system can be facilitated by the use of antioxidants (table 2.1) 
but conclusive evidence cannot be drawn from this alone. Spin-trapping of radicals, and electron 
paramagnetic resonance patterns are more informative of the presence of radical species (Floyd, Lewis 
and Wong 1984).
CHAPTER 2.6: HPLC ASSAY FOR 80HDG 
2.6.1: Introduction
80HDG is a product of hydroxyl radical damage to dG, either as a free base or derived from DNA. It 
was first described in two separate publications using GCMS (Dizdaroglu, 1985a) and HPLC (Kasai & 
Nishimura, 1984a). The use of HPLC to measure this altered DNA base has been pursued by several 
laboratories (Floyd et al., 1986b; Schraufstatter et al., 1988). The assay is «1000 fold more sensitive 
when compared with previous HPLC assays measuring the altered bases, thymine glycol and 5- 
hydroxymethyluracil, the increase in sensitivity being achieved using electrochemical detection (ECD) 
(Floyd et al., 1986b). Previous assays relied on the UV absorbance of the modified bases but by virtue 
of its low redox potential 80HDG not only responds to electrochemical oxidation but responds in a 
region where the native bases do not interfere.
2.6.2: Methods
2.6.2.1: Separation of 80HDG and 2'deoxyguanosine by HPLC/ECD
Measurement of 80HDG in native or ROS-denatured DNA required enzymic digestion of the DNA (as 
described in section 2.3.1.4) prior to analysis of the samples by HPLC/ECD . Samples of dG and ROS- 
denatured dG were analysed without further treatment.
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Table 2.1
Scavenger F in a l C oncentration Species Scavenged
Catalase 27,000 u n its /m l H2°2
SOD 3,000 u n its /m l 02 --
Thiourea 50mM OH- and m etal ch e la to r
M ann ito l 50mM OH-
D esferrioxam ine 0.5mM Chelates iro n
Ethanol 50mM OH-
Cysteine 50mM General scavenger o f R
in
in
Characteristics of the scavengers used in in vitro experiments to determine the individual effects of ROS on DNA. The final concentration and 
species scavenged by each of the reagents is shown. SOD = Superoxide Dismutase, ROS = reactive oxygen species.
Ten microlitres of sample was injected onto a reverse phase 25cm C-18 ODS S f i m  column. Separations 
were performed at a flow rate of 0.8ml/min with a mobile phase of 30mM sodium hydroxide, lOmM 
acetic acid, 41 mM sodium acetate and 12.5mM citric acid, pH 5.1 containing 10% methanol (from 
Kasai et al., 1986). The eluent was monitored simultaneously by absorption spectroscopy at 254nm and 
by ECD at 600mV oxidation as compared with the Ag/AgCl reference electrode.
Figure 2.2 shows a typical chromatogram of all four DNA bases measured by absorbance at 254nm. 
Figure 2.3 illustrates the electrochemical and UV response of 80HDG showing the significant 
enhancement in sensitivity from the ECD signal. Guanine (derived from RNA) in its native and ROS- 
denatured form did not give an electrochemical response at 600mV which eliminates the possibility that 
the 80HDG measured could be contaminated by RNA-derived guanine adducts.
The assay was standardised using dG, 2'deoxyadenosine (dA) and 80HDG and the presence of these 
compounds in DNA digests and other biological samples was confirmed by spiking the peaks with 
authentic compound. Further identification of the 80HDG peak was by GCMS (section 4,4) and by 
cyclic voltametry.
Cyclic voltametry can be used to determine the purity of a peak, each compound having a different 
curve, the shape of which is altered by contamination from a co-eluting product. The electrochemical 
response of pure 80HDG was monitored between lOOmV and 800mV oxidation as compared to the 
Ag/AgCl reference electrode and figure 2.4 shows the curve obtained plotting the percentage maximum 
peak height against mV (ie the hydrodynamic voltammogram). The maximum peak height was at 
600mV, the detection setting for the assay.
To confirm the identity of peaks co-eluting with 80HDG in later chapters a comparison of the 
voltammogram curve with the standard curve was made.
The coefficient of variation for the assay based on ten separate injections of 80HDG was 4.7 % and the 
detection limit of the assay was 0.1 picomoles 80HDG.
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If)
Representative chromatogram of the UV absorbance at 254nm of a DNA digest showing all four native DNA bases dG (deoxyguanosine), 
dA (deoxyadenosine), dT (deoxythymidine) and dC (deoxycytosine).
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Representative chromatogram of the electrochemical response at 600mV oxidation (broken line) and the UV response at 254nm (continuous line) of 
80HDG showing the significant enhancement in sensitivity from the ECD signal.
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Figure 2.4
The hydrodynamic voltammogram of 8-hydroxydeoxyguanosine (80HDG) as 
compared to the Ag/AgCl reference electrode compiled from the means ± ISD of 
readings obtained in three separate experiments. The 80HDG used in these 
experiments was supplied by Dr H Kasai.
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2.6.2.2: ROS-Mediated Production of 80HDG
80HDG cannot be bought commercially at present. It can be synthesised using the Udenfriend system 
(Kasai & Nishimura, 1984a) and this procedure was used to prepare 80HDG on a large scale from dG 
for use in quantitative determination by HPLC/ECD.
For the synthesis, Ig of dG was dissolved in 780mls of 0 .13M sodium phosphate buffer, pH 6.8, and 
140mls o f O.IM AA, 65mls o f O.IM EDTA and 13mls of O.IM Fe(NH^)^(SO^)^ were added 
successively. The solution was incubated at 37®C in the dark whilst constantly bubbling pure oxygen 
through it. After 3 hours, the solution was adjusted to pH 3.7 with IM HCl, and lOg charcoal powder 
was added with stirring. The charcoal was recovered by filtration and packed in a column (2 x 13cra). 
The column was washed with SOOmls water and then the compounds of interest were eluted with 500mls 
of aqueous acetone (T. 1, v/v). The eluate was evaporated to dryness and the residue was fractionated by 
HPLC.
To separate 80HDG from the unmodified base, the eluate was injected onto the 25cm C-18 ODS 5;tm 
column and eluted with 10 %  aqueous methanol. The small peak eluted just after the main peak of dG 
was collected and evaporated to dryness. The residue was crystallised from water.
80HDG was stored at a concentration of Img/ml at -20°C and was found to be stable for the duration of 
storage (3 months maximum). This is in agreement with data from Floyd et al., (1990) who found that 
optimum storage of 80HDG was at neutral pH. The concentration of 80HDG was determined by UV 
absorbance at 245nm using the extinction coefficient of 12,300 as stated by Kasai & Nishimura (1984a). 
A comparison with a sample of 80HDG kindly donated by Dr Kasai, and analysis of the standard by 
GCMS (section 4.4.3) confirmed the authenticity of the prepared product.
CHAPTER 2.7: STATISTICAL ANALYSIS
Statistical analysis was performed using the Students "t" test, for parametrically distributed results, 
which were expressed as means and standard deviations in the figures or tables.
Groups of biological data were analysed using non-parametric statistics (Mann-Whitney U test) and are 
presented as medians and ranges, or scatter plot diagrams.
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SECTION 3:
MOLECULAR CHARACTERISATION OF ROS-INDUCED DAMAGE
TO DNA IN VITRO
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CHAPTER 3:
The DNA molecule consists of a backbone of deoxyribose moieties linked together by phosphodiester 
bonds. Attached to each deoxyribose is one of the four heterocyclic bases, guanine, adenine, thymine or 
cytosine. It is the DNA bases that carry the genetic information whilst the sugar and phosphate groups 
play a structural role.
DNA exists as a helix consisting of two of these backbone structures running in opposite directions, the 
structure being stabilised by hydrogen bonds between complementary bases. Adenine pairs with 
thymine and guanine pairs with cytosine. The diameter of the DNA helix is 2nm and adjacent bases are 
separated by 0.34nm, the helical structure repeating itself after 10 residues on each chain.
The amount of DNA in the 46 chromosomes of a normal human cell is « 6  x 10’'^g which would stretch 
a distance of 2 metres if it w'as not packaged into nucleosomes. These structures are disk-like with a 
thickness of 5.7nm and a radius of 5.5nm with two coils of DNA wrapped around each circumference, 
2.7nm apart. The nucleosome core is made up of histone proteins, but is not tightly packed and contains 
hydration (bound) water.
The effects of ionising radiation on DNA have been extensively studied, and are justified by the central 
role DNA plays in cell development. As a major cellular target for ROS-induced damage (Ward, 1985; 
Hagen, 1986), cell death, mutagenesis and transformation may all be caused by damage to this 
molecule.
Ionising radiation can cause damage to DNA directly by energy deposition in the molecule or indirectly 
by ionisation of other molecules that then attack DNA (Ward, 1985). The major source of indirect 
damage is the ionisation of water, which produces ROS. The water molecules bound to DNA are 
particularly important because they allow production of radical species in close proximity to the DNA. 
DNA bound metal ions, which form an integral part of the DNA molecule (Mello Filho, Hoffmann and 
Meneghini, 1984) and act to stabilise the DNA structure (Minchenkova and Ivanov, 1967) are also 
important in site-directing reactions of ROS to cause damage (see section 1.1.5.4).
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High energy irradiation of DNA in aqueous solution produces ROS which cause damage at all levels of 
the structure; single-strand breaks (Rhaese and Freese, 1968), double-strand breaks, base liberation 
(Rhaese and Freese, 1968), base damage (Massie, Samis and Baird, 1972) and inlra- and inter-strand 
cross-links (Lesko, Drocourt and Yang, 1982). These changes may have important biological 
implications if they become incorporated into the germ-line (section 1.1.5.4).
Experiments in this chapter have utilised model systems to generate ROS, the aim being to characterise 
the changes to DNA induced by ROS at the molecular level; specifically, damage to bases and the ribose 
moiety as well as structural changes to the overall molecule by analysing strand breaks and damage to 
specific epitopes.
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CHAPTER 3.1: BASE DAMAGE 
3.1.1: Introduction
ROS are difficult to measure in vivo since they are present in low concentrations and have very short 
half-lives { i ' / i  for OH- is =» 10'® seconds - Roots and Okada, 1975). However, the detection of specific 
products generated by ROS, reacting with for example, DNA, help to affirm their presence in vivo and 
also demonstrate the ability of certain ROS to diffuse into the nucleus before reacting.
The inherent problem in the detection of ROS-damaged DNA is the measurement of very low levels of 
adducts in the presence of normal bases, the ratio of damaged ; normal bases being typically 1 : 10® 
(Park, Cundy and Ames, 1989). Selectivity, to distinguish clearly between the unmodified and modified 
base residue, and sensitivity are, therefore, essential in the determination of DNA base adducts.
DNA bases react with OH- produced by water radiolysis (Ward, 1981) at almost diffusion-controlled 
rates (4 x lO’ M"' s"'). The major reaction of OH- is with double bonds of molecules (positions 5,6 for 
pyrimidines and positions 4,5 for purines). Reaction of OH- with thymine is almost exclusively with the 
5,6 double bond and there is a clear preference of reaction of OH- with thymine over cytosine > 
adenine > guanine (Huttermann et al., 1978).
The p roducts  m ost w ell characterised  follow ing reaction o f OH- with DNA include 5- 
hydroxymethyluracil, 8-hydroxyadenine, 4,6-diamino-5-formamidopyrimidine(FAPY adenine), 2,6- 
diamino-4-hydroxy-5-formamidopyrimidine (FAPY Guanine) and thymine glycol (Jackson et al., 1989).
Thymine glycol is one of the most studied of the oxidised DNA bases and has been measured by HPLC 
(Frenkel, Goldstein and Teebor, 1981), and by enzyme immunoassays using both polyclonal 
(Rajagopalan et al., 1984) and monoclonal antibodies (Leadon, 1987). More recently, two groups using 
different methodology described a novel base adduct, 80HDG. Kasai and Nishimura (1984a) developed 
an HLPC procedure using UV detection to analyse the oxidatively modified DNA base, whereas 
Dizdaroglu (1985a) developed an assay to measure a range of oxidised DNA bases including 80HDG, 
by GCMS. Floyd et al., (1986b) improved the sensitivity of the HPLC assay by three orders of
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magnitude (to femtomolar levels of determination) by incorporating electrochemical detection (ECD) 
into the assay.
Many base adducts are electrochemically active whilst normal bases are not. The only exception is 
guanine, which has an ECD response at an oxidation potential of >0.8V  versus Ag/AgCl reference 
electrode. This phenomenon serves to increase the selectivity of the HPLC/ECD assay for monitoring 
altered DNA bases (Park, Cundy and Ames, 1989).
There are many examples of the production of 80HDG during oxidative stress in vivo and in vitro: 
80HDG has been detected in DNA following its exposure to X-rays (Kasai, Tanooka and Nishimura, 
1984), gamma radiation (Dizdaroglu, 1985a), asbestos and (Kasai and Nishimura, 1984b), UV and 
(Floyd et al., 1988) and autoxidising aminophenols and polyphenols (Kasai and Nishimura, 
1984c). Using whole cell systems, 80HDG has been isolated from the DNA of leucocytes stimulated 
with tetradeconylphorbolacetate (Floyd et al., 1986a) and HeLa cells after irradiation in culture (Kasai et 
al., 1986), while in an in vivo model it was isolated from liver extracts of mice following total body 
irradiation (Kasai et al., 1986). A recent review has suggested that 80HDG is the most suitable marker 
for measuring the steady state level of oxidative damage in normal tissues (Aruoma, Halliwell and 
Dizdaroglu, 1989). Its credibility as a marker of oxidative damage has been enhanced by the 
observations that a) the levels of 80HDG and thymine glycol in cellular DNA and urine are of the same 
order (Simic, Bergtold and Karam, 1989) and b) mitochondrial DNA, which has immense oxygen 
metabolism, relatively inefficient DNA repair and an absence of histones has 80HDG levels of 1/8,000 
bases compared with 1/130,000 bases in nuclear DNA (Richter, Park and Ames, 1988). Furthermore, 
when lipid peroxidation is increased in mitochondrial membranes, there is a marked increase in the 
80HDG content of the DNA suggesting a relationship between two markers of oxidative stress 
(Hruszkewycz and Bergtold, 1990).
Successful validation of assays measuring 80HDG by several groups (Floyd et al., 1986b; Aruoma, 
Halliwell and Dizdaroglu, 1989) has confirmed its reliability as a measure of oxidative damage in DNA. 
Experiments in this section have used model systems to generate ROS, and have measured 80HDG, 
produced either from dG in free solution or from dG as an integral part of the DNA molecule, to
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Figure 3.1
Irradiation of 2.5mM dG in the absence (figure 3. la) or presence (figure 3. lb) of 1.3mM Fe(NH^)^(SO^)^ to produce 80HDG. In the 
absence of Fe(II) no significant 80HDG production was detected but addition of Fe(II) significantly enhanced the conversion of dG to 80HDG. 
Results are means ± ISD of five separate experiments.
To investigate the radical species responsible for this increase, irradiation of dG was repeated at the 
maximum dose of 500 Gy (which produced the maximum yield of 80HDG) in the presence of 1.3mM 
Fe(NH^)^(SOp^ to facilitate 80HDG production, and various scavengers of ROS. Table 3.1 shows the 
effects o f these scavengers on the conversion of dG to 80HDG. In the presence of lOOmM formate 
(producing pure O^-' - section 2.4.1) there was complete inhibition of 80HDG production at low doses 
of irradiation and at 500 Gy the level of 80HDG detected was not significantly elevated above 
background.
However, in the presence of lOroM phenylalanine, to generate peroxy radical species, there was a 
significant increase in the amount of 80HDG produced at every dose studied (p < 0.001).
Thiourea, a hydroxyl radical scavenger, also reduced the formation of 80HDG to background levels as 
did lOmM ethanol.
Thiourea may inhibit the production of 80HDG by scavenging the OH- produced in solution by gamma 
radiation and preventing it from reacting with dG. This is supported by strong evidence from other 
workers that the production of 80HDG is mediated by OH- (discussed in section 1.1.5.4 and in the 
introduction to this chapter). Thiourea is also a metal ion chelator. Although the ion predominantly 
chelated by this molecule is copper, at mM concentrations of iron it is possible that thiourea was also 
able to chelate some of the iron ions, clearly essential for efficient conversion of dG to 80HDG.
To further examine the role of Fe(ll) in the production of 80HDG, dG was irradiated in the presence of 
1.3mM Fe(NH^)^(SO^)^ and ImM, 5mM or lOniM desferrioxamine, a true iron chelator which binds 
Fe(III) to form a complex with high stability (Ka = 10^') (Lederman et al., 1984). The results show 
that at each of the concentrations studied the production of 80HDG was enhanced (figure 3.2).
3.1.3.2: Gamma Irradiation of DNA
Irradiation of 0.5mg/ml DNA in aerated 40mM sodium phosphate buffer resulted in a dose-dependent 
increase in the amount of 80HDG incorporated into the DNA; this was not significantly affected by the 
addition of 1.3mM Fe(NH^)^(SOp^ (figure 3.3).
Irradiation in the presence of lOOmM formate significantly inhibited the conversion of dG to 80HDG
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80HDG as % Of 
obta ined fo r
va lue  
500 Gy
dG DNA
C ontro l 98.2±1.79 97.411.34
100 mM Formate 3.810.7 p<0.001 5.110.7 p<0.001
10 mM P henyla lan ine 129.211.92 p<0.001 10412.77 NS
50 mM Thiourea 7.5410.38 p<0.001 13.1211.51 p<0.001
10 mM Ethanol 7.0610.57 p<0.001 8.2610.78 p<0.001
100 /Ltg/ml SOD 88.5213.47 p<0.01 95.412.07 NS
1 mM D esferrioxam ine 18716.96 p<0.001 173.415.5 p<0.001
cr>
VO
Table 3.1
Effect of ROS scavengers and the iron chelator desferrioxamine on the conversion of dG to 80HDG induced by irradiation of 2.5mM dG or
0.5mg/nil DNA with 500 Gy in the presence of 1.3mM Fe(NH^)^(SO^)j. The results are means ± ISD of three separate experiments with
significance values obtained by paired t-test.
Units of 80HDG
OmM Des 1mM Des 5mM Des 10mM Des
Figure 3.2
Effect o f desferrioxamine (des) on irradiation of dG in the presence of 1.3mM 
Fe(NH^)2(SO^)^. Results are the means ± ISD of five separate experiments.
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Units of 80HDG
Gamma Irr Gamma Irr + Fe
Figure 3.3
Dose-dei>endent increase in 80HDG production following irradiation of DNA with 
increasing doses of gamma radiation. Results are shown for DNA in the presence and 
absence of 1.3mM Fe(NH^)^(SO_^)^ and represent means ± ISD of five separate 
experiments.
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(p <  0.001) as did both the hydroxyl radical scavengers, thiourea and ethanol. The effect of 
phenylalanine enhancing the production of 80HDG was not as marked for DNA as for dG: although a 
slight increase in conversion of DNA-derived dG to 80HDG was noted, this was not significant. The 
presence of SOD caused no significant decrease in the production of 80HDG whilst ImM 
desferrioxamine enhanced the reaction by 73% (p <0.001) - table 3.1.
3.1.3.3: UV Irradiation of 2'deoxyguanosine
Irradiation of dG as described in section 2.4.2.2 produced 80HDG in a dose-dependent manner over a 
period of 60 minutes. Addition of Fe(II) promoted the conversion still further (figure 3.4a). Inhibition 
of this reaction was studied at 60 minutes UV irradiation of dG in the absence of iron to identify the 
ROS involved. is an intermediate in the production of OH- from UV (section 2.4.2) and this is
reflected in the 79 % inhibition of production of 80HDG caused by catalase. 91 % inhibition of 80HDG 
production was also caused by thiourea, whilst desferrioxamine promoted the reaction by 59%. SOD 
did not cause any significant change in 80HDG generation (table 3.2).
3.1.3.4: UV Irradiation of DiNA
Irradiation of DNA as in section 2.4.2.1 for a maximum of 60 minutes also produced 80HDG (figure 
3.4b). The reaction was not significantly increased in the presence of Fe(n) and was inhibited by 90% 
in the presence of thiourea and 81 % in the presence of catalase. The levels of 80HDG were unaffected 
by SOD, whilst desferrioxamine caused an enhancement of 19% (table 3.2). The concentration of 
adduct increased with the dose of UV irradiation. Although the absolute levels of 80HDG produced 
were the same as those produced by gamma irradiation, when compared in terms of radicals produced 
(500 Gy producing 200/xM OH-, 60 minutes UV producing 200^M H^O^, which theoretically can 
produce 400/tM OH- from homolytic fission - section 2.4.2) gamma irradiation appears to be more 
effective in the conversion of dG to 80HDG.
3.1.3.5: and 2'deoxyguano.sine
The reaction of with dG, in the presence of a reducing agent forms the basis of the Udenfriend 
assay which is described in section 2.6.2.2. This system is very effective in the production of 80HDG, 
converting «  1 in 10“* dG residues into 80HDG, and was used to assess the potential of a range of 
scavengers to inhibit the reaction. The results are shown in table 3.3. Mannitol and thiourea, both
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A. UV Irradiation of dG B. UV Irradiation of DNA
Unita o l eO H O Q Units o l aO H D Q
Figure 3.4
Effect of UV irradiation on dG (figure 3.4a) or DNA (figure 3.4b) in the absence or presence of 1.3mM Fe(NHp^(SO^)^. Levels of
80HDG produced represent means ± ISD of five separate experiments.
80HDG as % of value
obtained for 6o minutes exposure to UV radiation
C o n tro l
50 mM Thiourea
0.5 itiM D esferrioxam ine 
500 ixq/m l Catalase 
100 jLtg/ml SOD
dG DNA
98±1.5 9812.1
9.7±2.4 P<0.001 10.812.6 p<0.001
15912.9 P<0.001 11912.3 P<0.001
2111.6 p< 0 .001 1911.6 p<0.001
9411.2 NS 9611.8 NS
r '
Table 3.2
Effect of ROS scavengers and the iron chelator desferrioxamine on the conversion of dG to 80HDG by exposure of 2.SmM dG or 0.5mg/ml
DNA to 60 minutes of UV radiation. The results are means ± ISD of three separate experiments with significance values obtamed by paired t-test.
% 80HDG generated 
compared to control
Significance
(t-test)
2.5inM dG + 50mM H2O2 
50mM M ann ito l 
50mM Thiourea 
lOO/zg/ml SOD 
liiiM  D esferrioxam ine 
SOitiM Cyste ine
100±1.79
74±2.30
63±1.92
134±2.39
154±3.19
0.410.3
p<0.001 
p<0.001 
p<0.001 
p<0.001 
p<0.001
in
Table 3.3
Effect of ROS scavengers and the iron chelator desferrioxamine on the conversion of dG to 80HDG by exposure of 2.5mM dG to 50mM
HjOj in the Udenfriend reaction. Results are means ± ISD of three separate experiments and significance values were obtained by paired t-test.
hydroxyl radical scavengers, inhibited the conversion of dG to 80HDG by 26% and 37% respectively. 
Cysteine, a general scavenger of all oxygen radicals, was most effective in inhibiting the reaction with 
no significant production o f 80HDG above control values. Desferrioxamine caused a significant 
increase in generation of 80HDG (54% - p<0.001) as did SOD (34% - p<0.001).
3.1.3.6:HjOjand DNA
Hydrogen peroxide, in the presence of a reducing agent, lOmM AA, reacted in the absence of any added 
metal ions to produce 80HDG within the DNA backbone in a dose-dependent manner, the maximum 
concentration of used being 200|tM (figure 3.5a). The reaction was enhanced by addition of 
Fe(I0 to the DNA at concentrations up to 4mM, and plateaued with concentrations up to 8mM; beyond 
this the addition of Fe(II) inhibited the production of 80HDG (table 3.4). In the absence of H^O  ^ there 
was no significant reaction of either AA or Fe(II) with DNA in terms of 80HDG production; however, 
alone induced significant production of 80HDG (p<0.01) (figure 3.5b).
3.1.4: Discussion
In each of the model systems studied, there was no significant production of 80HDG in the control 
samples of DNA. This suggests that the preparations of DNA used did not undergo significant oxidative 
damage either in their commercial processing or during the extraction procedures described in section 
2.3.1.4.
Steady-state gamma radiolysis of dG produced 80HDG only after addition of Fe(II) to the solution. 
However, incubation of dG with Fe(II) alone did induce formation of 80HDG (figure 3.1). This may 
be accounted for by auto-oxidation of Fe(Il) to Fe(III) producing ROS (Halliwell and Gutteridge, 1985). 
Conversion of dG to 80HDG was inhibited by formate and thiourea, suggesting that O^-' does not 
directly contribute to the formation of the adduct, 80HDG (table 3.1). There is evidence that the 
conversion of 80HDG to dG is mediated by OH- in many but not all situations (Floyd et al., 1989; 
Kohda et al., 1987) and gamma irradiation is known to produce OH- free in solution (section 2.4.1). 
The poor yield of 80HDG from dG after gamma radiation in the absence of Fe(ll) suggests that 
exposure of dG to OH- does not proceed favourably unless metal ions are present. The conversion of 
dG to 80HDG was further enhanced in the presence of phenylalanine. Peroxyl radicals have a half-life 
of »5-10  times longer than OH- (von Sonntag, 1988) and probably enhance 80HDG production by
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Figure 3.5
Figure 3.5a shows the effect of in the presence of a reducing agent (AA) on 80HDG formation in DNA. Figure 3.5b shows the
contributions of AA, Fe(II) and alone, or in combination, to 80HDG formation in DNA. Results shown are means ± ISD of three separate
experiments.
C oncentra tion  
Fe(II) mM Arbitrary Units of 80HDG
0 7.4±1.2
1 1 5 .1±2.1
2 18.0±2.2
4 20.0±1.7
8 1 6 .1±1.9
16 7.311.3
32 1.1+0.9
64 0.510.2
00
O'
Table 3.4
Effect of increasing concentrations of Fe(II) - Fe(NH )^ (^SO )^ ,^ on 80HDG formation from 0.5rag/ml DNA incubated with 200/xM in
the presence of lOmM AA. Results are means ± ISD of three separate experiments.
increasing the time period over which .paconversion can take place. Peroxyl radicals are also more 
lipophilic than OH- (von Sonntag, 1988) and may be able to diffuse closer to the dG molecules that are 
themselves poorly soluble in water.
The ability of desferrioxamine to enhance the production of 80HDG was surprising, but may be 
explained by its chemical structure: desferrioxamine is a hydroxylamine compound containing three 
ionised hydroxamic acid groups (-NOH). On irradiation, a nitroxide free radical is formed (DFNO-) 
which is sufficiently long lived to be observed by electron spin resonance (Davies et al., 1987; Willson, 
1988). It is possible that this radical may also participate in the production of 80HDG and by virtue of 
its greater stability, will continue to react with dG after all the OH- has been consumed. The reaction of 
H^O  ^with dG was also enhanced by desferrioxamine, suggesting that H^O^-treated desferrioxamine may 
also generate a denaturing species, possibly the nitroxide radical (table 3.3). Alternatively, the 
enhancement o f the reaction may result from acceleration of the conversion of Fe(II) to Fe(III), 
generating ROS, catalysed by the removal of Fe(IlI) by chelation, which would otherwise drive the 
equilibrium reaction back in the direction of H^O  ^and Fe(II) formation (reaction 6, section 1.1.2.2)
Gamma irradiation of DNA produced 80HDG in a dose-dependent manner by a mechanism independent 
of exogenous Fe(II). The reaction was inhibited by thiourea, ethanol and formate (table 3.1). The 
enhancement of 80HDG production by phenylalanine was evident but not as marked as for dG in 
solution. Although irradiation of phenylalanine produces the peroxy radical which is more lipophilic 
than OH- and may be more able to diffuse into the groove region of the DNA molecule where the base 
residues are situated, the poor enhancement of the reaction suggests that the peroxy radical cannot react 
with the DNA base, dG, any more effectively than OH-, despite its longer half-life and different 
chemical characteristics. Alternatively it may be that peroxy radicals react preferentially with DNA 
components other than dG, to form damage products undetected in this system.
The mechanism of formation of 80HDG may differ between dG in solution and dG as an integral part 
of the DNA molecule because Fe(II) only serves to promote the production of 80HDG in the case of 
free dG. In DNA, addition of OH- to dG occurs in the absence of exogenous Fe(II). This is probably 
because stability is conferred on radical intermediates in the formation of 80HDG by interactions with 
neighbouring base residues, metal ions, and nuclear proteins and histones (Cullis et al., 1987). dG in
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solution lacks these groups to stabilise radical intermediates: this may explain the requirement of Fe(II), 
needed to lower the activation energy for product formation and to facilitate 80HDG production. It is 
also likely that DNA-bound metal ions act as catalysts of 80HDG production, as Fe(ll) in solution does 
when reacting with dG.
The different mechanisms of 80HDG production in dG and DNA suggest also that 80HDG is not 
produced by a direct energy effect of gamma radiation because this would be less likely to be affected 
by conformational restraints of the individual bases either in free solution or incorporated into DNA.
UV irradiation of dG and DNA produced similar results to those induced by gamma radiation although 
there was less dG converted to 80HDG per mole of radical produced, with each dose compared for UV 
versus gamma radiation. 500 Gy produces 200/rM OH- in solution, compared with UV producing 
200/uM which theoretically can give rise to 400/rM OH-. The lower rate of conversion in DNA 
for UV versus gamma radiation (1 in 10“* bases for UV compared to 1.5 in 10'* bases for gamma) 
probably reflects incomplete conversion of to OH-.
The increased conversion of dG to 80HDG in the presence of Fe(II) may again be explamed in terms of 
stability constants, but UV light also generates H^O  ^ (section 2.4.2) which, in the presence of catalytic 
metal ions, can react in a Fenton reaction to produce OH- (section 2.4.3). Thus, UV light has the 
potential to generate OH-, both from the energetic splitting of H^O^, and its metal ion catalysed 
decomposition, which produces OH- site-specifically. The role of H^O  ^in the production of 80HDG is 
confirmed by the ability of catalase to inhibit the reaction effectively.
Incubation of dG with H^Oj produced 80HDG in the absence of Fe(II) when the reducing compound, 
A A was present. A A has metal ions associated with it which probably react in a Fenton reaction to 
produce OH- (Gutteridge and Wilkins, 1982). Although most of these would preferentially react with 
AA, because of the short distance over which OH- diffuses once formed, some might react with dG. In 
support of this, the reaction was further enhanced in the presence of Fe(II). SOD was found to increase 
the production of 80HDG from 3 in 10  ^to 4 in 10  ^dGs. This finding may be partly explained if the 
catalytic role of SOD is considered: the production of H^O  ^is from the slow spontaneous or faster SOD- 
catalysed dismutation of two molecules of O^-' in an equilibrium reaction. The enhancement of this
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reaction in the presence of SOD ensures that the equilibrium lies in favour of reacting with Fe(II) 
to produce further OH- rather than reacting to produce O^-'.
Inhibition of the reaction of dG with H^O  ^by thiourea was not as marked as for inhibition of the gamma 
radiation induced 80HDG. This probably reflects the site-specific generation of OH- by H^O ,^ and is 
supported by marmitol providing even less inhibition, itself reacting with OH- at a rate « 4  times slower 
than thiourea. The importance of 80HDG as an oxidative product of DNA is shown by the significant 
inhibition of the reaction by cysteine, a scavenger of all reactive oxygen products.
The reaction of DNA with H^O^ to generate 80HDG was again enhanced by the presence of Fe(II) in a 
dose-dependent manner up to a concentration of «8mM (table 3.4). Further increases in concentration 
of Fe(II) in the medium caused a reduction in the levels of 80HDG produced. This suggests that 
may be rate-limiting such that there is no further H^O  ^ to react with the added Fe(II). However, since 
redox cycling of metal ions can also generate radicals (Halliwell and Gutteridge, 1985) it is likely that a 
fraction of the 80HDG formed after apparent saturation of the system is from iron-mediated reactions 
only. Since Fe(Il) would not normally inhibit this reaction it seems likely that the reduced levels of 
formation of 80HDG seen at high iron concentrations reflects a saturation of the solution with iron such 
that it successfully competes with the DNA for any OH- produced and in this way acts as a scavenger, 
preventing OH- from reacting with DNA.
In summary, there is a clear requirement for metal ions to catalyse the reaction of OH- with free dG, 
and to a lesser extent with dG in DNA, to produce 80HDG. This is probably explained by the presence 
of DNA-bound metal ions, which in turn will direct the production of OH- to localised regions of the 
DNA backbone. The difference in scavenging ability of thiourea, for example, also highlights the 
different mechanisms whereby OH- is produced. Thiourea can scavenge OH- produced by gamma 
irradiation of aqueous solution more effectively than OH- produced from H^O^, gamma radiation 
forming OH- in solution whereas H^O^ reacts with DNA-bound metal ions, forming OH- in close 
proximity to DNA where the scavenger has only limited access.
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CHAPTER 3.2: DAMAGE TO DEOXYRffiOSE 
3.2.1: Introduction
The sugar-phosphate backbone is the region of the DNA molecule exposed to the surrounding aqueous 
environment. It is therefore a primary target for attack by cellular and exogenous genotoxins including 
ROS.
In vitro it has been shown that high energy radiation of aqueous solutions and the oxidation of metal ions 
both produce OH- that can react with carbohydrates, such as deoxyribose, to form a TBA reactive 
product (Scherz, 1968; Halliwell and Gutteridge, 1981). The TBA reaction has been used extensively to 
detect oxidative damage to lipids: during lipid peroxidation the peroxides break down to form carbonyls, 
which form a characteristic chromogen with 2 molecules of TBA (Sinnhuber, Yu and Yu, 1958).
Malondialdehyde (MDA) is one such carbonyl produced during lipid peroxidation measured by the TBA 
assay; it has been suggested that free MDA is a minor component of oxidised lipid, and that most of the 
MDA is derived from peroxidic precursors which decompose to MDA during the acid heating stage of 
the assay (Gutteridge, 1981). In a similar way, Halliwell and Gutteridge (1981) have demonstrated that 
deoxyribose reacts in the presence of Fe(II) to form a TBA-reactive compound in a hydroxyl-radical 
mediated reaction.
However, reaction of deoxyribose within the DNA molecule has not previously been investigated for 
ROS generated in the model systems described in section 3.2.2. Since deoxyribose degradation is 
known to be associated with the formation of single strand breaks, the TBA assay was used to 
investigate the effects of ROS on deoxyribose, as an integral part of the DNA molecule rather than as an 
isolated sugar, thereby characterising damage to the DNA backbone.
3.2.2: Methods
The TBA reactivity of deoxyribose as a component of the DNA backbone was investigated using an 
assay based on that described by Halliwell and Gutteridge (1981). The reaction mixture contained 
Fe(NHPj(SOp^ at a Final concentration of 4mM, and human dsDNA at 50^ig/ml in a final volume of 
1ml PBS, pH 7.4.
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The reagents were incubated at 37°C for one hour after which 1ml of I % TBA and 1ml of 2.8% 
trichloroacetic acid were added to all the samples prior to a second incubation at 100°C for 10 minutes. 
The samples were left to cool and the chromogen was measured fluorimetrically at excitation 532nm and 
emission 553nm using excitation and emission slit widths of lOnm.
All reagents were made up daily for the assay.
3.2.3: Results
3.2.3.1: Gamma Irradiation of DNA
DNA (0.5mg/ml in 40mM sodium phosphate buffer) was denatured by gamma radiation as described in 
section 2.4.1.1, at increasing doses from 0 to 1000 Gy. The DNA was diluted to 50/ig/ml in PBS for 
use in the TBA assay.
Native dsDNA showed no significant reactivity with the TBA reagent. However, following exposure to 
irradiation there was an increase in TBA reactivity, which was linear up to «750 Gy. Higher doses of 
radiation did not cause any further significant increase (figure 3.6a).
3.2.3.2: UV Irradiation of DNA
DNA irradiated by UV as described in section 2.4.2.1 was assessed for TBA reactivity at 50/rg/ml. The 
DNA was irradiated for a maximum of 60 minutes, with aliquots removed at 15 minute intervals. 
During this time there was no significant increase in the TBA reactivity above the background level 
(figure 3.6b).
3.2.3.3: and DNA
DNA was denatured with H^O  ^and AA as described in section 2.4.3.1 using doubling dilutions of H^ O^
from 220^M to 3.44fiM; TBA reactivity of 50^g/ml DNA was assayed.
It was found that production of the chromogen increased exponentially following exposure of DNA to 
H^O^ (figure 3.6c).
For comparison of results on the basis of moles of radicals produced, data is shown up to 220fiM H^O  ^
only.
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Figure 3.6
The formation of TBA reactive products following exposure of DNA to gamma radiation (3.6a), UV radiation (3.6b) and (3.6c). 
Figure 3.6c shows the effects of serial two-fold dilutions of causing an exponential increase in the TBA reactive products. Results shown in 
each graph are means ±  ISD of three separate experiments.
3.2.4: Discussion
Intact deoxyribose does not react with TBA to give a coloured chromogen; it must first be degraded by 
Fe(II) to generate a reactive carbonyl. Native dsDNA at concentrations of 0-100/ig/ml when incubated 
with Fe(II) and TBA reagents did not give a positive reaction. This supports data from Gutteridge, 
Beard and Quinlan (1985) who showed that only after addition of bleomycin to iron and DNA (thus 
forming ROS), did a positive TBA reaction occur. This suggests that deoxyribose, when incorporated 
into the DNA backbone, cannot react with Fe(II) to form a TBA reactive carbonyl.
Nonetheless, ROS-denatured DNA does produce a TBA-reactive compound, probably because 
deoxyribose is exposed and can react with Fe(II). It cannot be determined from these experiments 
whether free deoxyribose is released from DNA before reacting with Fe(II) or whether relaxation of the 
DNA structure by strand breakage is sufficient to allow the TBA reaction to proceed.
The damage caused by gamma radiation reached a plateau at »750 Gy whereas damage induced by 
continued to rise dose-dependently beyond 220/xM. This phenomenon may reflect positioning of 
metal ions along the DNA backbone which direct the production of OH- to sugar residues when reacting 
with By increasing the concentration of H^O^, more metal ions can be reduced back to their1 2 '
reactive state as can act as a reductant and react with Fe(III) to regenerate Fe(II) (reaction 7 - 
section 1.1.2.2).
Gamma radiation produces OH- free in solution (section 2.4.1). Whilst increasing doses may produce 
more OH- (1000 Gy producing »400/xM OH-), there is no targeting of these radicals to the sugar- 
phosphate backbone specifically. OH- will react preferentially with base residues, rather than with the 
sugar-phosphate backbone to produce a single strand break. Therefore, it is possible that initially OH- 
react with the sugar residues to cause strand breaks, base residues being unaccessible. However, this 
will cause a relaxation in the conformation of the DNA molecule due to a reduction in base stacking 
interactions thus rendering OH- accessible to the base residues. OH- will then react preferentially with 
the bases (Prigodich and Martin, 1990) rather than the sugar-phosphate backbone and therefore, any 
further DNA damage caused will not be detectable in the TBA assay.
UV light showed no significant ability to produce a TBA reactive product from DNA. Whilst UV light
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is predominantly absorbed by the DNA bases (Deering, 1962), it is known to cause strand breaks by 
cleaving the sugar-phosphate backbone (Kaufmann and Briley, 1987). Therefore, it seems likely that 
UV light does affect deoxyribose. It is, however, possible that the magnitude of damage caused to 
deoxyribose during strand break production cannot be detected by the TBA assay system used.
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CHAPTER 3.3: ANALYSIS OF DNA STRAND BREAKS 
3.3.1: Introduction
There are at least two postulated mechanisms by which DNA strand breakage can occur: via the 
cleavage of the phosphodiester linkages in one of the polynucleotide chains (a mechanism used by DNA 
repair enzymes), or via destruction of the deoxyribose ring.
The presence of a single-strand break in DNA causes localised denaturation of the molecule and 
increases the probability of further attack at this site by nucleases, and potentially ROS, due to the loss 
of the protective effect of base-stacking interactions. The single-strand break is one of the major types 
of lesions produced by reaction of OH- with DNA but is not usually lethal (Ward, 1985); it is double­
strand breaks which are thought to be the lesions responsible for causing cell death following oxidative 
damage (section 1.1.5.4) (Frankenberg et al., 1981).
Since low levels of base damage have been previously difficult to measure by physical or chemical 
means, (Paterson, 1978) strand break assays, by virtue of their greater sensitivity, have been widely 
employed by radiation biologists, to characterise DNA damage. The two techniques commonly used are 
alkaline filter elution and alkali unwinding. In alkaline solution, hydrogen bonds stabilising the DNA a  
helix are broken and the two strands unwind. The rate of unwinding is accelerated in the presence of 
strand breaks (Ahnstrom and Erixon, 1973). In such alkaline conditions the types of lesions measured 
include acUial strand breaks and alkali-labile bonds; the latter can be further divided into base deletions, 
apurinic/apyrimidinic sites, neutral labile sites and alkali-labile sites. Therefore both assays are 
measuring the sum of the yields of a variety of distinct chemical lesions.
The principle of the alkaline elution assay is to measure strand breaks based on the molecular weight 
dependent retention of the molecule on a 2/im pore size polyvinylchloride filter. The initial DNA 
elution rate and the logarithm of the unaffected DNA fraction are both proportional to the amount of 
DNA damage (Blakely, Ward and Joner, 1982). However, the assay requires radiolabelling of cellular 
DNA prior to analysis, which is not appropriate for non-dividing cells and is very time-consuming.
The alternative alkaline-unwinding assay (FADU) uses the fluorescent dye, ethidium bromide, as a 
direct probe of DNA structure (Bimboim and Jevcak, 1981). Ethidium bromide will selectively bind to
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double-stranded DNA in the presence of single-stranded DNA, when short duplex regions in single- 
stranded DNA are destabilised by alkali. Conditions of the assay show fluorescent enhancement 
preferentially with dsDNA with little interference from RNA, ssDNA or other cellular molecules 
(Bimboim and Jevcak, 1981).
The FADU assay was used to analyse directly strand breaks induced by different ROS interacting with 
the DNA molecule, to compare the damage caused by each of the ROS-generating systems, and to 
investigate the effects of the strand breaks produced on cell viability.
3.3.2: Methods
The principle of the FADU assay is to calculate the percentage double stranded DNA in a sample, based 
on the difference in fluorescence between a sample containing total dsDNA and a sample containing 
negligible dsDNA.
The contribution to fluorescence by components other than dsDNA is estimated from a blank sample (B) 
in which the cell extract is sonicated and then treated with alkali under conditions which cause complete 
unwinding of low molecular weight dsDNA.
A second sample measures total fluorescence (T). The difference provides an estimate of the amount of 
double-stranded DNA in the extracts. The strand breaks induced by a DNA damaging agent in a 
particular sample (P) are measured as the fluorescence of the sample less the fluorescence of the blank 
(P-B) and are expressed as a percentage of the total double-stranded DNA (T-B).
The double-stranded DNA remaining (D) is calculated as:
D = (P-B)/(T-B) x 100
To determine the strand breaks induced by ROS in the DNA of PBMC, the cells were isolated from 
whole blood as described in section 2.3.3.1 and resuspended to a final concentration of 5 x 10* cells/ml 
in 0.25M meso-inositol-lOmM sodium phosphate-lmM MgCl^ (pH 7.2). Aliquots of this suspension 
(0.2ml) were distributed in quadruplicate to disposable glass tubes, designated T, B, or P. 0.2ml 9M 
urea-lOmM NaOH-2.5mM cyclohexanediaminetetraacetate-0.1 % SDS (A) was added to each tube, 
which were then incubated at 0“C for 10 minutes to allow cell lysis and chromatin disruption to occur.
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All tubes were then transferred to an area of subdued lighting for completion of the assay. To tubes P 
and B, 0.2ml of 0.45 volumes A in 0.2M NaOH was added gently without mixing and the tubes were 
incubated for a further 30 minutes at 0°C allowing alkali diffusion into the lysed cell suspension. The 
contents of tubes designated B were then sonicated for 1-2 seconds to cause rapid denaturation of the 
DNA in alkali, and both tubes P and B were incubated at 15®C for 15 minutes. Denaturation was 
stopped by chilling the tubes to 0 “C and adding 0.4ml IM glucose-14mM mercaptoethanol. After 
mixing, the tubes were vortexed, diluted with 1.5mls 6.7/<g/ml ethidium bromide-13.3mM NaOH and 
the fluorescence read immediately at excitation 520nm, emission 590nm. A lOnm slit band width was 
used for both wavelengths.
The T tubes d iffe r from  the P tubes in that the neutralising so lu tion  (IM  glucose-14mM  
mercaptoethanol) is added before the alkaline solution (0.45 volumes A in 0.2M NaOH) so that the 
DNA is never exposed to a denaturing pH. The percentage D values were calculated as described above 
for damage to DNA induced by ROS.
3.3.3: Results
3.3.3.1: Gamma Irradiation of PBMC
Isolated cellular DNA (section 3.3.2) was exposed to gamma radiation from 0 to 200 Gy at a dose of 25 
Gy/minute at O 'C, and was analysed for the presence of DNA strand breaks and for cell viability 
(section 2.3.3.3). An initial lag in the development of strand breaks was seen, followed by a rapid 
decrease at doses greater than 100 Gy (figure 3.7a). Parallel investigation of viability showed that the 
greatest reduction in cell viability occurred before the rapid decrease in dsDNA (figure 3.8a).
The formation of strand breaks was inhibited by irradiating cells in the presence of 50mM thiourea 
(p<0.01) and lOmM ethanol (p<0.01) (figure 3.9). Catalase, desferrioxamine and SOD did not inhibit 
the formation of strand breaks in this system.
3.3.3.2: UV Irradiation of PBMC
PBMC were irradiated on ice for a maximum of 60 minutes to produce DNA strand breaks. An initial 
lag in the onset of strand breaks was followed by a linear decrease in dsDNA plateauing after 30
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Figure 3.7
Effect of increasing exposure of DNA from PBMC to gamma radiation (3.7a), UV radiation (3.7b) and (3.7c). Results show the % 
dsDNA remaining with increasing doses of ROS, as means ± ISD of three separate experiments.
A. C stls  Exposed  to Oamma Radiation B. Cells Exposed  to UV Radiation C. Cells Exposed  to H 202
Figure 3.8
Decreases in cell viability induced by exposure of PBMC to increasing doses of the ROS-generating systems: gamma radiation (3.8a), UV 
radiation (3.8b) and (3.8c). Results are means ± ISD of three separate experiments.
100
% dsD N A  remaining
Bb I  0 Gy NW^WNl 200 Gy
Omni ♦Thiourea i I ♦Ethanol
Figure 3.9
Effect of desferrioxamine (desfer - 0.5mM), catalase (27,000 units/ml), thiourea 
(50mM), ethanol (lOniM) and SOD (3,000 units/ml) on the %  dsDNA remaining after 
exposure to 200 Gy. The control value (0 Gy) and the %dsDNA remaining after 
exposure to 200 Gy in the absence of any inhibitors are shown for comparison. Results 
are means ±  ISD of three separate experiments.
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minutes UV irradiation with =20% dsDNA remaining (figure 3.7b). Viability studies showed that the 
decrease in dsDNA corresponded well with cell death (figure 3.8b).
The presence o f catalase and thiourea inhibited the reaction significantly, (p <0.001 and p < 0.01 
respectively) (figure 3.9). Ethanol also inhibited the formation of strand breaks by 41% (p<0.01) 
but irradiation in the presence of desferrioxamine and SOD had no significant effect on the level of 
DNA damage caused as measured by the FADU assay.
3,3.3.3: HjOj and PBMC
Incubation of PBMC with increasing concentrations of from 0 to 200/rM at 37°C for 30 minutes 
induced strand breaks in the DNA, (figure 3.7c) and a decrease in cell viability (figure 3.8c). The 
percentage dsDNA remaining did not decrease significantly beyond 75^ <M at which point 21% of 
cells were still viable.
Catalase inhibited the reaction by 93% (p< 0.001), thiourea by 54% (p<0.01) and desferrioxamine by 
66% (p<0.01) (figure 3.9). Ethanol inhibited the formation of strand breaks by 43% (p<0.05) but 
SOD was once more ineffective in preventing strand break damage to DNA.
3.3.4: Discussion
The FADU assay measures strand breaks in DNA by the intercalation of the fluorescent dye, ethidium 
bromide, into the intact structure. The results demonstrate that ROS generated by each of the model 
systems produces strand breaks.
The incorporation of scavengers into the experimental ROS generating systems shows that O^-' is not 
responsible for the DNA strand breaks, SOD being unable to inhibit the production of strand breaks. 
Since all systems generate OH-, the results also show that gamma radiation produces OH- that can be 
scavenged more effectively than OH- generated by UV or since thiourea and ethanol inhibited the 
formation of strand breaks to a greater extent in the radiolysis system. This almost certainly reflects the 
potential for gamma radiation to form OH- free in solution by the energetic cleavage of water molecules 
(section 2.4.1). These radicals are accessible to scavengers, whilst UV, and H^O  ^especially are more 
dependent on DNA-bound metal ions to form OH- (sections 2.4.2 and 2.4.3). These radicals react site-
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specifically and therefore, preferentially, with DNA rather than the scavenger molecules.
Inhibition by desferrioxamine in the model, infers that DNA bound metal ions are involved in the 
generation of strand breaks. In the UV model, can be split into OH- by homolytic cleavage, as 
well as reacting with any DNA bound metal ions: as a result, OH- formation is not so dependent on 
metal ions. Inhibition of strand break formation with desferrioxamine was not as marked in the UV as 
in the H^O^ system, and although it caused a slight increase in the level of dsDNA remaining this was 
not significant.
The different mechanisms of OH- generation also appeared to affect the targeting of the DNA damage: 
after exposure to gamma radiation, in contrast to the iron chelator desferrioxamine, OH- scavengers 
were effective in the prevention of strand break formation. This may be partly a result of the generation 
o f OH- independently of metal ion catalysis and partly due to the generation of strand-breaking 
nitroxide radicals (Davies et al., 1987; Willson, 1988) following irradiation of the desferrioxamine 
molecule.
Comparing the three models of ROS generation, there is always an initial lag before the percentage 
dsDNA decrease to =20%  dsDNA. This level is reached following irradiation of cells with 200 Gy 
(equivalent to formation of 80^M OH-), or by incubating cells with =75/xM H^O ,^ which can give rise 
to the same concentration of OH-. For UV, at 30 minutes irradiation the concentration of OH- in 
solution can approach 200/rM if there is complete conversion of H^O  ^ to OH- by homolytic fission. 
However, the results suggest that OH- levels reached by UV in solution only approach 100/iM if strand 
breaks are formed by the same mechanism in each of the systems studied. This may represent either 
incomplete homolysis of or reaction of two molecules of OH- together, to drive the equilibrium 
reaction back in the direction of formation.
The initial lag period before the rapid decrease in dsDNA in each of the systems (figures 3.7a, 3.7b and 
3.7c) were also seen in studies by Ward (1975). This probably represents the formation of initial strand 
breaks which do not change the conformation of the DNA molecule and therefore do not allow 
penetration of the dye into the structure. Once a critical number of strand breaks has been produced, 
unwinding is accelerated (figure 3.7).
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Whilst the three systems damage cellular DNA to the same extent in terms of percentage strand breaks 
formed, analysis of the cell viabilities suggests that strand breaks induced by gamma radiation are 
potentially more lethal to the cell than those produced in the other two systems. Gamma radiation 
produces spurs in which radicals are highly concentrated and can react to produce multiple damaged 
sites, ie many radical attacks in close proximity to each other (Ward, 1985). These have been shown to 
be more lethal than singly damaged sites (Ward, 1988). Since reacts with bound metal ions, it 
will produce OH- at these discrete sites along the DNA backbone. From these results obtained in this 
section, it appears that this distribution of damage is more easily tolerated by the cell than the multiple 
site damage caused by gamma radiation.
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CHAPTER 3.4: ANALYSIS OF DNA STRAND BREAKS IN NUCLEOIDS 
3.4.1: Introduction
When cells are lysed in the presence of non-ionic detergents and high salt concentrations, structures 
resembling nuclei are released (Cook and Brazell, 1976). These are referred to as nucleoids and contain 
nearly all nuclear DNA and RNA but are depleted of histones and lack most chromatin proteins (Cook, 
Brazell and lost, 1976).
The DNA packaged in nucleoids is superhelical and about lO”* single strand breaks are required to 
destroy the DNA supercoils (Cook and Brazell, 1975).
The conformation of populations of nucleoids has been measured by sedimentation in sucrose gradients, 
any single strand breaks present, allowing the DNA to unwind and sediment less rapidly than a 
population of intact nucleoids (Pitout et al., 1982). This principle has been applied by Milner, Vaughan 
and Clark (1987), to determine damage to nucleoids using a flow cytometer. Extracted nucleoids 
stained with the fluorescent dye, ethidium bromide, are individually exposed to laser light within the 
flow cytometer. The intensity of scattered and fluorescent light from each are expressed graphically as a 
frequency histogram.
Allan et al., (1988) have successfully demonstrated the use of this technique to analyse ROS damage to 
nucleoids isolated from PBMC. In the following section damage to DNA nucleoids has been studied 
more extensively in an attempt to identify the precise ROS involved and their mechanism of action.
3.4.2: Methods
PBMC were isolated from whole blood as described in section 2.3.3.1 and exposed to ROS (see sections 
2.4.1.3, 2.4.2.3 and 2.4.3.3). Irradiation of RPMI-1640, or supplementation of the medium with 
H^O^, provided a highly reproducible oxidant environment in which to culture cells. The cells were 
resuspended immediately after recovery from the culture medium, at a concentration of 1 x 10* cells/ml 
in 1ml lysis buffer containing 2M NaCl, lOmM Tris (hydroxymethyl)methylamine and lOmM EDTA. 
The cell suspension was stored on ice for 30 minutes and then analysed by FACS according to the 
method of Milner, Vaughan and Clark (1987).
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Briefly, each sample was stained with 50^g/ml ethidium bromide and analysed 90 seconds later, 
approximately 45 seconds after dye-substrate equilibrium had been reached. Nucleoids were drawn into 
a flow chamber and ejected singly through a 60 diameter orifice in a stream of PBS at a rate of 
400/second. Ten microns below the point of injection the sample stream was intercepted by an argon 
488nm laser beam, and light scattered from the nucleoids was collected by a photomultiplier array and 
single semiconductor detector. Forward scattered laser light was detected by the semiconductor sensor 
lying opposite the light source. The intensity of scattered light from each nucleoid was recorded as a 
digital signal and stored by the computer as a data point in a frequency histogram (10,000 nucleoid 
events were recorded for each sample).
3.4.3: Results
3.4.3.1: Gamma Irradiation of RPMl-1640
PBMC were incubated in irradiated RPMI-1640 (0-1000 Gy), for 24 hours prior to analysis of the cell 
derived nucleoids by FACS.
The expansion of PBMC-derived nucleoids following exposure to ROS generated by gamma irradiation, 
was not linear; there was only a significant difference between the unirradiated control sample and the 
PBMCs exposed to RPMI-1640 which had received a dose of 1000 Gy (figure 3.10).
To investigate the effects of ROS scavengers and the iron chelator desferrioxamine, these reagents were 
added to the RPMI-1640 prior to its irradiation. 50mM thiourea and lOmM ethanol were able to protect 
the cells against the damage caused by a dose of 1000 Gy by 50% (p<0 .01) and 62% (p<0.01) 
respectively; desferrioxamine in contrast, offered no significant protection (figure 3.10).
3.4.3.2: UV Irradiation of RPMI-1640
RPMI exposed to UV light for a maximum of 60 minutes was then incubated with PBMC for 24 hours 
prior to FACS analysis. The effect of ROS scavengers and the iron chelator desferrioxamine was 
investigated by UV irradiation of the culture medium in the presence of catalase (27,000 units/ml), 
thiourea (50mM) or desferrioxamine (0.5mM).
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Figure 3.10
Effect of gamma radiation on nucleoid expansion and the protective nature of 
thiourea (50mM), ethanol (lOruM) and desferrioxamine (0.5mM). The nucleoids were 
isolated from PBMC incubated for 24 hours in complete culture medium (section 2.1,6) 
which had been exposed to gamma radiation prior to use (section 3.4.3.1). Results are 
means + ISD of the median channel numbers of three separate experiments.
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Following exposure to UV radiation, a dose-dependent increase in the median channel number was 
observed (figure 3.11) representing an increase in the size of the nucleoid population.
Catalase was an effective inhibitor of the damage, reducing nucleoid expansion by 40% (p<0.01) in 
samples exposed to 60 minutes UV. Thiourea, an OH- scavenger and metal ion chelator, also offered 
significant protection against ROS-mediated damage (53% - p<0.01). Again, desferrioxamine, showed 
no significant inhibition of the effect of UV light on nucleoid populations.
3.4.3.3: and RPMI-1640
The effect of addition of to PBMC from 0 to 200//M for 24 hours on the cell-derived nucleoids is 
shown in figure 3.12. Concentrations of up to 50^M appeared to be tolerated by the cells; at lOOuM 
concentration there was a significant increase in median channel number indicative of nucleoid 
expansion, with a further increase after exposure to 200^M H^O .^ The effect of ROS scavengers and 
the iron chelator desferrioxamine was investigated by adding these reagents to the medium with H^O .^
As for gamma radiation, thiourea was an effective inhibitor of the production of DNA strand breaks 
induced by 200/rM (54% - p < 0 .01). In this case, desferrioxamine also inhibited nucleoid
expansion (31 % - p < 0.01).
3.4,4; Discussion
This technique uses FACS to measure differences in light scatter between a control population of 
nucleoids and a population of nucleoids exposed to ROS generating systems. An increase in light scatter 
represents a relaxation of the DNA structure and this has been postulated to be caused by strand breaks 
nicking the superhelical structure (Milner, Vaughan and Clark, 1987). Alternatively, a diminished 
pattern of light scatter represents a decrease in size of the nucleoid population and is caused by increased 
association or cross-linking of the DNA within the superhelix.
Gamma irradiation of RPMI-1640, and its subsequent addition to cells, caused a significant increase in 
the size of the nucleoids analysed only after exposure to a dose of 1000 Gy. Irradiation of the medium 
produces OH- but these species have a short half-life and would not be predicted to remain in the 
medium. Instead, the radical species most likely to predominate is the longer-lived peroxy radical.
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Effect of UV radiation alone and in the presence of catalase (27,000 units/ml), 
thiourea (50mM) and desferrioxamine (0.5mM) on PBMC nucleoid expansion. The 
nucleoids were isolated from PBMC previously incubated for 24 hours in complete 
culture medium (section 2.1.6) which had been exposed to UV radiation prior to use 
(section 3.4.3.2). Results are means ± ISD of median channel numbers obtained in 
three separate experiments.
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F igu re  3.12
Effect of H^O^ alone and in the presence of thiourea (SOmM), desferrioxamine 
(O.SmM) and mannitol (SOmM) on PBMC nucleoid expansion. The nucleoids were 
isolated from PBMC previously incubated for 24 hours in complete culture medium 
(section 2.1.6) to which 200^M had been added. Results are the means ± ISD 
of median channel numbers from three separate experiments.
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formed from the interaction of ROS with lipids and aromatic amino acids present in the culture mediunL 
The results would suggest that a high dose of gamma radiation (1000 Gy), is required to produce 
sufficient concentrations of the damaging agent to cause strand breaks that induce nucleoid expansion. 
Both thiourea and ethanol were able to offer protection against nucleoid-damage. Both are OH- 
scavengers and their presence in solution consumes free OH-, thereby preventing the formation of any 
longer-lived radical species such as the peroxy radical. Desferrioxamine can chelate iron to prevent 
Fenton-generated OH- but this is not the major mechanism for the production of OH- in a gamma 
irradiated system. Desferrioxamine can also react with OH- (K »  lO'® M‘* s ') (Hoe, Rowley and 
Halliwell, 1982; Halliwell and Gutteridge, 1989, pp 188-276) but as described in section 3.1.4 upon 
irradiation it can also form a long lived nitroxide free radical. Therefore, the lack of protection by 
desferrioxamine against damage is most likely explained by its inability to prevent the formation of a 
longer-lived radical species which could cause DNA damage in this system.
In a similar study of the effects of gamma radiation on nucleoid expansion, Allan et al., (1988) found 
that preincubation of PBMC with desferrioxamine prior to direct irradiation of the cells was also unable 
to prevent ROS-induced damage to DNA. This might also be explained by formation of the nitroxide 
radical species and an inability of desferrioxamine to scavenge OH- as effectively as thiourea or ethanol.
UV irradiation of medium caused a dose-dependent increase in nucleoid expansion. The effect was 
inhibitable by catalase and thiourea; desferrioxamine also reduced nucleoid expansion but this was not 
significant. This suggests that produced in solution by UV light, may react with DNA-bound
metal ions to produce OH-, which damage the DNA in a site-specific manner. However, the 
predominant OH- production is from direct homolytic fission of H^O .^
Similar results were obtained for cells cultured in medium containing H^O .^ Whilst low concentrations 
of H^O  ^appeared to be tolerated well by the cells, significant damage was detected in samples incubated 
with concentrations of H^O^ exceeding lOO/rM. At concentrations lower than this, the strand breaks 
randomly induced along the DNA backbone may be present in such insufficient numbers and so spatially 
distributed that they do not cause a significant relaxing of the superhelical structure.
At 37°C cells also have the capacity to repair single strand breaks (Ward JF et al., 1987). DNA
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damage has been shown to stimulate the nuclear enzyme, poly-ADP-ribose polymerase (Schraufstatter et 
al., 1986), which is associated with DNA repair and catalyses the conversion of NAD to nicotinamide 
and protein-bound poly-ADP-ribose. This process depletes the cell of NAD and subsequently of ATP, 
such that excessive repair of single strand breaks leads to cell death, not as a direct result of the 
presence of strand breaks but from depletion of cellular metabolites. This process may, however, be an 
inbuilt suicide mechanism for the cell. As described in section 1.1.5.4, strand breaks opposite each 
other may be incorrectly repaired, and as the concentration of strand breaks increases this event will 
become more frequent. The energy depletion caused by large numbers of strand breaks prevents repair 
of these strand breaks so ensuring that mis-paired strands are not replicated. This mechanism acts to 
maintain the fidelity of the genetic code.
It is possible that the lack of nucleoid expansion induced by low concentrations of represents a 
tolerance to damage by repair of strand breaks and that expanded nucleoids reflect DNA derived from 
cells of low viability no longer able to repair ROS-induced DNA damage.
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CHAFl'ER 3.5: CIRCULAR DICHROISM 
3.5.1: Introduction
Circular dichroism (CD) is a type of electronic absorption spectroscopy that uses circularly polarised 
light. It is sensitive to the conformation of a molecule and can be applied to randomly orientated 
molecules in solution (Johnson, 1978). To exhibit a CD spectrum a molecule must be assymetric. 
Since most biological molecules are assymetric, CD spectroscopy has been used extensively to 
investigate the conformation of proteins (Cassim and Yang, 1970), nucleic acids (Lewis and Johnson, 
1974) and sugars (Nelson and Johnson, 1976).
CD spectra are sensitive to secondary structure in biopolymers. In native dsDNA the differences in base 
composition and sequence are not sufficient to lead to noticeable differences in the spectra in the UV 
region (400-200nm); however, base-base interactions and the relative orientation of the bases can be 
detected in the vacuum UV region (200-100nm) (Brahms and Mommaerts, 1964; Johnson, 1978).
The CD spectra of native dsDNA typically consists of two parts, one positive with a maximum at 
»273nm and one negative with a minimum at «243nm. At about 252nm the CD is zero and changes 
sign (Brahms and Mommaerts, 1964). In general, the CD spectra of DNA molecules are of low 
intensity but this does not represent a lack of helical organisation in solution (Luzzati, Nicolaleff and 
Masson, 1961). It is thought that within the DNA double helix, with two anti-parallel strands, the 
chromophores within each strand may lead to CD contributions of opposite signs and the resulting 
rotational strengths are therefore subtractive (Josse, Kaiser and Kornberg, 1961; Brahms and 
Mommaerts, 1964).
The experimental evidence indicating that the CD bands of nucleic acids are related to the helical 
conformation, is supported by the fact that disordered forms show no such bands. An increase in 
temperature inducing DNA melting causes a decrease of the CD bands, corresponding to a loss of 
secondary structure (Brahms, 1965).
In this section, the effects of ROS on the gross physical structure of the DNA molecule were 
investigated using this technique.
1 0 4
3.5.2: Methods
CD sp>ectra were recorded on a JASCO J-40CS CD spectrophotometer. The concentration of DNA was 
100/ig/ml in PBS. The optical pathlength used was 1cm. Absorption spectra were measured prior to 
CD measurement on a Cary 17 spectrophotometer.
3.5.3: Results
3.5.3.1: Gamma Irradiation of DNA
DNA was denatured as in section 2.4.1.1 from 0 to 1000 Gy. The CD spectrum obtained for native 
dsDNA showed the typical minimum and maximum at =245nm and «275nm respectively. Irradiation 
of DNA at doses of 200 Gy and 500 Gy showed no significant difference in the CD spectra when 
compared to the control. However, the trace for DNA exposed to 1000 Gy showed a significant 
reduction in both the minimum and maximum peaks which are characteristic of the helical conformation 
of DNA (figure 3.13). The CD spectra obtained following irradiation in the presence of lOOmM 
formate or lOmM phenylalanine were not significantly different from that obtained for the native 
dsDNA.
3.S.3.2: UV Irradiation of DNA
DNA was denatured as in section 2.4.2.1 at 15 minute intervals for a maximum of 60 minutes. Again 
no dose-dependent decrease in the minimum and maximum at =245nm and =275nm was observed, 
with exposure up to 30 minutes. At 45 minutes exposure, however, a sudden shift occurred in the 
spectrum; there was no further detectable change in the DNA structure at 60 minutes (figure 3.14). The 
decrease in both the minimum and maximum peaks by UV irradiation was of a similar nature but of 
lower magnitude to that observed after gamma irradiation. This suggests less damage to the DNA 
molecule occurred causing a smaller change in conformation.
The most obvious change to the DNA following UV irradiation was detected in the 220nm region. 
There was a dose-dependent shift towards the region of far-UV noticeable at 15 minutes increasing 
further with time. There was also a slight increase in intensity of this peak (figure 3.14).
3.5.4: Discussion
The decrease in both minimum and maximum peaks after exposure to gamma irradiation (at a dose of
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Figure 3.13
Effect of gamma radiation on the CD spectrum of DNA. The continuous line represents native dsDNA. The broken line represents dsDNA
exposed to a dose of 1000 Gy. Doses of 500 Gy and less had spectra not significantly different from that of the native dsDNA. Results are averaged
curves from three separate samples exposed to the same doses of radiation in different experiments.
oFigure 3.14
Effect of UV radiation on the CD spectrum of DNA.
— = O minutes UV
—  = 15 minutes UV 
= 30 minutes UV
------ _  45 muiutes UV
Changes were maximum at 45 minutes with the curve for 60 minutes exposure not significantly different from that of 45 minutes. At 15 and 30 
minutes the traces were only different in the 200-220nm region. Results are averaged curves from three separate samples exposed to the same dose 
of radiation in different experiments.
1000 Gy) suggests that the integrity of the DNA structure is altered upon exposure to ROS (section 
3 .5 .1). The lack o f dose-response to gamma radiation implies that the strand breaks induced by 
exposure to low doses of irradiation are not able to cause gross structural damage to the DNA, until they 
are present in large numbers. The ability of formate or phenylalanine to prevent changes to the CD 
spectra occurring, suggests that OH- alone was responsible for the changes induced by exposure to 
gamma radiation.
UV irradiation of an aqueous solution produces 200^M H^O  ^over a period of 60 minutes, the majority 
of this having been formed after 30 minutes. This has the potential to produce 400/rM OH- in solution. 
The changes in CD spectra following UV denaturation of DNA reflect this conversion of water 
molecules to ROS, with the shift in spectra maximised at 45 minutes.
Gamma radiation, however, produces OH- dose-dependently, a dose of 1000 Gy forming 400/xM OH- in 
aqueous solution. The CD spectra for gamma irradiation of DNA showed a greater conformational 
change as a result of reaction of a greater concentration of OH- with the DNA.
In both cases the changes in maximum and minimum peaks were not dose-responsive but occurred after 
a finite amount of damage. This probably reflects the initial protective effect of the hydrogen bonded a  
helix which can tolerate a number of single strand breaks before the secondary structure undergoes 
conform ational changes. The ability of UV derived OH- to cause such changes at a lower 
concentration, may reflect the site-specific production of OH- as a result of the DNA-bound metal ion 
reduction of H^O^ rather than the complete random generation of the molecule in free solution.
The change in the CD spectra at »220nm reflects a change in base interactions (Johnson, 1978). It is 
known that UV light causes production of thymine dimers in DNA (Cerutti, 1976). These dimers are 
cross-linked residues of thymine which can cross-link either the same or the opposite DNA strand. 
Cross-linking will exert a new stability on the DNA molecule which may account for the minor change 
in the maximum and minimum peaks »275nm and =-245nm. The production of thymine dimers 
following exposure to UV was suggested by the appearance on the absorption spectra of a compound 
absorbing at 310nm, characteristic of the dimer residue, which increased with UV dose. Thymine
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dimers are bulky residues and it is this parameter that may influence the CD spectra as demonstrated by 
the shift in the peak maximum from 219nm to 212nm.
Analysis of CD spectra has been used to determine the secondary structure of nucleic acids, chromatins, 
nucleoids, and different forms of DNA and RNA which all give characteristic spectra (Isenberg and 
Johnson, 1971; Rill and Van Holde, 1973). CD has probably been applied most successfully to the 
determination of unknown conformations using previously characterised data. It is clear that the 
changes induced by ROS do not alter the secondary conformation of DNA to an extent that is easily 
detected by CD. Therefore, other methods of structural and chemical determination would seem to be 
more suitable for analysis of ROS-induced damage to DNA.
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CHAPTER 3.6: MONOCLONAL ANTIBODY BINDING TO DNA 
3.6.1: Introduction
In man, the spontaneous production of autoantibodies reactive with DNA and other intracellular and cell 
surface antigens is characteristic of SLE and has been addressed in detail in section 1.2.4. In view of 
the poor immunogenicity of native dsDNA the availability of a mouse model of SLE from which 
monoclonal antibodies (MCA) can be produced is particularly useful.
Autoantibodies from mice with lupus-like disease have been well characterised, and a library of MCA 
reactive with DNA have been derived from two strains, (NZB x NZW)Fj and M R L / M p - l p r / l p r  (Morgan 
et al., 1985a). These have similar characteristics to those produced by Hahn et al (1980) and Jacob and 
Tron (1982).
The MCA can be classified on immunochemical criteria into five groups (Table 3.5). Of these, DNA 
reactive MCA which show cross-reactivity with cardiolipin and other ligands are predominantly 
members of groups II and III, the common property being recognition of different determinants 
expressed on both ssDNA and dsDNA. dsDNA specific antibodies (group I) do not react primarily with 
phosphodiester configurations and MCA reactive with base-dependent determinants do not bind 
cardiolipin.
A panel of these MCA was used to probe the structure and antigenicity of dsDNA following attack by 
ROS, to determine the changes induced by each of the model systems.
3.6.2: Methods
Changes to dsDNA induced by ROS were analysed by MCA in a competition ELISA, the principle of 
which is described in section 2.3.2.2. Volumes pipetted into wells were consistently 50/rl and between 
each stage in the assay the plates were washed three times with PBST. Nunc 96 well plates were pre­
sensitised with poly-L-lysine (25/xg/m] in PBS) for 18 hours at 4®C. Native dsDNA was then added at 
20/tg/ml in PBS for 1 hour at 37°C. Any remaining binding sites were blocked with lOO^g/ml albumin 
for 1 hour at 37 °C to prevent binding of the competing DNA to the poly-L-lysine as well as the MCAs 
themselves. The competing antigen, ROS-denatured DNA, diluted in PBS and titrated at doubling 
dilutions across the ELISA plate from lOOO^g/ml to 2/xg/ml final concentration, was incubated at 4®C
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for 2 hours before an equal volume of MCA (at its optimum working concentration - Table 3.5) was 
added to the wells thus diluting the competing antigen by a factor of 2. The incubation was continued 
for a further 2 hours at 4®C to allow the MCA to bind to the immobilised DNA and the DNA free in 
so lu tion . The plate was then washed and peroxidase-conjugated goat anti-mouse polyvalent 
immunoglobulins diluted 1/350 in PBS were added to label the MCA bound to the immobilised antigen. 
The reaction between and OPD at pH 5 was measured spectrophotometrically at 492nm.
3.6.3: Results
DNA, denatured by ROS, as described in sections 2.4.1.1, 2.4.2.1, 2.4.3.1 and 2.4.4 was used as a 
competing antigen against native dsDNA and probed in a competition ELISA with MCAs of the five 
distinct groups whose antigenic specificities are described in table 3.5. The optimum working 
concentration for each antibody is also shown in table 3.5.
3.6.3.1: Group 1
MCAs 402 and 410 bind to the conformational determinants on dsDNA only. When DNA was exposed 
to 1000 Gy from a Co*® gamma source, the resulting antigen showed an increased binding affinity to 
both MCAs, represented by a negative shift in the binding curve by 2.5-fold and 8-fold for MCAs 410 
and 402 respectively (figure 3.15).
UV radiation for 60 minutes, which theoretically generates the same amount of OH- as 1000 Gy from 
gamma radiation, resulted in a smaller increase in binding affinity to the denatured antigen as 
demonstrated by the smaller changes in the ID50, with no apparent change in the number of available 
binding sites. This was not true of DNA expo.sed to DNA incubated with only
showed a slight increase in the number of binding sites which was further increased by incubation of 
DNA with the same concentration of in the presence of AA, this was not significant. The major 
change induced by and A A was a two-fold increase of the binding affinity of MCA 410 to the
conformational determinants on dsDNA. The cross-over of the two curves suggests that on 
denaturation there was a change in nature of the antigenic determinants, the MCAs possibly recognising 
a new epitope.
I l l
Taxonomic Group MCA number Working
D ilu t io n
A n tig e n ic  Determ inant 
recognised
1 402, 410 1/5120 C onform ational determ inants
on dsDNA on ly  -  recogn is ing  groove
re g io n .
2 212, 405 1/160, 1/320 C onform ational determ inants 
on sugar -  phosphate backbone 
expressed weakly on dsDNA.
3 152 1/640 Determ inants on ssDNA expressed 
weakly on dsDNA
rH
4 233, 228 1/640 Base-dependent determ inants on ssDNA
5 223 1/640 Determ inants on ssDNA e x c lu s iv e ly .
Table 3.5
Classification of DNA-reactive murine monoclonal antibodies (MCA) showing the antigenic determinant and working dilution of each MCA
used in all experiments.
Qamma Radiation / M CA  402 UV Radiation / M CA  402 H 2 0 2  / M CA  402
Gamma Radiation / MCA 410
- ONA • H ao t • AA
UV Radiation / MCA 410 H202 / MCA 410
n
- DNA • H302 • AA
Figure 3.15
Exposure of DNA to ROS from gamma radiation, UV radiation and and subsequent effects on monoclonal antibody binding to DNA. 
The figure shows %  binding of MCA from group 1 (table 3.5) to DNA immobilised on the ELISA plate, with serial two-fold dilutions of the 
competing antigen (Nat-DNA or ROS-DNA). For gamma radiation the ROS-DNA was exposed to 1000 Gy; for UV radiation the ROS-DNA was 
exposed to UV light for 60 minutes and for the effects of 200/xM alone and in the presence of lOmM AA were studied. Results are 
means of three separate experiments.
3.6.3.2: G roup  2
MCAs 212 and 405 bind to the sugar-phosphate backbone of both dsDNA and ssDNA.
Both gamma and UV radiation of DNA caused an increase in affinity of the binding interaction between 
the MCAs and ROS-denatured DNA (figure 3.16). Gamma radiation caused a two-fold greater shift in 
the binding curves when compared to U V, reflecting possibly the lower concentration of radicals 
generated by the latter.
Incubation of DNA with and AA caused a significant positive shift in the titration curve (p<0.01) 
increasing the ID50 by a factor of =3. This represents a decrease in binding affinity. The intersection 
of the two titration curves suggests that a modification of the antigenic determinant recognised was also 
caused by exposure of DNA to ROS.
3.6.3.3: G roup  3
MCA 152 recognises determinants on ssDNA that are expressed weakly on dsDNA.
Gamma and UV radiation of DNA induced an increase in binding affinity for this MCA which binds 
very poorly to native dsDNA. Gamma radiation caused a 6-fold reduction in ID50 compared to a 2-fold 
reduction for UV (figure 3.17).
and AA reacted with DNA to cause a slight, but not significant increase in the binding of this 
antibody to DNA. This reflects an increase in availability of the ssDNA determinants recognised by 
MCA 152.
3.6.3.4: Group 4
MCAs 233 and 228 recognise base residues on single-stranded regions of DNA.
Both MCAs showed poor reactivity with native dsDNA but were able to bind more effectively to a 
ROS-denatured antigen. Exposure of DNA to gamma and UV irradiation and to caused an 
increase in binding affinity of these MCAs to base residues. The ID50 was reduced significantly by 0.5
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Qamma Radiation / M CA  212 UV Radiation / M CA  212 H 2 0 2  ! MCA 212
Qamma Radiation / MCA 406 UV Radiation / MCA 406
- DMA > H201 • AA
H202 / MCA 406
infH
iH
- DMA • H202 • AA
Figure 3.16
Exposure of DNA to ROS from gamma radiation, UV radiation and and subsequent effects on monoclonal antibody binding to DNA. 
The figure shows % binding of MCA from group 2 (table 3.5) to DNA immobilised on the ELISA plate, with serial two-fold dilutions of the 
competing antigen (Nat-DNA or ROS-DNA). For gamma radiation the ROS-DNA was exposed to 1000 Gy; for UV radiation the ROS-DNA was 
exposed to UV light for 60 minutes and for the effects of 200/rM alone and in the presence of lOmM AA were studied. Results are 
means of three separate experiments.
Qamnui Radiation / M C A  162 UV Radiation / MCA  162 H 202  / M CA  162
V O
- ON* •  H 20I • AA
Figure 3.17
Exposure of DNA to ROS from gamma radiation, UV radiation and and subsequent effects on monoclonal antibody binding to DNA. 
The figure shows %  binding of MCA from group 3 (table 3.5) to DNA immobilised on the ELISA plate, with serial two-fold dilutions of the 
competing antigen (Nat-DNA or ROS-DNA). For gamma radiation the ROS-DNA was exposed to 1000 Gy; for UV radiation the ROS-DNA was 
exposed to UV light for 60 minutes and for the effects of 200/itM alone and in the presence of lOmM A A were studied. Results are 
means of three separate experiments.
(p<0.01), 2 (p<0.01) and 5-fold (p< 0.001) for H^O ,^ UV radiation and gamma radiation respectively 
(figure 3.18).
The nature of the curves obtained for the MCA 233, suggests that the change in affinity induced by 
exposure of DNA to gamma and UV radiation was not shown as clearly for DNA incubated with H^O .^ 
In this case the nature of the antigenic determinant appears to have been altered as shown by a change in 
shape of the titration curve.
3.6.3.5: Group 5
MCA 223 binds exclusively to ssDNA and indeed showed poor reactivity with the native molecule. UV 
irradiation of DNA did not change significantly the ID50 of > lOOO/rg/ml for this MCA and there was 
no change in affinity of binding. Gamma radiation, producing = twice the concentration of OH- in 
solution than UV caused a significant increase in binding affinity to regions of single stranded DNA, 
reducing the ID50 from > 1000/ig/ml to 251;ng/ml. The change induced by also showed a trend 
towards production of regions of single stranded DNA but this was not significant (figure 3.19).
3.6.3.6: Effects of Scavengers on MCA Binding
The scavengers behaved similarly for the five groups of MCA studied but differently between the 
models of ROS generation. Thiourea and ethanol inhibited gamma-induced ROS production such that 
no significant difference was observed between Nat-DNA and ROS-DNA for any of the MCAs; 
mannitol offered 74 ±6 % (p <0.001) inhibition whilst desferrioxamine and SOD had no effect on the 
titration curves.
In the case of U V-induced damage, thiourea and ethanol were again effective inhibitors reducing the 
maximum difference between the two curves by 81 ±3% (p<0.001) and 75±4% respectively 
(p<0.001). Mannitol and desferrioxamine also inhibited the ROS-induced changes by 42±4% and 
49 ±5% respectively, whilst SOD was ineffective as an inhibitor.
None of the inhibitors offered significant protection for damage induced by reaction of H^O  ^ only. 
However, for H^O  ^and AA reacting together, desferrioxamine and thiourea significantly inhibited the
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Oamma Radiation / MCA  226
Oamma Radiation / MCA 233
%  BWidkta of MCA to ItnmobilUtd DNA
UV Radiation / M CA  226
UV Radiation / MCA 233
H202 / MCA 226 
% MoOlna of MCA to Immobillood ONA
- ONA • H202 « AA
H202 / MCA 233
CO
- DNA « H202 • AA
Figure 3.18
Exposure of DNA to ROS from gamma radiation, UV radiation and and subsequent effects on monoclonal antibody binding to DNA. 
The figure shows % binding of MCA from group 4 (table 3.5) to DNA immobilised on the ELISA plate, with serial two-fold dilutions of the 
competing antigen (Nat-DNA or ROS-DNA). For gamma radiation the ROS-DNA was exposed to 1000 Gy; for UV radiation the ROS-DNA was 
exposed to UV light for 60 minutes and for the effects of 200/iM alone and in the presence of lOmM AA were studied. Results are 
means of three separate experiments.
Qamms Radiation / MCA 223 UV Radiation / M CA  223 H 202  / M CA  223
o\
rH
H
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Figure 3.19
Exposure of DNA to ROS from gamma radiation, UV radiation and and subsequent effects on monoclonal antibody binding to DNA. 
The figure shows %  binding of MCA from group 5 (table 3.5) to DNA immobilised on the ELISA plate, with serial two-fold dilutions of the 
competing antigen (Nat-DNA or ROS-DNA). For gamma radiation the ROS-DNA was exposed to 1000 Gy; for UV radiation the ROS-DNA was 
exposed to UV light for 60 minutes and for the effects of 200/iM alone and in the presence of lOmM AA were studied. Results are 
means of three separate experiments.
reactions by 52±3%  and 34±2% respectively. SOD, mannitol and ethanol did not cause a significant 
change in the ROS-DNA titration curve.
3.6.3.7: DNA Denatured by Neutrophil-Derived ROS
DNA isolated from stimulated and resting neutrophils was also used as the competing antigen in the 
ELISA assay. Using the reduction of cytochrome c as an indicator of the O^-' produced (section 2.4.4), 
activated neutrophils generated 200^M / 10* cells / hour of which at least 80% is known to dismutate to 
form (Root and Metcalfe, 1977).
Results of DNA isolated from resting lymphocytes showed no significant difference from native dsDNA, 
and DNA from activated cells produced titration curves that were superimposable on the curves obtained 
from DNA incubated with HjOj in the presence of the reducing agent, AA (figures 3.15-19).
3.6.4: Discu-ssion
The monoclonal antibodies used in these studies have been well characterised by Staines, Thompson and 
Morgan (1986). They show that ROS generated in different systems have diverse effects on the DNA 
macromolecule. The changes induced by UV and gamma irradiation do not always reflect the changes 
induced by exposure to H^O^/AA. Gamma radiation can produce OH- free in solution following 
ionisation of water molecules surrounding DNA, and UV can form OH- in solution from the energetic 
dissociation of their high reactivity these OH- can only react with DNA if produced in
close proximity to the macromolecule. Scavengers can compete with the DNA for reaction with OH- as 
illustrated by the ability of ethanol and thiourea to protect against damage. SOD catalyses the 
dismutation of O^-' to and this might be predicted to accelerate the production of OH-, although no 
enhancement of DNA damage was seen.
The production of OH- by 1000 Gy is 400/fM compared with 200^iM H^O  ^by 50 minutes exposure to 
UV light that can also potentially give rise to 400/xM OH-. The greater effect of damage seen in the 
DNA exposed to ionising radiation probably arises from the distribution of OH- in solution: gamma 
radiation produces OH- in spurs (see section 3.3.4) and in aqueous solution the concentration of OH- 
within a spur is »0.5M  (Ward, 1988), Reaction of OH- at several sites on DNA in close proximity to
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each other enhances the damage done to a localised area. UV light does not produce OH- in this way 
but from the breakdown of which has a more even distribution in solution.
In the absence of metal ions in solution (following chelex treatment of all reagents), can react only 
with DNA-bound metal ions to generate OH-. This model gives rise to site-specific DNA damage by 
virtue of the diffusion limited potential of OH- to react within 1.5nm of its site of generation (Ward JF 
eta l., 1987).
Damage caused by this site-specific interaction of OH- with DNA produced a pattern of change in DNA 
atypical of that produced by the two models of high energy radiation. The changes involved, affected 
the affinity of the binding reaction more commonly than the number of available binding sites.
The changes seen in ROS-denatured DNA suggest that a relaxation of the dsDNA helix occurs. MCAs 
402 and 410 indicated an increase in binding affinity to conformational determinants on dsDNA 
following exposure of DNA to UV and gamma radiation, suggesting that these determinants are partially 
shielded by the native conformation. Exposure to H^O  ^may also increase availability of previously 
shielded epitopes to the MCA since it appears that new epitopes are recognised following site-specific 
damage to the DNA molecule as catalysed by DNA-bound metal ions.
MCAs 152 and 223 suggest that the denaturation of DNA by ROS does not reflect damage induced by 
heating. Both these MCAs recognise determinants on ssDNA. H^O  ^could not significantly induce 
changes to dsDNA that could be recognised by these antibodies, indicating that large regions of ssDNA 
were not formed. However, binding of MCAs 233 and 228 to base residues after ROS denaturation by 
gamma and U V radiation suggest that the damage induced does expose the usually protected base 
residues. The affinity change suggests that epitopes recognised by the MCAs may be altered increasing 
the affinity of the interaction post-irradiation. Again, H^O  ^ modification appeared to expose new 
epitopes; these may be oxidised derivatives of the native bases such as 80HDG, shown to be formed in 
such ROS-mediated reactions in section 3.1.
The results of experiments using DNA derived from activated neutrophils suggest that reaction of DNA 
with HjO^ in the presence of a reducing agent provides a reliable model system for ROS generated
121
during inflammation. It further shows that excessive ROS production such as that generated during the 
respiratory burst of neutrophils is detrimental to the cell, causing severe DNA damage.
The protection offered by the scavengers was most effective in the models of radiation-generated ROS. 
Thiourea, an OH- scavenger and a metal ion chelator, inhibited the effects of H^O  ^most effectively but 
did not cause significant reduction of the reaction of DNA with alone. Thiourea seemed to play a 
more significant role in the prevention of reduction of the DNA-bound metal ions, thus diminishing 
perpetuation of the denaturing Fenton reaction. The poor protection seen with mannitol and ethanol may 
reflect an inability of the scavengers to gain access to the OH- before it reacted with DNA, since the 
OH- is generated on the DNA backbone directly at the metal ion binding sites. Also, thiourea is 4.7 
times more effective at scavenging OH- than mannitol (Halliwell and Gutteridge, 1989 pp 22-85).
Desferrioxamine did not significantly inhibit the gamma irradiation-induced changes; this may again 
reflect the interaction of ROS with desferrioxamine itself, which appears to affect the characteristic 
inhibition seen by the native molecule (Halliwell and Gutteridge, 1989 pp 188-276).
The monoclonal antibodies derived from mouse models of SLE bind to DNA and, by virtue of their 
classification, can provide information concerning the structure of the molecule. It has been 
demonstrated that different methods of ROS production give rise to distinct and characteristic changes to 
DNA which can be used further to probe DNA that is suspected to have been exposed to ROS.
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The work described in this chapter utilised several techniques to measure the effects of ROS on the 
biomolecule DNA.
The conclusions drawn from the results obtained are as follows:
The hydroxyl radical appears to be an important damaging species in all ROS-generating systems used. 
However, the scavenging potential of agents such as thiourea and ethanol in these systems differs. The 
damage induced by gamma radiation is inhibited by these scavengers much more effectively than 
damage induced by UV or H^O^. This most probably reflects the metal ion dependency of OH- 
formation in the latter two systems, particularly H^O .^
As all reagents were chelex-treated, metal ions were restricted to the DNA itself. The ability of 
scavengers to inhibit at all in this situation probably reflects the type of metals bound to DNA. Whilst 
copper ions have a very strong association with DNA and produce OH- that are not significantly 
scavenged (Stoewe and Prutz, 1987; Dizdaroglu, Aruoma and Halliwell, 1990), the association between 
iron and DNA is weaker, allowing some ions to be chelated.
This may be important in biological systems. During inflammation neutrophils produce O^-', 80% of 
which dismutates to H^O^ (Root and Metcalfe, 1977). This then reacts to produce OH-. The natural 
scavengers of OH- such as ascorbate and uric acid (section 1.1.6) may be unable to prevent ROS- 
induced damage in this case since they are inaccessible to site-specifically generated OH-. They may, 
however, be more able to prevent ROS from UV light (producing some OH- in solution) reacting with 
DNA.
CHAPTER 3.7: SUMMARY
In addition to damage caused by OH-, other radical species, postulated to be peroxy radicals, appeared 
also to be important in these systems. Peroxy radicals have extended half-lives compared to OH- and 
may be very relevant in vivo, since they are formed from reaction of OH- with lipids and amino acids. 
They may be formed within the nuclear membrane as radicals diffuse towards DNA: whilst this 
membrane may provide a protective barrier, it may also produce these long-lived radical products that 
can damage DNA.
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The scavengers studied behaved similarly in each of the ROS-generating systems differing only in the 
extent of protection they afforded, with the exception of the chelator, desferrioxamine.
This molecule chelates iron and can also scavenge OH-. In experiments where desferrioxamine was 
added to cell preparations, it protected DNA damage from H^O^, where metal ions are involved, but 
was unable to protect DNA from the effects of UV or gamma radiation. In contrast, addition of 
desferrioxamine directly to dG or DNA consistently resulted in increased damage by all three ROS- 
generating systems.
There is evidence for the generation of a long-lived nitroxide radical following gamma irradiation of 
desferrioxamine (Davies et al., 1987; Willson, 1988) and this may account for the increased DNA 
damage, the nitroxide radical increasing the time of radical exposure. Since UV and H^O  ^also generate 
similar radicals it is likely that desferrioxamine can be altered by these agents also. However, the 
results suggest that the generation of nitroxide radicals in a whole cell system is in some way prevented, 
since the enhancement of DNA damage was not seen in these situations. The prevention of nitroxide 
radical formation may occur if desferrioxamine complexes with cellular protein, or binds more 
efficiently to DNA. It is also possible that nitroxide radicals are produced, but are scavenged by cellular 
components.
This highlights the caution that must be used when interpreting data using scavengers to implicate 
radical species and reiterates the need for several scavengers of any one radical, such as thiourea, 
ethanol and mannitol for OH-, to be used.
1
Although each of the three model systems generating ROS consistently damaged DNA by the same 
mechanisms as determined by scavenger studies, the measurable end points of DNA damage varied both 
in their sensitivites and specificities.
Using CD to monitor structural changes to DNA induced by ROS, it was demonstrated that the 
technique detected changes in UV-damaged DNA more easily than DNA damaged by exposure to 
gamma radiation, UV light producing bulky adduct residues. The CD spectra gave a crude estimation 
of alterations to DNA and was only able to reflect modifications to DNA that resulted in extreme
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structural changes. It would clearly not be appropriate for measuring low levels of damage that might 
persist in the germ-line and have biological relevance.
Changes in DNA structure caused by levels of ROS found in vivo (ie. 200^M H^O^) were more 
successfully determined using a panel of murine monoclonal antibodies. Although the method is not 
particularly sensitive, using several antibodies with different binding specificities a detailed pictureof 
the DNA damage could be obtained. In later chapters, where DNA was isolated from biological 
material in sufficient quantity, this method was chosen to assess DNA structural changes in different 
disease pathology.
Two assays were used to measure strand breaks in DNA. Neither assay allowed differentiation of 
double strand breaks from single strand breaks, both estimating strand breakage on the basis of ethidium 
bromide dye intercalation into the DNA structure. Strand breaks produced by very low levels of ROS 
were detected by both assays; combined with viability data, this provided an index of lethality. In later 
chapters the nucleoid assay was used in conjunction with other assays to give an estimation of the initial 
damage to DNA caused by exposure to ROS and to quantify this damage. It was chosen due to its better 
reproducibility and simplicity compared with the FADU assay.
The TEA assay was not used further. Although damage to deoxyribose could be detected, the assay was 
not sensitive enough to detect changes in all systems. Furthermore, there is evidence that products 
measured in this assay may be generated during the assay itself, so it is not considered to be a definitive 
measure of ROS damage.
The assay used predominantly to assess oxidative damage to DNA in the following chapters is 
measurement of 80HDG by HPLC/ECD. There is considerable evidence to support 80HDG as a 
reliable indicator of OH--induced damage to DNA (see section 3.1) and this is supported by the findings 
in this chapter. The assay itself is quick to perform and very sensitive, detecting levels of 80HDG 
down to 0.1 picomoles. Specificity can be achieved using ECD, since most bases do not give a signal at 
the applied potential (600mV). It is therefore ideal for measurement of DNA damage and has been 
applied here to the analysis of ROS-induced DNA damage produced during inflammation.
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SECTION 4:
ROS D A M A G E TO DNA IN INFLAMMATORY DISEASE STATES
1 2 6
The general in vivo defence mechanisms that limit the concentrations of ROS, and the damage they 
induce to biological material have been described in sections 1.1.5, 1.1.6 and 1.1.7. A further specific 
m echanism  for m ain tenance  o f the in teg rity  o f nuclear DNA in mammalian cells is its 
compartmentalisation away from peroxisomes and mitochondria, where most radicals are likely to be 
generated (sections 1.1.4.2 and 1.1.4.4) (Richter, Park and Ames, 1988).
Also, most rion-replicating nuclear DNA is surrounded by a protective barrier of histones and 
polyamines. In spite o f this, DNA is still susceptible to spontaneous damage such as attack by 
endogenous and exogenous agents and ionising radiation, all of which can cause strand breakage and 
modification of base residues (Ward, 1985; Hagen, 1986). To avoid the detrimental biological 
consequences of this, most of the types of DNA damage can be removed by efficient repair systems 
(Lindahl, 1982).
Most cells contain a few enzymes that specifically reverse DNA damage. Examples include photolyase, 
which reverses the photochemical fusion of adjacent pyrimidine bases into pyrimidine dimers caused by 
UV (Haseltine, 1983); and 0*-methylguanine methyl transferase, which enzymatically removes methyl 
groups from the highly mutagenic base adduct as well as from the phosphodiester backbone (Cairns et 
al., 1981). However, the predominant mechanism of DNA repair is excision repair (Lindahl, 1982). 
This involves removal of a single base or a segment of DNA producing a single strand break or a gap in 
the DNA helix; from this gap, DNA polymerase can initiate synthesis of a new strand using the 
complementary strand as a template. Alternatively, glycosylases act by removing the damaged base 
from the sugar residue leaving the backbone intact and creating a hole (an AP site - apurinic or 
apyrimidinic) (Coulondre et al., 1978). This hole is recognised by an AP endonuclease which cleaves 
the backbone upstream from the site of damage and DNA polymerase again initiates synthesis of the 
DNA.
Once removed from DNA, the damaged DNA bases may, if released as deoxynucleotides, lose a 
phosphate to become deoxynucleosides, which are not metabolised further (Ames, 1988). The low
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molecular weight of these residues allows them to pass easily through the filtration system of the 
glomerular capillaries and be excreted in the urine (section 4.1.2.4).
Measurement of DNA bases recovered in the urine can be used as an indicator of the level of DNA 
damage and assays have been described for detection of thymine glycol (Cathcart et al., 1984; Adelman, 
Saul and Ames, 1988) and 80HDG (Shigenaga, Gimeno and Ames, 1989; Fraga et al., 1990).
Other workers have measured DNA base adducts in tissues rather than urine because considerable 
preparation of urine is needed before analysis (Floyd et al., 1986a; Fraga et al., 1990). Also, many 
products excreted in urine are electrochemically active and present in concentrations many times greater 
than DNA bases. DNA isolated from tissues can be easily purified and since most DNA bases do not 
give an electrochemical signal there is less interference from other products (section 3.1.1). However, 
measurement of DNA damage, in tissues only, does not give an indication of excreted damaged DNA 
bases, only the accumulation in the individual cells.
Several preparatory procedures have been described to facilitate analysis of DNA-derived compounds in 
urine by HPLC/ECD (Gundy, Kohen and Ames, 1988; Shigenaga, Gimeno and Ames, 1989) and with 
the use of cyclic voltametry as described in section 2.6.2.1 to determine peak purity, urinary levels of 
DNA bases can be accurately measured.
The methods for detection of damage to DNA have been described in chapter 3. In this section they 
have been used to assess DNA damage caused by the inflammatory process. The specific aims were to 
investigate and m onitor 80HDG as a marker of oxidative damage to DNA occurring in the 
inflammatory diseases SLE and RA, and in healthy controls.
80HDG was measured in preference to other DNA base adducts, since, as described in section 3.1.1 it 
is a reliable indicator of ROS-mediated damage to DNA that can be sensitively detected using HPLC 
with ECD (Floyd, 1990). However, in view of the difficulties of measuring urine-derived compounds 
by HPLC/ECD, a further confirmatory technique was used to detect 80HDG. This was GCMS which 
detects compounds on the basis of molecular weight, each compound giving a signal, characteristic of 
that compound and distinct from any other signal.
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CHAPTER 4.1: MEASUREMENT OF 80HDG IN URINE 
4.1,1: Introduction
RA is a chronic inflammatory disorder with the inflammation located predominantly in the joints. The 
characteristic swelling, pain and loss of function of the joint are mediated by neutrophils accumulating in 
the synovial fluid, producing levels of O^-' at a rate exceeding lOOnM/min. O^-', and its derivatives 
(section 1.1.2) can then react with surrounding biomolecules to cause tissue damage (section 1.1.7).
Previous work has shown that IgG denatured by ROS in vitro, closely resembles IgG which has been 
isolated from the serum and synovial fluid of patients with RA (Griffiths and Lunec, 1991). It has also 
been shown that ROS-denatured IgG binds better than native IgG to serum rheumatoid factor (Lunec et 
al., 1986; Swaak et a l . , 1989), suggesting that the altered antigenicity of the ROS-denatured IgG 
molecule may play a role in the production of anti-IgG autoantibodies in RA (Griffiths and Lunec, 1988; 
Kleinveld et al., 1989).
Damage to DNA from cells in the rheumatoid synovium has not been characterised; evidence relating to 
tissue damage and studies related to DNA damage in isolated neutrophils however, suggest that DNA 
damage does occur during periods of oxidative stress (Floyd et al., 1986a).
In SLE, another chronic inflammatory disorder, antibodies that react with DNA are found in the serum 
(Stollar, 1981). The potential role of a ROS-denatured DNA molecule in the pathogenesis of SLE has 
been tentatively suggested by Halliwell (1982), Emerit and Michelson (1981), and Johnson and Ward 
(1982).
80HDG, excreted in the urine of SLE and RA patients and controls, was measured as a marker of 
oxidative stress to further investigate the role of a ROS-denatured DNA in inflammation in general and 
more specifically in SLE.
Measurement of 80HDG in urine was used as an indicator of the levels of altered DNA base removed 
from cellular DNA following oxidative insult, and as a marker of the ability of the patients to cope with 
any DNA damage caused during periods of disease activity.
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4.1.2: Methods 
4.1.2.1: Clinical Samples
Early morning urine samples were collected from 33 SLE patients with normal renal function (29 
female, 2 male, age range 20-64, median = 39), 10 RA patients (9 female, 1 male, age range 57-80, 
median = 67) and two groups of 10 norma] controls: young normal controls (8 female, 2 male, age 
range 20-47, median = 26) not differing significantly in age or sex from the SLE group, and elderly 
normal controls (9 female, 1 male, age range 62-82, median = 70) not differing significantly in age or 
sex from the RA patients. Samples were stored at -20°C prior to analysis.
RA patients were prospectively selected to have an active inflammatory status based on an elevated level 
of the acute phase protein, C-reactive protein (CRP). In this group CRP values ranged from 42-123 
mg/1, median = 64 mg/1 (normal range < 6 mg/1).
The 33 SLE patients studied had a range of inflammatory disease activity as determined by levels of 
erythrocyte sedimentation rate (ESR) (5-92 mm/hour, median = 26 mm/hour - normal range < 20 
mm/hour).
Two different indicators of inflammatory status were used because CRP is not a good indicator of 
inflammatory activity in SLE, whilst disease-associated anaemia can affect ESR but not CRP values in 
RA.
4.1.2.2: IVeparation of Urine Samples for Analysis by HPLC/ECD
Urine contains many electrochemically active compounds in high concentrations, whilst products of 
DNA damage are present at concentrations in the picomolar range. Therefore, before analysis by 
HPLC/ECD it was necessary to remove selectively these compounds, which would otherwise mask the 
presence of the DNA base.
This was done using cartridges of reverse phase material. The selective precolumn separation of 
80HDG from other urinary components was achieved using increasing concentrations of aqueous 
methanol as described below.
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Urine (500^1) was added to a 1ml C-18 SEP-PAK column preconditioned with lOmls methanol and 
lOmls water. The eluant was discarded and the column washed with 5 %  aqueous methanol. The 
fraction containing 80HDG in highest concentration was then eluted with 15% aqueous methanol. The 
eluant was evaporated to dryness and the sample resuspended in 200^1 mobile phase (section 2.6.2.1).
The percentage recovery of 80HDG, based on calculations using a urine sample spiked with a known 
concentration of authentic standard, was 59+6%. The value obtained is similar to the values of 55-65% 
for purification of thymine glycol and thymidine glycol from urine (Cathcart et a!., 1984) and compares 
favourably to the value of »  35 % for extraction of 80HDG from urine (Shigenaga, Gimeno and Ames, 
1989).
The percentage recovery reflects the inability to recover 80HDG from residual volumes remaining on 
the column at each stage of the extraction, and the particularly low recovery of 35 % obtained by 
Shigenaga, Gimeno and Ames (1989), reflects an increased number of column extractions compared to 
the method used here.
4.1.2.3: HPLC Analysis
10^1 of the final fraction of the urine sample was analysed by HPLC/ECD as described in section
2.6.2.I.
Results are expressed as picomoles 80HDG excreted, determined by comparison with a known 
concentration of standard 80HDG, per /anofcreatinine.
4.1.2.4: Correction of Results for Renal Function
Plasma creatinine passes freely through the glomerular filter and is neither absorbed nor excreted by the 
tubules. Therefore, the quantity excreted in the urine is identical with the amount filtered by the 
glomeruli. However, damage to the kidneys can cause a decrease in the glomerular filtration rate which 
subsequently causes a rise in serum creatinine as less of the molecule is excreted.
Measurement of creatinine was used in this study as an indicator of urine concentration in patients 
selected to have normal renal function, since in patients with abnormal renal function creatinine
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Creatinine was measured by a commercial kit (Sigma) using a colorimetric assay based on the reaction 
of creatinine with picric acid, under alkaline conditions, to produce a yellow-orange complex 
(Heinegard and Tiderstrom, 1973).
For measurement of 80HDG in urine results were standardised for the concentration of urine by 
determination of creatinine concentration. Early morning urine samples were used in the analysis 
because of the diurnal variation in excretion, and these samples are, in general, more concentrated thus 
increasing the levels available for detection.
4.1.3: Results
The results of measurement of 80HDG in patients with SLE, RA and the two control groups are shown 
in Figure 4.1 and table 4.1. Levels of 80HDG were undetectable in all SLE patients studied ie levels 
were < 0.1 picomole 80HDG / /aIH creatinine. The normal ranges established from the control groups 
were 1.0-5.2 picomoles 80HDG / /im creatinine (median = 3.0 picomoles 80HDG / creatinine) 
for the young normal controls, and 0.75-3.9 picomoles 80HDG / /rm creatinine (median = 2.5 
picomoles 80HDG / /xin creatinine) for the elderly normal controls. The difference between these two 
control groups was not significant.
In RA, the levels of 80HDG excreted were 25-32 picomoles 80HDG / f j t i n  creatinine (median = 29.5 
picomoles / f x m  creatinine) and were significantly different from the values obtained for the elderly 
controls (p< 0.001).
There was no significant difference between voltammograms (section 2.6.2.1) of the authentic 80HDG 
standard and peaks co-eluting with authentic 80HDG in either the RA or control group (figure 4.2).
4.1.4: Discussion
The results obtained for the normal controls in this study are of the same order of magnitude as those 
described by Gundy, Kohen and Ames (1988). There was no significant difference in the levels of 
80HDG excreted by the young and elderly normal controls, although a slight decrease is noticeable in
clearance is impaired and is no longer an accurate measure of urine concentration.
132
100
S 10
1
10
0 1
• •
Detection Limit ef Assay
nmmi
SLE YOUNG
CONTROLS
RA ELDERLY
CONTROLS
Figure 4.1
Log plot of levels of 80HDG found in early morning urine samples of SLE patients 
(n=33), young normal controls (n = 10), RA patients (n = 10) and elderly controls (n 
= 10). The figure shows the median and ranges for each of the groups, all the results 
for the SLE group being below the detection limit of the assay. Each point plotted 
represents the mean of triplicate urine samples analysed for each person studied.
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n age range median pmoles 80HDG//iM 
range
c re a tin in e
median
SLE 33 20-64 39 <0.1 -
C on tro l (I) 10 20-47 26.5 1 .0 -5 .2 3 r>rH
RA 10 57-80 67.5 25-32 29.5
C o n tro l (II) 10 62-72 70 0.75-3 .9 2.5
Table 4.1
Measurement of 80HDG in urine from patients with SLE and RA and in two control groups aged and sex matched for SLE (I) and RA (II) 
respectively. Results are expressed as medians and range of pmoles 80HDG / ( M  creatinine. Each value represents the mean of results obtained 
from triplicate urine samples.
RA/Normal Sample ~ 80HDG Standard
Figure 4.2
A representative hydrodynamic voltammogram of 8-hydroxydeoxyguanosine 
(80HDG) peaks from normal and RA urine samples (continuous line) compared to the 
Ag/AgCl reference electrode, and compiled from the means ± ISD of readings 
obtained in three separate experiments. The 80HDG used as the reference in these 
experiments (broken line) was supplied by Dr H Kasai.
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the figures obtained for the elderly group. Fraga et al., (1990), have shown that in rats there is a 
significant decrease in the level of excreted 80HDG with age but a significant increase in the levels of 
80HDG found in DNA in some but not all tissues. Although this decrease in the rate of excretion has 
not been confirmed in humans it is thought that ROS damage to DNA could contribute to the aging 
process (Ames, 1983; Cutler, 1984). This is believed to be due to a slow loss of DNA nuclease activity 
but may also be due to an increase in the rate of oxidative DNA damage.
In RA, there was a significant increase in the levels of 80HDG excreted, compared to normal. There 
are at least two explanations for this. The RA patients studied were selected for their active disease 
based on serological measurements of CRP. In an active inflammatory state production of ILl, IL6 and 
TNFa can cause pyrexia which in turn can increase the basal metabolic rate of the patients. This alone 
could be responsible for the elevation of DNA damage products: previous work has shown a positive 
correlation between metabolic rate and excreted DNA base adducts for a number of altered DNA bases 
including 80HD G and thymine glycol (Adelman, Saul and Ames, 1988; Bergtold et al., 1988; 
Shigenaga, Gimeno and Ames, 1989). There is also an inverse correlation between metabolic rate and 
life span suggesting that oxidative damage causes irreversible DNA damage over a period of time that 
results in an increased risk of malignancy towards the end of the life span and finally death (Ames, 
1988). This finding may be relevant to patients with RA since they have a greater incidence of certain 
malignancies compared to controls (Miller, 1967; Louie and Schwartz, 1978).
A second possible reason for the observed increase in excretion of 80HDG in RA patients with active 
disease is increased oxidative damage to DNA caused by an exacerbated inflammatory response. This 
damage is predominantly in the joint, where the synovial fluid is heavily infiltrated by neutrophils, and 
deposits of iron in the synovial lining can catalyse ROS production (reviewed by Blake, Allen & Lunec, 
1987).
Purity of the 80HDG peaks were confirmed by voltammograms. This eliminates the possibility of 
drugs or other compounds interfering in the assay and giving false positive results.
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The group of patients with SLE had a range of ESR values (5-92 mm/hour - median = 26 mm/hour), 
some indicative of high inflammatory activity and others not significantly raised above the normal range 
( < 20 mm/hour).
Extrapolating from the results for the RA patients, it would be expected that if similar mechanisms of 
80HDG excretion exist in SLE, there would be increased levels of 80HDG in the urine of SLE patients 
with active disease and high ESR values, and lower values in patients with inactive disease and normal 
ESR values. However, all SLE patients studied had undetectable levels of 80HDG in the urine.
This is unlikely to be due to inadequate sensitivity of the assay since normal controls with no 
inflammatory activity had measurable levels of 80HDG. It cannot be explained by abnormal renal 
function and clearance either, since all patients were specifically selected to have normal renal function.
In view of this, possible explanations for the lack of excretion of 80HDG in urine of SLE patients 
included an inability of SLE cells to repair 80HDG, or accumulation of damaged DNA in circulating 
immune complexes which are known to occur in this disease.
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CHAPTER 4.2: 80HDG IN DNA AND SUPERNATANTS OF SLE AND NORMAL CELLS 
4.2.1; Introduction
The mechanisms for removal of damaged DNA bases from the intact strand have been described in 
section 4.1.1. This involves excision of the DNA base adduct from the cell and its removal from the 
body in urine. The apparatus for repair is contained within the cell and cells in culture have been used 
as a model for the assessment of DNA repair. Hariharan and Cerutti (1974), demonstrated successfully 
the removal of damaged thymine residues from an ROS-damaged synthetic polymer of adenine and 
thymine using crude extracts of Escherichia coli.
In this study, whole cells were exposed to H^O^. Cellular DNA and supernatants of these cells were 
collected over a period of time, and assessed for 80HDG content.
Cells used were PBMC which can be easily separated from other blood components to produce a healthy 
population of cells (section 2 .3 .3 .1). In SLE and RA there is immunological dysfunction and an 
abnormal production of autoantibodies from lymphocytes results. These patients are also more 
susceptible to malignancy, particularly those affecting the immune system ie. lymphomas and 
leukaemias (Miller, 1967; Louie and Schwartz, 1978; Green, Dawson and Walker, 1978). Both these
disease associations could arise from cellular dysfunction following DNA damage at sublethal levels.
More recent evidence suggests that susceptibility to malignancy may be more related to therapy than to 
an immune dysfunction (Green et al., 1986).
PBMC were incubated with physiological concentrations of to determine the effects of ROS on 
SLE PBMC DNA, and to compare these effects with DNA from PBMC of normal controls.
4.2,2: Methods 
4.2.2.1: Clinical samples
PBMC were isolated from peripheral blood of 23 SLE patients (22 female, 1 male, age range 21-56, 
median = 33) and 20 normal controls (19 female, 1 male, age range 22-51, median = 34) as described 
in section 2.3.3.1. Cells were resuspended to 1 x 10* / ml and cultured in 24 well plates in a volume of 
2mls complete culture medium (see section 2.1.6).
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4.2.2.2: FACS Analysis
FACS analysis of cell nucleoids was shown in section 3.4.4 to be an indicator of ROS-raediated damage 
and was used to measure any differences between SLE and normal cells following the initial ROS insult.
SLE and normal PBMC isolated as above were incubated with 200/rM for 24 hours. The cells 
were then washed twice in PBS, resuspended to a concentration of 1 x 10® / ml in lysis buffer and 
analysed by FACS as in section 3.4.2.
4.2.2.3: Cell Incubation
Cells from each individual were incubated in the presence or absence of 200/xM for 7 days. At 
intervals during this period cell viability was determined as in section 2.3.3.3 and cells and supernatants 
collected.
The cells were separated by centrifugation at 300 x g for 10 minutes at 4®C, washed twice in PBS and 
resuspended to 10® / ml in ice-cold TE. DNA was isolated from cells as described in section 2.3.1.1 
and digested as in section 2.3.1.4 before analysis by HPLC/ECD.
Supernatants were collected after centrifugation and 2 volumes of ice-cold ethanol was added to each 
sample. Any DNA was allowed to precipitate at -20°C for 24 hours and pelleted by centrifugation at 
0°C for 10 minutes in an Eppendorph centrifuge. The remaining supernatant was freeze-dried and 
resuspended in 1 ml sterile water. Ethanol precipitation of the supernatants was used to remove large 
fragments of DNA arising from cell death so that the only detectable 80HDG was from individual bases 
or small fragments of DNA arising from excision repair.
4.2.2.4: HPLC/ECD Analysis of DNA and Supernatants
10;rl of digested DNA or resuspended supernatant was analysed by HPLC/ECD as described in section
2.6.2.I.
4.2.3: Results 
4.2.3.1: FACS Analysis
Incubation of PBMC from SLE and normal patients with 200/rM caused a significant increase in
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nucleoid size, p < 0 .0 5  for both groups. There was, however, no significant difference between the 
untreated SLE and normal PBMC, or between the two groups incubated with for 24 hours (figure 
4.3).
4.2.3.2: Cell Viability
No significant difference was found between the loss of viability for SLE and normal cells incubated in 
the absence of H^O^. In the presence of a significant decrease in viability was found both in SLE 
(p<0.001) and normal (p<0.001) cells when compared with the untreated cells between days 2 and 7 
(figure 4.4a and figure 4.4b respectively).
SLE cells (figure 4.4a) showed a significantly greater reduction in viability compared to normal cells 
(figure 4.4b) under H^O^-induced oxidant stress (p<0.05). This was evident between days 2 and 6.
4.2.3.3: 80HDG in Cell Supernatants
80HDG was measured in the supernatants collected from cells incubated with and without There
was no detectable 80HDG in the supernatants from normal or SLE PBMC incubated in the absence of
H ,0 ,.
2 2
However, 80HDG was detectable in the supernatants of both SLE and normal PBMC incubated with 
(figure 4.5). Levels of 80HDG in normal cell supernatants reached a maximum at day 2 and 
slowly decreased after this. Such an initial increase in the 80HDG levels was not observed in SLE 
supernatants, but a very gradual increase was seen over the 7 day period (figure 4.5).
4.2.3.4: 80HDG in Cellular DNA
DNA isolated from the cultured cells was digested and analysed by HPLC/ECD for 80HDG content. 
The results are expressed as pmoles 80HDG / ^g DNA (1/xg DNA was extracted from = 10* cells).
Cells incubated in the absence of had detectable levels of 80HDG in the DNA after 4 days. For 
normal cells, levels of 80HDG then plateaued at a constant level for the remainder of the incubation 
period. In contrast, the level of 80HDG in SLE cells continued to rise gradually, and appeared to be 
still increasing at day 7 (figure 4.6a).
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Figure 4.3
Effect of exposure of PBMC to 200/xM on nucleoid expansion. Results are 
shown for PBMC from SLE patients (n = 23) and normal controls (n = 20) incubated 
in the presence or absence of H^O .^ Results represent the mean ± ISD for the median 
channel numbers of each sample.
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Figure 4.4
Decrease in cell viability of SLE (4.4a) and normal (4.4b) PBMC incubated in the presence or absence of 200/iM H^O .^ Results show the 
means ± ISD of three separate experiments.
pmoles 80HDG /  10E6 cells
Figure 4.5
Picomoles o f 80HDG excreted into the supernatants of SLE and normal PBMC 
incubated with H for a period of seven days. Results are expressed as picomoles of 
80HDG / 10® cells and represent the mean ± ISD of three separate experiments.
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Figure 4.6
Picomoles of 80HDG in cellular DNA from SLE and normal PBMC incubated in the absence (4.6a) or presence (4.6b) of 200^M for 
a maximum of seven days. Results are expressed as picomoles 80HDG / 10* cells from which ,l^g DNA was obtained and represent the mean ± 
ISD of three separate experiments.
DNA isolated from cells incubated in the presence of had the highest level of 80HDG at »day 1 
in both the SLE and the control group. In normal cells, this level decreased rapidly and reached a 
minimum at day 6. This was not significantly different from the level at the equivalent time point in the 
untreated cells. The profile of 80HDG as a component of DNA in SLE cells differed from that of the 
normal cells: whilst a similar peak of 80HDG production was achieved at =5 day 1, the rapid return to 
baseline was not seen; there was a more gradual reduction in the level of 80HDG (figure 4.6b). The 
differences in the two curves at days 2, 4, and 5 were significant at p<0.01.
4.2.4: Discussion
The viabilities of the normal and SLE PBMC cultured without were not significantly different 
during the seven day incubation period. Since the blood was separated into components by Ficoll on the 
basis of density (Boyum, 1968), the layer containing mononuclear cells is likely only to contain healthy 
cells; any abnormal cells probably sedimenting at a greater rate. On this basis, SLE cells would be 
expected to have similar properties to those of normal mononuclear cells; this might explain the similar 
viabilities of the two groups of cells in an unstressed environment.
Exposure of both SLE and normal cells to led to a significant reduction of their viabilities. On 
day 1 of the experiments the viabilities of the H^O^-treated cells for the SLE and normal group were not 
significantly different by conventional counting. However, from day 2 onwards there was a 
significantly greater decrease (p<0.05) in the viabilities of SLE cells compared to normal cells. These 
results suggest that SLE cells are more susceptible than normal to as a ROS-generating system.
Increased sensitivity of SLE cells to ROS-producing systems such as UV light has been reported 
previously (Compton, Steinberg and Sano, 1984; Golan and Borel, 1984): the mechanisms involved 
have been suggested to include accumulation of DNA-damage products and an increased susceptibility of 
the DNA to degradation.
To investigate any difference in the induction of DNA damage, FACS analysis was used to monitor 
changes in nucleoid expansion as a marker of structural changes in DNA. On day 1 of exposure 
there was no significant difference in the size of the nucleoids from SLE or normal cells. This 
corresponded well with viability data from day 1 which showed no significant difference between SLE
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and normal cells at the same time point. It is suggested that ROS, produced from reacting in a 
DNA-bound metal ion catalysed reaction to produce OH-, damage DNA from both SLE and normal 
cells by the same mechanism. From these results it appears that DNA of SLE cells is not more 
susceptible to ROS-mediated damage than normal. The decreased viability of SLE cells therefore is due 
to an event following the initial induction of damage.
Supernatants of SLE and normal PBMC cultured with or without were collected for analysis of 
80HDG. They were mixed with ethanol to remove any large fragments of DNA arising from cell lysis; 
thus, any 80HD G in the remaining fraction was assumed to arise from excision repair of DNA. 
Supernatants of untreated cells did not contain detectable levels of 80HDG. Although 80HDG is 
known to be produced during normal metabolism, this occurs only at a low rate of conversion (1 in 10^  
dGs - <  0.03 pmoles/|xg DNA, Floyd et al., 1986a) and when excreted into the culture medium it was 
probably diluted to a level undetected in the system.
Supernatants from H^O^-exposed cells contained 80HDG, whether these were normal or SLE derived. 
In the normal supernatants, there was a rapid excision of 80HDG from DNA increasing until day 2, 
after which the level declined slowly until at day 7 there was < 1 picomole 80HDG / 2 x 10* cells. 
The maximum excretion of 80HDG at day 2 follows the damage induced by ROS seen both by FACS 
analysis and by the maximum conversion of dG to 80HDG in cellular DNA on day 1 (figure 4.6b). 
The added to the cells acts initially to produce DNA damage but by reacting becomes degraded. 
Any intracellular catalase would also contribute to the degradation of to H^O. Therefore the 
decrease in 80HDG after 2 days was probably due to removal of the ROS.
SLE supernatants showed a different pattern of 80HDG excretion. There was a slow increase of 
80HDG which persisted beyond day 7. Data from the FACS experiments indicated that an equivalent 
amount of DNA damage had been caused by H^O^ to SLE cells and this was confirmed by the 
incorporation of 80HDG in cellular DNA not differing significantly between the SLE and normal cells. 
However, once formed, the 80HDG in SLE cells was clearly not repaired as in the normal cells.
The 80HDG content of DNA from the SLE and normal cells also showed a different pattern of 
distribution. DNA from untreated normal cells contained detectable levels of 80HDG at day 3, and this
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level then remained constant. On day 4, 36% of the cells were dead and the build up of 80HDG 
probably reflects decreasing exonuclease activity of the remaining viable cells. Untreated SLE cells also 
had levels of 80HDG detectable from day 4 but the level continued to rise suggesting that 80HDG was 
accumulating. This could be because of an inability to excise 80HDG from the DNA, which would in 
turn contribute to the number of cells dying by decreasing the integrity of the DNA.
Both normal and SLE cells exposed to showed a rapid conversion of dG to 80HDG at day 1 
suggesting that the two cell populations were equally susceptible to damage. However, whilst normal 
cells showed a rapid removal of the damaged mutagenic base from the DNA paralleled by an increase of 
the base in the supernatant, SLE cells showed a considerable decrease in this rate of removal.
The results obtained suggest that SLE cells are not abnormally sensitive to the initial effects of ROS- 
induced damage, ie the formation of the oxidative products, but that they are unable to mount an 
adequate re fu se  to repair this damage. This seems to involve an impaired repair system for 80HDG in 
SLE. As a result the cells accumulate the altered base adduct which is mutagenic, causes mispairing of 
DNA (Kuchino et a l., 1987; Shibutani, Takeshita and Grollman, 1991), and contributes to cell death. 
This would account for the decrease in viability of SLE cells following exposure to as well as UV 
and other ROS-generating systems when compared with normal.
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CHAPTER 4.3: ANALYSIS OF DNA ISOLATED FROM IMMUNE COMPLEXES 
4.3.1: Introduction
Circulating immune complexes represent a normal and effective immunological effector mechanism for 
the clearance of antigens (Contreras et al., 1982), complement aiding this process by inducing their 
solubilisation. However, immune complex deposition may also play an important pathogenic role in 
diseases such as SLE as described more fully in section 1.2.5.
As shown in section 4.1.3, inflammation in RA is associated with elevated levels of the excreted DNA 
damage product 80HDG in urine. This does not appear to be the case in inflammation associated with 
SLE.
Preceding repair, damaged DNA bases may be excised. In this case only a few nucleotides are linked, 
which are not modified further and appear in the urine. However, extensive DNA damage results in cell 
death due to depletion of essential energy sources such as ATP and NAD (Schraufstatter et al., 1985; 
Schraufstatter et al., 1986). The energy sources are cofactors for the repair of DNA strand breaks. If 
sufficient DNA damage occurs to deplete the cell of ATP and NAD during repair, cell death occurs.
Therefore, beyond a critical level of DNA damage, the DNA repair process causes cell death and lysis, 
releasing DNA of high molecular weight (Schraufstatter et al., 1986). This may be a mechanism to 
eliminate cells that have undergone extensive DNA damage.
DNA is known to be found in circulating immune complexes in SLE (Bruneau and Benveniste, 1979; 
Adu, Dobson and Williams, 1981; Contreras et al., 1987) and may be derived from cells following 
lysis. The persistence in the circulation may then result from a failure to clear the immune complexes 
containing the bound DNA effectively.
The hypothesis that a ROS-denatured DNA molecule may persist in the circulation of SLE patients and 
play a role in the pathogenesis of the disease was investigated by isolating DNA from immune 
complexes from sera of SLE patients and analysing this DNA for 80HDG as a marker of oxidative 
damage.
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Immune complexes were also isolated from a group of normal controls to determine if DNA could be 
detected. This was investigated to see if immune complexes are normally involved in the clearance of 
cellular DNA.
Immune complexes were also isolated from a group of RA patients as an inflammatory control group to 
investigate the effects of increased cellular DNA damage on immune complex clearance of antigen.
4.3.2: Methods
4.3.2.1: Clinical Samples
Plasma was collected as described in section 4.3.2.2 from 29 SLE patients, 14 with normal renal 
function (12 female, 2 male, age range 25-51, median = 31), and 15 with abnormal renal function (15 
female, age range 27-66, median = 37). Also from 10 RA patients (9 female, 1 male, age range 57-80, 
median = 67) and two groups of 10 normal controls (8 female, 2 male, age range 20-47, median = 
26.5) and (9 female, 1 male, age range 62-82, median = 70) not differing significantly in age or sex 
from the groups of SLE and RA patients respectively.
4.3.2.2: Isolation of Im m une Complexes from Sera
Venous blood was collected into heparin and centrifuged for 30 minutes at 1500 x g. The temperature 
of the blood was maintained at 37°C immediately after collection and throughout the duration of the 
centrifugation procedure. Plasma (lOmls) was collected from the blood sample and incubated at 4°C for 
7 days to induce cryoprecipitation. 0.01 %  sodium azide was added to the samples as a preservative and 
antioxidant.
After incubation, the 10ml aliquots were centrifuged at 800 x g for 30 minutes at 4°C; the supernatant 
was discarded and 1ml of cold PBS added; after 1 hour at 4°C the tubes were centrifuged at 800 x g for 
30 minutes at 4°C; the supernatant was discarded and the pellet washed three times with lOmls PBS 
(800 X g, 30 minutes, 4°C). Finally 1ml PBS was added to the samples which were stored at 4“C. The 
samples were incubated at 37°C for 1 hour to allow resolubilisation immediately prior to analysis.
4.3.2.3: Isolation of D N A  from Im m une Complexes
Proteinase K (100/xg/ml) and 1 %  SDS in a 1ml volume of 20mM EDTA, pH 8.0, were added to the 1ml
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volume of resolubilised immune complex and the mixture was incubated at 65®C for 30 minutes (from 
Contreras et al., 1987). The protein was removed by extracting three times with 1/2 volume of phenol 
and 1/2 volume of chloroform (Maniatis, Fritsch and Sambrook, 1982, pp 458-462). To precipitate the 
DNA, 2 volumes of cold ethanol in the presence of 0.3M sodium acetate were added to the aqueous 
phase which was then left at -20°C for 24 hours. The DNA was washed with 70% ethanol, lyophilised 
and resuspended in 100/rl TE.
4.3.2.4: Analysis of DNA Isolated from Serum Immune Complexes by HPLC/ECD 
An aliquot of the DNA isolated from immune complexes was digested to individual nucleosides as 
described in section 2.3.1.4. Ten rhicrolitres of the digested DNA was then injected onto the HPLC 
column and 80HDG detected as described in section 2.6.2.1.
A further aliquot was used to determine the amount of DNA in the sample as described in section 
2.3.1.2.
Results are expressed as moles 80HDG per ;tg DNA, the volume of sera from which the DNA was 
obtained being the same in each case.
4.3.2.5: Analysis of DNA Isolated from Serum Immune Complexes by Agarose Gel Electrophoresis 
An aliquot of DNA was loaded onto an agarose gel as described in section 2.3.1.3 for analysis of size. 
This was determined by its ability to move through the gel at an applied voltage, and by comparison of 
the bands obtained with markers of known molecular weight (from lambda DNA cut with the restriction 
enzymes, EcoRl and Hind 111).
4.3.3: Results
Cryoprecipitates were isolated from the plasma of 27/29 SLE patients studied, 10/10 RA patients and 
3/20 normal controls.
The amount of DNA isolated from each of these cryoprecipitates, from lOmls plasma was measured. 
There was no significant difference between the amount of DNA isolated from the groups of SLE 
patients with (lOO-270/xg) and without (105-248^g) renal disease. There was, however, significantly
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less DNA isolated from the cryoprecipitates of normals { 2 - 1  n g  -  p <0.001) and RA patients (2-8/ig -
p<0.001).
Figure 4.7 shows the concentration of 80HDG, corrected for the amount of DNA isolated from the 
immune complex for each of the patient groups. There was no detectable 80HDG in the DNA isolated 
from the RA or normal cryoprecipitates (ie < 0.1 picomole 80HDG / f i g  DNA) and when compared 
with the SLE group with normal (2.3-9.25nM / /xg DNA) or abnormal (1.35-12.7nM / /xg DNA) renal 
function this reduction was significant for both groups at the p<  0.001 level.
A comparison of the two groups of SLE patients (with or without associated renal complications) 
showed that as for the amount of isolated DNA, there was also no significant difference between the 
amount of 80HDG isolated from DNA of these immune complexes.
Analysis of the molecular weight of DNA isolated from the immune complexes showed that the DNA 
was consistently =20 kilobases based on a comparison with the gel markers (figure 4.8). There was no 
difference in the size of the DNA obtained from patients with or without renal disease, or from patients 
with RA or the normal controls (figure 4.9).
4.3.4: Discussion
Immune complexes play a role in the clearance of antigens but are quickly solubilised by complement. 
There is evidence of defective solubilisation and clearance of immune complexes from the circulation in 
SLE (Baatrup et al., 1983). This is reinforced by the results obtained in this study. 27 of the 29 patients 
investigated had cryoprecipitable circulating immune complexes.
RA is also an autoimmune disease associated with circulating immune complexes, consisting 
predominantly of IgG and autoantibodies reactive with IgG. These may arise from oversecretion of 
immunoglobulins capable of associating to form complexes or from an interaction between autoantibody 
and antigen (Nydeggar and Lambert, 1982).
All 10 patients with RA also had immune complexes in their plasma. However, cryoprecipitable 
material was isolated only from three of the normal controls, two from the elderly group and 1 from the
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Figure 4.7
Log plot of nmoles of 80HDG / f i g  DNA detected in DNA isolated from SLE and 
RA patients and normal controls. Levels of 80HDG in the RA and control groups 
were below the detection limits of the assay. The median and ranges of values for the 
SLE group, subdivided into patients with or without normal renal function are shown.
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Figure 4.8
A typical gel of DNA isolated from an SLE immune complex showing in lane 2 the 
predominant band of DNA corresponding to »20  Kbases from comparison with the 
molecular weight markers of lambda DNA cut with the restriction enzymes, EcoRl and 
Hindlll which give the molecular weight fragments shown.
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Figure 4.9
A typical gel of DNA isolated from immune complexes of SLE, RA and control 
sera. Lane 1 represents DNA from sera of an RA patient, lanes 2-4 DNA from sera of 
SLE patients, and lanes 5-7 DNA from normal controls. Although the DNA recovered 
varies in amount, there is no significant difference in size.
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group age-matched for SLE patients. This supports evidence for an imbalance in the immunological 
network and reduced clearance of circulating immune complexes in SLE and RA.
The results obtained from analysis of the cryoprecipitates for DNA content suggest that autoantibodies 
play a major role in the formation of immune complexes in both SLE and RA and the constituents found 
therein.
However, the mechanisms for immune complex formation may differ in the two diseases. In SLE, 
antibodies to double and single stranded DNA are found in the serum (Stollar, 1981). DNA is not 
usually found in the circulation and anti-DNA antibodies with the potential to bind to DNA, released 
from cells for example, may inhibit the action of nucleases which would normally degrade the released 
DNA.
Once formed, these complexes may, due to the presence of tissue surface antigens also in the complex, 
become deposited in tissues. Complexes containing DNA and anti-DNA antibodies have been isolated 
from glomerular basement membranes (section 1.2.5).
In RA, the complexed antigen is IgG, itself an antibody which is commonly found in the circulation. 
The antibodies to IgG are of the IgM class, predominantly, and IgM can form large lattice complexes as 
a result of its pentameric valency (Pope, Teller and Mannik, 1974). Therefore, in RA, immune 
complexes may form more readily due to the overproduction of immunoglobulins and the favourable 
binding properties of IgM.
It is suggested that although immune complexes may be formed in normals to permit antigenic clearance 
(Contreras et al., 1982), and in RA because of an immunological imbalance (Gronowicz and Coutinho, 
1976; Shlomick, Nemazee and Sato, 1986), DNA does not naturally become sequestered into these 
complexes because it is degraded by nucleases. Only when the DNA is complexed to an anti-DNA 
antibody, which protects again.st the degradative effects of nucleases, does DNA become incorporated 
into cryoprecipitable complexes and persist in the circulation of SLE patients.
The lack of a significant difference between DNA found in circulating immune complexes from patients
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with and without normal renal function suggests that a finite amount of complexes containing DNA may 
circulate with no detrimental effect to the kidney (as demonstrated by the presence of DNA/anti-DNA 
antibody complexes in the circulation of patients with normal renal function). However, once there is 
deposition o f these complexes in the kidney an equilibrium may exist between DNA containing 
complexes in the serum and those bound to the tissue such that deposition of complexes in tissues does 
not deplete the presence of complexes in the circulation completely.
In RA, although DNA damage does occur, the DNA does not become trapped in a complex as shown in 
the results (section 4.3.3). The lack of DNA in RA complexes may infer that the anti-DNA antibodies 
sometimes associated with RA, with specificities to predominantly ssDNA, are of low affinity with low 
dissociation constants, thereby enabling the nucleases to degrade the DNA more easily than the DNA 
bound by high affinity antibodies in SLE.
The size and conformation of the isolated DNA will be discussed more fully in section 5.1 but from 
these results it is clear that the size of the DNA fragments isolated from the complexes are consistently 
»20 kilobases. From this it is suggested that this DNA is from cells following lysis that accompanies 
cell death rather than from active excision of DNA from the intact genome. The concentration of 
80HDG in this DNA suggests that ROS-mediated damage in SLE cells produces 80HDG but that this 
lesion is not effectively repaired, contributing to or resulting in cell death.
The DNA isolated from immune complexes of RA patients and normal controls did not contain 
detectable levels o f 80HD G. It is known that 80HDG is formed as a result of normal oxidative 
metabolism (Richter, Park and Ames, 1988) as well as during periods of oxidative stress such as 
inflammation (Floyd et al., 1986a). The lack of detection of the altered base in these samples provides 
further evidence that an effective repair mechanism exists for repair of this potentially mutagenic base. 
This repair process, by producing single bases or small fragments of DNA too small to be antigenic, but 
removing the lesions from cellular DNA, prevents anti-DNA antibody formation and releases these 
damaged bases into the circulation for final excretion in urine.
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C H A P T E R  4.4: G A S - C H R O M A T O G R A P H Y  M A S S  S P E C T R O S C O P Y  
4.4.1: Introduction
Analysis of compounds by HPLC/ECD relies on the identification of an unknown by comparing its 
elution time with that of a pure standard and "spiking" the sample containing the unknown with this 
standard. This gives rise to the possibility that a compound with the same retention time but a different 
chemical composition could produce a false positive result in a chemical assay. To overcome this, if the 
compound is UV absorbing a comparison of the maxima and minima absorption values can be made and 
in the case of a compound detected by ECD a voltammogram can be compiled from the response of the 
compound at increasing voltages (see section 2.6.2.2). In both cases different compounds are unlikely 
to give the same response but to identify the exact chemical composition of a molecule a technique such 
as mass spectroscopy must be applied.
Gas-chromatography combined with mass-spectroscopy has been used successfully to analyse radiation 
damage to the DNA sugar moiety (Dizdaroglu, von Sonntag and Schulte-Frohlinde, 1975) and more 
recently applied to the detection of damage to DNA bases (Dizdaroglu, 1985a; Dizdaroglu, 1985b; 
Dizdaroglu and Bergtold, 1986). GCMS can detect damage to DNA bases at levels that are biologically 
relevant (Dizdaroglu, 1986a; Dizdaroglu, 1986b; Dizdaroglu and Bergtold, 1986) ie levels from which 
the cells can recover. It also has the advantage over many other analytical procedures for the analysis of 
base damage to DNA, that products of the four bases can be well separated from one another and also 
from the four intact bases.
Before analysis by GCMS, because of their low volatility, bases must be derivatised to make them 
suitable for analysis.
The process of gas chromatography involves the physical separation of a moving gas phase by 
adsorption onto a stationary phase consisting of an inert solid such as silica gel coated with a non 
volatile liquid (silicone oil), on the inner surface of a long heated capillary tube. A constantly flowing 
stream of an inert gas such as helium keeps the volatile compounds moving through the column. 
Separation of the vaporised DNA bases is dependent on the differing affinities of the comp>ounds of the 
gas mixture for the stationary phase. Gases which are strongly attracted to the stationary phase move
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through the column at a slower rate and emerge later than those that are less attracted.
As the individual products emerge from the column, they are detected by mass-spectroscopy. This 
involves bombardment of the molecule with high energy electrons, causing it to fragment into ions 
characteristic of that compound. The ions of most importance in this study are the intact molecular ion 
(M'*’), and M-15'*’, typical of trimethylsilylated derivatives arising from loss of a methyl radical from 
(Dizdaroglu, 1989).
Sensitivities of as low as 10 femtomoles per injection have been achieved by incorporating selected ion 
monitoring (SIM) into the GCMS assay (Dizdaroglu and Bergtold, 1986). In the SIM mode the mass 
spectrometer is set to measure only those ions that are characteristic of a specific compound in a 
complex mixture. This is more sensitive than total ion monitoring because it permits the mass analyser 
to dwell longer on, and monitor only specific masses.
When signals of specifically monitored ions, with their typical abundances relative to one another are 
detected, a positive identification is assumed.
GCMS/SIM was used to measure 80HDG in urine and cryoprecipitate DNA to confirm the identity of 
the products that had been detected by HPLC/ECD.
4.4.2: Methods
For analysis o f DNA isolated from immune complexes (section 4.3.2.3), the DNA was ethanol 
precipitated as in section 2.3.1.1, and freeze dried. 2.5 nmoles 8AZA were added before the modified 
DNA bases were cleaved from the polynucleotide chain prior to analysis. This was achieved by 
hydrolysis of the DNA samples with 1ml of formic acid (88%) in evacuated and sealed tubes at 150°C 
for 30 minutes.
After hydrolysis, samples were lyophilised, and derivatised by trimethylsilylation with 0.25ml of a 1.5:1 
mixture of BSTFA, containing 1% trimethylchlorosilane and acetonitrile, in polytetrafluoroethylene 
capped hypovials, by heating at 130°C for 30 minutes. The derivitisation was to enable the samples to 
vaporise in the injection port of the GCMS apparatus.
158
Hydrolysed and derivatised DNA samples were then analysed by GCMS/SIM using a mass selective 
detector controlled by a computer work station and interfaced to a gas chromatograph. The injection 
port and the ion source were kept at 250°C. The GCMS interface was maintained at 270®C. 
Separations were carried out on a fused silica capillary column (12.5m x 0.32mm i.d) coated with 
crosslinked 5% phenylmethyl silicone gum phase (film thickness, 0.17/rM). The column was 
programmed from 120°C to 250°C at 8°C/min, after 2 minutes at 120®C. Helium was used as the 
carrier gas at an inlet pressure of 10 KPa. Samples were injected using the splitless mode. Mass 
spectra were obtained at 70 eV.
When used for calibration of the GCMS system, standard individual DNA bases were analysed as for 
DNA omitting the hydrolysis step. When used as internal standards, the bases were added prior to any 
preparation of the DNA samples and were therefore hydrolysed.
DNA bases, excised from the polynucleotide chain, are excreted in the urine in monomeric form. 
Therefore, urine samples, were prepared as in section 4.1.2.2, and freeze dried. 8AZA (2.5 nmoles) 
was added to each urine sample and the mixture freeze dried again. The samples were then analysed 
without undergoing acidic hydrolysis, by GCMS as described for DNA.
The injection volume for all standards and samples was l^tl.
4,4.3: Results:
Quantitative analysis of base damage to DNA is dependent on the selection of appropriate internal 
standards, and calibration of the mass spectrometer for its response to standard quantities of the internal 
standards and the compounds of interest.
8AZA was used as an internal standard because it is structurally similar, differing from the normal 
purine residue only by substitution of an N atom at C-8. (8-azaguanine has very low solubility in 
aqueous solution and was therefore unsuitable). 8AZA also eluted close to the compound of interest but 
was well separated from all the components in the mixture and was found to be stable during preparation 
of the samples.
1 5 9
8AZA (2.5 nmoles) was added to all samples before hydrolysis and derivitisation (10 pmoles per 
injection).
A calibration curve for the response of the mass spectrometer to known quantities of both 80HG and 
8AZA was obtained by p lo tting  the ratio of the areas under the curve (ion current ratio) for 
80HG:8AZA against the ratio of the amount of 80HG:8AZA (Figure 4.10). The slope of the line (3.6 
in this case) represents the relative molar response factor (RMRF) for 80HG. Values of 80HG in 
samples were calculated using the formula:
amount of standard (8AZA) x peak area of analyte (80HG)
RMRF =
amount of analyte (80HG) x peak area of standard (8AZA)
To determine retention times of the DNA base adducts, the following standards were injected onto the 
column;
8AZA - retention time 8.979 ± 0.071 mins (mean ± ISD)
80HG - retention time 13.99 ±  0.065 mins (mean ± ISD)
FAPY adenine - retention time 9.582 ± 0.577 mins (mean ± ISD)
5-hydroxyuracil - retention time 5.979 ± 0.478 mins (mean ± ISD)
The characteristic M'*’ and ions for each of these compounds are shown in table 4.2 and the mass
spectrum for each of these compounds is shown in figure 4.11.
Using these times the mass spectrometer was set up to monitor each ion for a specified period only (SIM 
mode).
Five samples of DNA, isolated from cryoprecipitates of SLE patients, were analysed by GCMS/SIM 
quantitatively for 80HG and qualitatively for other base adducts. The concentrations of 80HG found in 
the samples, corrected for the amount of DNA isolated from the cryoprecipitates (section 4.3.2.3) are 
shown in table 4.3 and compared with the values obtained by HPLC/ECD. The spectra obtained for one 
of the cryoprecipitates illustrating the bases, 80HG (1) and 8AZA (2) is shown in Figure 4.12. The 
other numbered peaks represent FAPY adenine (3), 80HA (4), 5-hydroxycytosine (5) and 5- 
hydroxyuracil (6).
Figure 4.13 shows no detectable levels of 80HG in the sample analysed. This sample was obtained
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Ion Current Ratio
Figure  4.10
Calibration plot of the trirnethylsilyl derivatives of 80HG relative to 8AZA. The 
slope of the line represents the relative molar response factor (RMRF) for 80HG and 
each point represents the mean ± ISD of three experiments. Data were fitted by least 
squares linear regression analysis.
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Table 4.2
(M+) (M-15'
8AZA 280 265
80HG 455 440
80HA 367 352
FAPY Adenine 369 354
5 -h y d ro x y u ra c il 344 329
5-hyd roxycy tos  in e 343 328
(N
M>
rH
Molecular weights of the intact molecular ion (M'*') and M-15^ (typical of trimethylsilylated derivatives arising from loss of a methyl radical from
M '*’) for the oxidised products of DNA base residues analysed in this assay.
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Figure 4.11
Total-ion chromatograms and mass spectra of the standard peaks of A) FAPY Adenine, B) 8AZA, C) 5-hydroxyuracil and D) 80HG are 
shown. The characteristic and M-15^ ions for each of the compounds are listed in table 4.2.
cecipitate 80HD6
(nmoles)
GCMS
80HDG
(nmoles)
HPLC/ECD
DNA
(Mg)
nmoles 80HDG//xg DNA 
GCMS nmoles 80HDG/Mg HPLC/ECD
1 274±22 171119 12714 2.1610.25 1.3510.04
2 1219147 1458141 18213 6.710.37 8.0110.14
3 472119 373123 13516 3.510.31 2.7610.07
4 767146 784125 11817 6.510.82 6.7410.15
5 535130 579127 10415 5.110.04 5.5710.17
VO
Table 4.3
Comparison of values of 80HDG found in five cryoprecipitate samples analysed by GCMS and HPLC/ECD. Results (means ± ISD) are
expressed as nmoles 80HE>G / /xg DNA of three separate experiments by both GCMS and HPLC/ECD.
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in
Selected-ion chromatogram of trimethylsilylated DNA base products found in DNA isolated from a circulating immune complex of a patient 
with SLE. Peak identification is:
1. 80HG 2. 8AZA 3. FAPY Adenine 4. 80HA 5. 5-hydroxycytosine 6. 5-hydroxyuracil.
8A7A « k/i I / ' •0 .2^0 I r>
rt IJUUKI I 
« ■ : 
____ ic ife3t3l3"J
:: 1 I
—  «  - - ^
• -  > 1 I /It i4I COCr* i
D ry ky
1—>—»—I—I—»-
c / ^
yf'im ~M i  5 S '• ''L n  i  r  0  6
l \ f  rs4 M C . i
___\
1
i^ L  ^  ^
\c
::; ? . n rs - i  » 1“• 4^ i
v-> 1 csr*^  "i 
c z  • • - - - ’ 
1 8AZA
I 1 ASA. t ns 1 rb I
Figure  4.13
Selected-ion chromatogram of trimethylsilylated DNA base products found in DNA 
isolated from a circulating immune complex from a normal control. The mass spectra 
shows the presence of the internal standard (8AZA) in the sample but there was no 
detectable level of 80HDG.
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Eight urine samples were also analysed by GCMS. Figure 4.14 shows a total ion chromatogram for one 
of the control urine samples and figure 4.15 shows the same sample analysed using selected ion 
monitoring, demonstrating the overall reduction in size of the peaks in figure 4.15 but amplification of 
the relevant peaks by SIM. It is still noticeable that more compounds are detected in the urine samples 
in this mode than for the DNA preparations.
The values obtained for each of the samples are shown in table 4.4.
4.4.4: Discussion
The levels o f 80HG detected in DNA from the cryoprecipitates of five SLE patients were not 
significantly different from the values obtained by HPLC/ECD (table 4.3). There was also no detected 
80HG in the sample isolated from plasma of a normal control even though the sensitivity of the 
technique was =  10  ^ times greater.
The results for the urine samples from normal controls were again found not to be significantly different 
from the results obtained by HPLC/ECD. However, for the urine samples from SLE patients, whilst 
80HDG was undetectable by HPLC/ECD, it was positively identified in the urine by GCMS/SIM.
GCMS has been used with a confirmatory application and the results obtained for the DNA from SLE 
and normal cryoprecipitates, and for the urines from normal controls were of the same order as those 
obtained by HPLC/ECD. This confirmed the presence of this altered DNA base in the samples 
analysed. The detection of the two characteristic ions (M"*" and M-15''’) in equal amounts confirms the 
purity of the peak by GCMS and the fact that there was no significant difference between these and the 
values measured by HPLC/ECD strongly suggests that the peaks measured by the latter were not 
contaminated with other co-eluting compounds.
from a cryoprecipitate isolated from a normal control.
The detection of 80HG at concentrations of the same order as those detected by HPLC/ECD also 
suggests that there is no significant contribution to the 80HG detected by GCMS from RNA. The 
HPLC method measures 80HDG with the deoxyribose sugar still attached to the modified base as a
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Figure 4.14
Total-ion chromatogram of a urine sample from one of the normal controls. There is a high relative abundance of three peaks which 
reduces the peaks of interest to undetectable levels.
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Selected-ion chromatogram of the same urine sample analysed in figure 4.14 from a normal control. The chromatogram shows peaks of
abundances of several magnitudes lower than those in figure 4.14 but allows detection of compounds present in low concentrations such as 80HG.
The mass spectra shows identification of 80HG in this sample.
U rine age sex U rine
C re a tin in e
(mM/1)
80HDG/MM
C re a tin in e
C o n tro l 22 F 7.310.04 2.5 pmole
C o n tro l 22 M 13.410.03 6.2 pinole
SLE 22 F 6.610.05 20 fmole
SLE 27 F 3.910.04 10 fmole
SLE 28 M 5.910.10 12 fmole
SLE 32 F 12.210.02 6.6 fmole
SLE 25 F 6.910.04 4.5 fmole
SLE 29 F 5.610.11 9.2 fmole
o
rH
Table 4.4
Values of 80HDG analysed by GCMS/SIM in two control and six SLE urine samples expressed as pmoles or fmoles 80HDG / fiM
creatinine. Results are means ± ISD of three separate analyses of each sample.
label that the base has been derived from DNA. It has also been shown that 80HG is not detected under 
the conditions of this assay (section 2.6.2.1) and therefore is unable to contribute to the level of 80HDG 
detected. However, the acidic hydrolysis removes the sugar residue from the DNA base and the 
remaining, measurable 80HG by GCMS could theoretically arise from either DNA or RNA.
Detection of 80HG in the urine of SLE patients at levels of femtomolar/;tM creatinine may be explained 
by a decreased excretion of the damaged DNA base, 80HDG that was not detectable by HPLC/ECD. 
However, it may also reflect detection of 80HG derived from RNA, at levels that did not significantly 
affect measurement of picomoles of 80HDG derived from DNA.
Damage to DNA is repaired by excision of the base from the DNA strand and the base is then excreted 
in urine. The lack of 80HDG in the urine of SLE patients may arise from a defective repair mechanism 
for 80HDG. There is known to be defective repair of the base, 0*-methylguanine in DNA of patients 
with SLE and other autoimmune diseases (Harris et a!., 1982). This base is premutagenic and its 
accumulation in the cell is potentially lethal. 80HDG has been shown to have mutagenic properties 
(Kuchino et al., 1987; Shibutani, Takeshita and Grollman, 1991) and similarly would be detrimental to 
the cell if not effectively repaired. The considerably reduced excretion of 80HDG seen in SLE patients 
does suggest that there is poor excision of the DNA adduct. The concentration of 80HDG in the DNA 
isolated from the circulating immune complexes also could account for the lack of the adduct in the 
urine. However, the DNA found in the immune complexes was »20  kilobases in size which is much 
larger than the fragments removed from DNA as a result of excision repair. This suggests that the DNA 
in the immune complexes is derived from cells, following death and subsequent lysis. The presence of 
80HDG in this DNA suggests that in SLE, 80HDG is not easily repaired and its accumulation may be 
responsible for cell death. In addition, as a result of the inflammatory response, it is likely that ROS 
generated by neutrophils and macrophages will be increased especially in localised areas of 
inflammation, and that this would contribute to an increased conversion of dG to 80HDG.
Evidence to support the role of neutrophil-derived ROS in the DNA damaging process is documented by 
Jackson et al., (1989) who showed that the DNA base products formed from ROS generated by gamma 
irradiation differ significantly from those formed in reactions of DNA with neutrophil-derived ROS. 
80HA, which was the predominant altered DNA base found in the cryoprecipitate samples analysed, is
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found in low yield in gamma irradiated DNA but is the major product of neutrophil-derived damage and 
so further supports the hypothesis that DNA bound to cryoprecipitates has been exposed to ROS.
Finally, in section 3.6 it was shown that DNA derived from activated neutrophils, when probed with the 
panel of MCAs, had a similar binding profile to DNA denatured with rather than DNA denatured 
with gamma or UV radiation. This provides further evidence that DNA damage may arise from a 
neutrophil-mediated inflammatory reaction.
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SECTION 5:
ANTIGENIC PROPERTIES OF ROS-DNA
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CHAPTER 5:
Antibodies to native dsDNA represent a characteristic serological finding in patients with SLE, and are 
of important diagnostic and clinical value. They are thought to be highly specific for this disease, 
particularly when renal complications are present (Aitcheson and Tan, 1982), but they also reflect 
disease activity (Isenberg et ah, 1986) and associate with hypocomplementaemia.
DNA/anti-DNA complexes (Adu, Dobson and Williams, 1981) in SLE sera may also play a role in the 
pathogenesis of the disease, particularly when they are deposited in tissues, such as the glomerular 
basement membrane (Bruneau and Benveniste, 1979). However, the significance of circulating 
DNA/anti-DNA complexes remains uncertain.
The effects of ROS on the physicochemical properties of DNA have been discussed in chapter 3. It has 
also been described how neutrophil-derived might damage DNA by virtue of its ability to cross 
cellular and nuclear membranes (section 1.1.5.4). This process would be detrimental to any cell, but 
more so in SLE, since cells from SLE patients appear to have a reduced capacity for repair of the ROS- 
induced lesion 80HDG (section 4.2). As a result of this, and possibly other mechanisms of DNA repair 
processing which may be impaired (Harris et al., 1982), large fragments of DNA, containing ROS- 
induced products, persist in the circulation of these patients.
Work predominantly on UV-irradiated DNA has led to the general belief that denaturation of DNA 
increases its antigenicity (Tan and Stoughton, 1969) and there is compelling evidence to suggest that 
ROS-denatured DNA molecules induce an increased immune response on injection into animals 
compared with native DNA (Natali and Tan, 1971; Jansson, 1985).
The following sections were aimed to investigate: a) the role of ROS-DNA as a potential antigen and 
immunogen for anti-DNA antibody production in SLE, and b) the possible use of ROS-DNA as a 
substrate in the development of a sensitive ELISA for measurement of anti-DNA antibodies.
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CHAPTER 5,1: CHARACTERISATION OF DNA IN SEE SERUM 
5.1.1: Introduction
The evidence for the presence of DNA in circulating immune complexes in SLE sera has been presented 
in section 1.2.5 and the isolation of DNA from these complexes is described in section 4.3.2.3. Since 
DNA is usually packaged into the cell nucleus and quickly degraded by nucleases on entering the 
circulation, the ability of DNA to act as an antigen against which antibodies can be raised has been 
questioned (Schwartz and Stollar, 1985; Isenberg and Shoenfeld, 1987). The presence of immune 
complex-associated DNA in the circulation is possibly the only source of available antigen against which 
anti-DNA antibodies can be raised, if DNA is the true immunogen at all (Schwartz and Stollar, 1985).
The ability of ROS modification to alter the antigenicity of DNA has also been discussed (section 1.2.6). 
In animal models, ROS-denatured DNA has elicited the production of anti-DNA antibodies with 
affinities predominantly for the altered DNA, but also some cross-reactivity with native dsDNA (Tan 
and Stoughton, 1969; Jansson, 1985).
In the following section, the conformation and chemical characteristics of the DNA isolated from the 
sera of SLE patients were studied, using the panel of MCAs described in section 3.6.
5.1.2: Methods
5.1.2.1: Clinical Samples
5 SLE patients having concentrations of cryoprecipitable DNA of >200/ig/ml were selected from the 
group described in section 4.3.3. Plasma (50mls) was then collected from each of these patients over a 
period of time. The extracted DNA was pooled, and its final concentration was measured as in section 
2.3.1.2. DNA was resuspended in PBS at a concentration of 1000/tg/ml.
Similarly, DNA extracted from cryoprecipitates of 2 normal controls and 3 RA patients was collected 
and pooled from a total plasma volume of 200mls. The DNA concentration was again measured and the 
samples finally resuspended at a concentration of 100/rg/ml.
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The ELISA assay for determination of monoclonal antibody binding to plasma cryoprecipitate DNA 
compared with native dsDNA was as described in section 3.6.2. For DNA isolated from SLE plasma 
the competing antigen was titrated in PBST from lOOOpg/ml in doubling dilutions across the plate. For 
DNA isolated from the sera of RA patients and the normal controls the competing antigen was titrated 
from lOO^g/ml again in doubling dilutions across the plate.
The cryoprecipitate4 DNA was probed with three different MCAs: 212 - recognising the sugar- 
phosphate backbone on ss- and dsDNA, 228 - recognising bases on ssDNA only, and 402 - recognising 
conformational determinants on dsDNA (table 3.5).
5.1.3: Results
Figure 5.1 shows the titration curves for the three MCAs binding to commercially prepared native 
DNA, and DNA isolated from the cryoprecipitates of each of the normal controls and RA patients. For 
each MCA there was no significant difference between the curves.
Figure 5.2 shows the titration curves for the same MCAs binding to native dsDNA and DNA isolated 
from SLE cryoprecipitates.
For MCA 212, there is a significant positive shift in the binding curve signifying a decrease in affinity 
of the available binding sites on SLE-derived DNA compared to Nat-DNA, and the cross over of the 
curves suggests a change in the binding avidity of the MCA to the SLE-derived DNA.
MCA 228 shows an increased binding affinity to the base determinants of SLE-derived DNA compared 
to native dsDNA as illustrated by the positive shift in the titration curve.
The curve for MCA 402 binding to SLE-derived DNA shows an increased affinity as well as an increase 
in the number of available binding sites for dsDNA conformational determinants compared to native 
dsDNA.
The differences in each of the binding curves for the three MCAs were significant at the p<0.01 level.
5.1.2.2: ELISA Assay
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Figure 5.1
%  Binding of MCAs 212, 228 and 402 to serial two-fold dilutions of native dsDNA or DNA isolated from circulating immune complexes of 
normal controls (N) and RA patients (RA). Points plotted are means of triplicate samples.
M CA  212 M C A  228 M CA  402
CO
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Figure 5.2
% Binding of MCAs 212, 228 and 402 to serial two-fold dilutions of native dsDNA or DNA isolated from circulating immune complexes of 
5 patients with SLE. The points plotted are the means of the values obtained for the 5 patients, samples for each patient being assayed in triplicate.
The binding specificities of monoclonal antibodies derived from mouse models of SLE have been 
characterised and it has been shown that mouse monoclonal DNA-binding antibodies are very similar to 
those found in humans with SLE (Morgan et al., 1985b). Also the diversity of specificity of DNA- 
reactive antibodies is small (Morgan et al., 1985b).
In this section, MCAs were used to show that there is a difference between DNA isolated from patients 
with SLE, and the control and RA groups on the basis of differences in MCA binding to the DNA 
samples. This supports data from studies of 80HDG analysis by HPLC/ECD and GCMS which showed 
evidence of ROS-induced damage to cryoprecipitate DNA only in patients with SLE (sections 4.3 and 
4.4).
The presence o f 80HDG in the SLE cryoprecipitate DNA is an indicator that the DNA has been 
exposed to ROS, and particularly to OH--mediated reactions (see sections 1.1.5.4 and 3.1). However, 
in chapter 3 the pattern of damage inflicted on DNA has been shown to differ between ROS-inducing 
systems detected by the differing binding capacities of MCAs which recognise a variety of epitopes 
(table 3.5). This seems to relate to the distribution of metal ions along the DNA backbone catalysing 
site-specific OH- in -producing systems, and random generation of OH- by the gamma radiation- 
mediated homolytic fission of water molecules. The characteristic pattern of DNA damage detected by 
MCA binding was used to compare any changes in the cryoprecipitate DNA with DNA exposed to the 
ROS-generating systems (section 3.6.3).
There was no significant difference between DNA isolated from cryoprecipitates of normal controls or 
RA patients and native dsDNA when probed with the MCAs. This suggests that the DNA in these two 
groups is predominantly native dsDNA. The size of the isolated DNA (»20  kilobases - section 4.3.3) 
suggests that this DNA is most likely derived from a lysed, dying cell. Its presence as part of a 
circulating immune complex may represent a normal mechanism for the removal of circulating antigens, 
as mentioned in sections 1.2.5 and 4.3.1. There was also significantly less DNA found in the immune 
complexes of these two groups, compared to the SLE patients and this may result from quicker and 
more effective clearance of DNA. This is supported by evidence that DNA persists longer in the
5.1.4: Discussion
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circulation of patients with SLE (Frost and Lachmann, 1968; Chitrabamrung, Rubin and Tan, 1981), 
and also by the difference in urinary excretion patterns for the altered DNA base, 80HDG (section 4.1).
The results from MCA binding studies suggest that the DNA from the SLE complexes is different from 
native dsDNA. There was an increase both in number and affinity for dsDNA conformational 
determinants. Also, a reduction in binding affinity and a change in the nature of the determinants 
expressed on the sugar-phosphate backbone, as well as an increase in binding affinity to base residues.
These appear to be similar to induced by reacting with DNA and do not reflect the damage 
induced by ionising radiation (section 3.6.3). This indicates that DNA found in circulating SLE immune 
complexes has been exposed to a ROS-generating system that produces a pattern of damage typical of 
expo.sure to H^O .^ It was shown in section 3.6.3.7 that neutrophil-derived ROS produced a pattern of 
damage typical of that produced by reacting with DNA-bound metal ions. Therefore, the damage 
to DNA found in SLE sera may have been mediated by derived from O^-' produced from
activation of the NADPH oxidase of activated neutrophils and macrophages during inflammation.
The data from the studies using GCMS to monitor base damage also support neutrophil-derived ROS (ie. 
Oj-‘ reacting with metal ions to form and OH- - section 1.1.4.7) as the damaging agents in the 
modification of SLE cryoprecipitate DNA (section 4.4.4) (Jackson et al., 1989).
The small distance over which OH- can diffu.se (Ward, Blakely and Joner, 1985) limits its reactivity to 
the region in close proximity to the DNA-bound metal ions. Damage to specific bases in preference to 
others may reflect the positioning of metal ions along the backbone, for example regions of 
polydeoxyguanosine with a high electronegativity are favourable positions for metals to bind (section 
1.1.5.4).
TTie results suggest that the DNA bound to circulating SLE immune complexes has been exposed to 
ROS and that these ROS are produced during the respiratory burst of phagocytic cells.
SLE cells do not appear to excise 80HDG from their DNA as effectively as normal cells (section 4.2); 
this would account for the fact that DNA derived from dying SLE cells contains increased levels of
1 8 0
damaged-DNA products. However, it cannot be excluded that the DNA persisting in the circulation of 
SLE patients (Frost and Lachmann, 1968; Chitrabamrung, Rubin and Tan, 1981) becomes damaged by 
ROS produced extracellularly after it enters the circulation since serum has little SOD or catalase 
activity (section 1.1.6).
Regardless of the mechanism responsible, the presence of an altered form of DNA in the circulation 
may be involved either in the production of antibodies to DNA, or it may affect the affinity and/or 
avidity of binding and thus the pathogenicity of existing antibodies.
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CHAPTER 5.2: POLYCLONAL ANTIBODY BINDING TO ROS-DENATURED DNA
5.2.1: Introduction
is sufficiently lipophilic to permeate both cellular and nuclear membranes (Halliwell and 
Gutteridge, 1985) and has been shown to be capable of reacting with DNA to induce conformational 
changes (Allan et al., 1988), base damage (Massie, Samis and Baird, 1972) and double- and single­
strand breaks (Rhaese and Freese, 1968; Ward JF et al., 1987).
This modification is possibly important in SLE since a distinct population of anti-DNA antibodies 
recognise determinants on denatured forms of DNA (Stollar, 1973) which may be exposed when dsDNA 
is damaged by ROS. Antibodies from SLE sera have been characterised as binding to:
1. Purine or pyrimidine bases (Stollar and Levine, 1963), which are exposed only in ssDNA and 
denatured dsDNA.
2. The linear sugar-phosphate backbone conformation on dsDNA. These antibodies may also recognise 
helical regions of ssDNA (Stollar, 1981).
3. Conformational determinants on the dsDNA helix (Steinman, Deesomchok and Spiera, 1976). These 
antibodies are specific for dsDNA.
Using an antibody reference serum (sero-positive for anti-dsDNA antibodies), the role of DNA 
denatured by ROS (ROS-DNA) as a potential antigen for anti-DNA antibody production was 
investigated by measuring binding of SLE anti-DNA antibodies to ROS-DNA compared with binding to 
native dsDNA (Nat-DNA).
5.2.2: Methods
5.2.2.1: Preparation of ELISA Antigens 
5.2.2.1.1: Native DNA (Nat-DNA)
Double-stranded human DNA was dissolved in chelex-treated PBS at 2.5mg/ml. Dilution to 0.5mg/ml 
with O.IM acetate, pH 4.8, containing 0.05M zinc chloride and subsequent incubation with SI nuclease 
(100 units/mg DNA) at 45°C for 1 hour digested any contaminating ssDNA. The DNA was recovered 
by phenol/chlorofonn extraction and ethanol precipitation as described in section 2.3.1.1 and the final
182
A260nm/A280nm of the preparation was greater than 1.85, indicating that the preparation was 
effectively free from contaminating protein.
Single-stranded DNA was prepared by immersing a sample of this stock solution in a boiling water bath 
for 15 minutes then rapidly cooling on ice.
dsDNA and ssDNA were diluted to 100/;rg/ml in 0.05M carbonate buffer, pH 9.6, for coating to the 
ELISA plates.
5.2.2.1.2: ROS-Denafured DNA (ROS-DNA)
dsDNA and ssDNA at 0.5mg/ml in PBS prepared fresh from the stock solution were incubated in 
separate experiments with 200/iM and lOmM AA at 37®C for 1 hour. All preparations of ROS- 
DNA were made immediately prior to use in the ELISA assay.
5.2.2.2: Scavenger and Chelator Studies
The following free radical scavengers were included in the preparation of ROS-DNA at the 
concentrations stated in table 2.1, to define the nature of the ROS responsible for changes induced in 
human DNA by H^O  ^ and AA: cysteine, histidine, SOD, mannitol and thiourea, and the iron chelator, 
desferrioxamine.
S.2.2.3: ELISA Assay
The ELISA assay was based on that described by Stokes, Cordwell and Thompson (1982) and was 
performed as described in section 2.3.2.1. ROS-DNA and Nat-DNA were bound to microtitre plates in 
carbonate buffer. Binding of anti-DNA antibodies in the seropositive antibody control sample to DNA 
was monitored using peroxidase-conjugated goat anti-human IgG, IgA and IgM antibodies at a working 
dilution of 1/1000 in PBST.
The coefficient of variation for intra- and inter-batch analysis for five separate preparations of ROS- 
DNA from the same stock solution, using the seropositive anti-DNA antibody control as a source of 
anti-DNA antibodies, was 3.06% and 6.8% respectively (table 5.1). For Nat-DNA the intra-batch 
variation was 2.7% and the inter-batch variation was 7.7%.
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Interbatch IntrabatchVariation Variation
0.406 1.050
0.442 1.090
0.497 1.063
0.495 1.101
0.408 1.070
0.466 1.133
0.466 1.144
0.455 1.089
0.448 1.076
0.476 1.052
1.045
1.118
1.107
1.040
1.115
1.043
1.110
Mean = 0.456 = 1.085
SD = 0.031 = 0.033
CV =6 . 8% = 3.06%
Table 5.1
Multiple analysis of serum samples to determine the interbatch and intrabatch 
variation of the ROS-DNA ELISA. The individual OD values are shown from which 
were calculated the mean, standard deviation (SD) and coefficient of variation (CV).
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5.2.3: Results
5.2.3.1: Optimisation of Coating Antigen Concentration
ELISA assays require efficient immobilisation of the coating antigen onto the plate and there are several 
techniques described to achieve this for DNA (Zouali and Stollar, 1986; Eaton, Schneider and Schur, 
1983). Coating DNA in carbonate buffer and coating DNA in PBS with a precoating of poly-L-lysine 
were initially investigated. Carbonate buffer was chosen as a means of immobilising the antigen in these 
experiments in preference to precoating the plates with poly-L-lysine since there was no significant 
difference in the DNA binding values and this reduced the number of steps in each assay.
At pH 9.6, DNA dissolved in carbonate buffer, is positively charged, and is therefore attracted to the 
negatively charged polystyrene ELISA plates.
To optimise the concentration of DNA required to give maximal coating of the ELISA wells, Nat-DNA 
and ROS-DNA were diluted from 500/[tg/ml to l/xg/ml in carbonate buffer, and the amount of anti-DNA 
antibody binding determined by optical density. This was performed for each DNA concentration and 
measured using a seropositive anti-DNA antibody control (reconstituted in 0.5ml PBS and used neat as 
recommended) and peroxidase-conjugated pooled anti-sera to IgG, IgA and IgM.
Table 5.2 shows the optical densities obtained for Nat-DNA and ROS-DNA. There was a dose- 
dependent increase in the amount of anti-DNA antibody bound from 1-100/ig/ml DNA after which the 
values plateaued and the difference in optical density for DNA concentrations of 100/ig/ml and 
200/ig/ml was not significant. Therefore, the coating concentration of DNA used in further experiments 
was chosen as 100/ig/ml.
5.2.3.2: Direct and Competition ELISAs for Anti-DNA Antibody Determination
The immobilisation of DNA onto an ELISA plate may shield epitopes on the DNA molecule and so
reduce the number and variety of interactions between antibody and antigen.
To establish the difference in binding of anti-DNA antibodies to immobilised DNA compared to DNA 
free in solution, a direct binding ELISA was compared with a competition ELISA.
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DNA Concentration 
/ig/ml
OD
Nat-DNA
OD
ROS-DNA
5 0 0
200
100
7 5
50
25
10
5
2 . 5
1
0
1 .4 0 5 ± 0 .0 1 4  
1 .3 9 7 ± 0 .0 2 4  
1 . 3 2 0 ± 0 .0 2 5  
1 . 0 6 2 1 0 .0 1 3  
0 .8 8 4 1 0 .0 1 2  
0 .7 3 0 1 0 .0 0 7  
0 .5 6 8 1 0 .0 0 4  
0 .4 6 2 1 0 .0 0 2  
0 . 3 2 9 1 0 .0 0 2  
0 . 2 3 4 1 0 .0 0 3  
0 . 12010.002
1 . 2 1 9 1 0 .0 4 3
1 .2 0 1 1 0 .0 2 3
1 .1 2 4 1 0 .0 3 4
0 . 9 8 7 1 0 .0 4 3
0 .8 0 9 1 0 .0 2 3
0 . 6 8 9 1 0 .0 2 4
0 . 5 9 4 1 0 . 0 1 9
0 . 4 8 7 1 0 . 0 1 2
0 . 3 1 8 1 0 . 0 0 7
0 .2 1 6 1 0 . 0 0 9
0 . 1 2 5 1 0 . 0 0 2
CO
Table 5.2
Binding of Nat-DNA and ROS-DNA to ELISA plates. The binding of Nat-DNA and ROS-DNA diluted in carbonate buffer, pH 9.6, over a range of 
concentrations, was measured using a seropositive anti-DNA antibody control and peroxidase-conjugated goat anti-human, IgG, IgA and IgM.
The results of anti-DNA antibody binding to increasing concentrations of DNA in a direct binding 
ELISA are shown in table 5.2.
For the competition ELISA, DNA was coated at lOOng/ml as for the direct binding assay and the 
protocol described in section 2.3.2.2 was followed. Nat-DNA or ROS-DNA was then titrated from 
lOOO^g/ml in doubling dilutions across the plate and incubated at 37°C for 1 hour. A seropositive anti- 
DNA antibody control was then added in equal volume to all wells and further incubated for 1 hour at 
37°C. The ELISA was then completed by addition of labelled anti-sera as in section 2.3.2.1. Results 
for anti-DNA antibody binding to the immobilised antigen in the presence of increasing concentration of 
competing antigen are shown in table 5.3.
There is no significant difference between the binding of the antibody to the DNA either free in solution 
or when bound to the solid matrix. Therefore, a direct binding ELISA was used for further analysis of 
the interaction between anti-DNA antibodies and DNA.
5.2.3.3: Anti-DNA Antibody Binding to ROS-DNA
The effect of and AA on the binding of seropositive anti-DNA antibody control serum to dsDNA 
and ssDNA is shown in figure 5.3. There is a dose-dependent increase in anti-DNA antibody binding to 
both dsDNA and ssDNA with increasing dose of for an AA concentration of lOmM. There was
no further increase in antibody binding beyond 200^M and this concentration was used for 
denaturation of DNA by ROS (section 5.2.2.1.2).
The contribution to the increase in antibody binding by 200/iM and lOmM AA alone, and in 
combination is shown in figure 5.4. There was no difference in binding as a result of incubating DNA 
with AA only, and although a slight increase was noted for incubation with alone, this was not 
significant. However, there was a significant increase in binding induced by in the presence of 
AA, the mean optical density increasing from 0.51 to 0.93 for dsDNA (p<0.001) and from 0.53 to 0.99 
for ssDNA (p <0.001).
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Concentration 
Competing 
DNA (/ig/ml)
OD
Nat-DNA
OD
ROS-DNA
0 1 .3 0 6 ± 0 .0 3 4 1 .4 7 5 ± 0 .0 5 4
1 1 .2 1 4 ± 0 .0 2 3 1 .4 2 3 1 0 .0 3 2
2 1 . 1 7 9 ± 0 .0 3 4 1 . 4 1 1 1 0 .0 3 3
4 1 .0 4 5 ± 0 .0 4 5 1 . 3 9 0 1 0 .0 3 4
8 0 . 9 4 9 ± 0 .0 5 5 1 .1 0 9 1 0 .0 1 2
16 0 .8 2 6 ± 0 .0 5 4 0 . 9 7 7 1 0 .0 2 2
32 0 . 7 3 1 ± 0 .0 3 2 0 . 8 1 9 1 0 .0 4 4
65 0 . 5 2 5 ± 0 .0 3 4 0 .6 7 3 1 0 .0 3 3
1 2 5 0 . 3 7 1 ± 0 .0 1 2 0 .5 2 6 1 0 .0 2 2
2 5 0 0 .3 0 6 ± 0 .0 3 2 0 .4 0 7 1 0 .0 2 1
5 0 0 0 . 2 4 4 ± 0 . 012 0 .3 2 3 1 0 .0 1 1
1 0 0 0 0 .2 1 6 ± 0 .0 2 3 0 .2 7 8 1 0 .0 1 1
CO
CO
Table 5.3
Comparison ELISA to compare binding of SLE serum antibodies to Nat-DNA and ROS-DNA in free solution. The binding of SLE anti-DNA antibodies to 
Nat-DNA and ROS-DNA was measured by binding Nat-DNA to the plate in carbonate buffer at 100 /rg/ml. Titrations of Nat-DNA and ROS-DNA in 
doubling dilutions across the plate were used as competing antigens. Seropositive and seronegative controls diluted 1/50 were added in equal volume to the 
DNA solutions and after incubation (37°C/1 hour), anti-DNA antibody binding to DNA on the solid phase was measured by peroxidase-conjugated goat anti­
human IgG, IgA and IgM in total.
OD at 492nm
Figure  5.3
Dose-dependent increases in anti-DNA antibody binding to single- and double- 
stranded DNA. Anti-DNA antibody binding to double (•)  and single (• )  stranded 
DNA, both incubated in the presence of lOmM AA, was measured as a function of 
increasing concentration.
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OD at 492nm
ssDNA
F igure  5.4
Effect of and AA on anti-DNA antibody binding. Double (■) and single (£s) 
stranded DNA were incubated with lOmM AA, 200;rM and PBS. Results are 
means ± ISD of four separate experiments.
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The seronegative control serum (reconstituted in 1ml PBS and used neat as recommended) showed no 
detectable binding, as determined by optical density values not significantly different from those of 
background, to either Nat-DNA or ROS-DNA.
5.2.3.4: Inhibition of Anti-DNA Antibody Binding to ROS-DNA by Scavengers 
The effect of various ROS scavengers on the induction of antigenic changes to both dsDNA and ssDNA 
is shown in figure 5.5. Thiourea, a hydroxyl radical scavenger and Cu^ '*’ chelator, caused inhibition in 
serum binding of 71% (p<0.001) and 62% (p<0.001) for ssDNA and dsDNA respectively, when 
compared to ROS-DNA. Similarly, the iron chelator desferrioxamine inhibited autoantibody binding by 
69% (p<0.001) for ssDNA and 78% (p<0.01) for dsDNA. Mannitol, histidine, cysteine and SOD did 
not offer significant protection against ROS-induced damage.
5.2.3.5: Detection of ROS-Induced Changes to DNA by Individual Isotypes
The differential binding of the major isotypes of anti-DNA antibodies to ROS-denatured DNA was 
measured by ELISA using anti-serum to individual isotypes as peroxidase conjugate rather than pooled 
anti-IgG, -IgA and -IgM. The IgG, IgA and IgM antibody isotypes all individually detected the increase 
in seropositive serum binding to ROS-denatured dsDNA and ssDNA compared to the control, at a 
significance level of p < 0.01 (figure 5.6). The inhibition induced by the presence of desferrioxamine 
and thiourea, however, varied between the isotypes. For example, desferrioxamine inhibited binding of 
serum anti-DNA antibodies to dsDNA by 20, 10 and 8% for IgG, IgA and IgM respectively, and 
thiourea sim ilarly inhibited by 14% for IgG, 10% for IgA and 3% for IgM. The decreases in 
absorbance for the IgM isotype were not significant for all inhibitors used; a significant decrease in anti- 
DNA antibody binding to DNA was detected by the IgG isotype for dsDNA incubated with 
desferrioxamine (p<0.01) and thiourea (p<0.01). Binding of the IgA isotype to both dsDNA and 
ssDNA was also significantly inhibited in the presence of thiourea (p<0.001) and desferrioxamine 
(p< 0.001). Although IgG and IgA isotypes showed a similar response, the actual OD measurements 
for the IgA isotype were =  4-times smaller than those for IgG.
5.2.4: Discussion
The results show that anti-DNA antibodies, such as those found typically in SLE, have a greater 
capacity to bind to ROS-DNA than to Nat-DNA. This denaturation, mediated by H^O^, is highly
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OD at 492nm
DNA +H202/AA +H202/AA +Des +H202/AA +Thio
dsDNA ■  ssDNA
Figure 5.5
Effect of radical scavengers on anti-DNA antibody binding. Results are means ± 
ISD of four experiments showing the inhibition by 0.5mM desferrioxamine and 50mM 
thiourea of the ROS-induced increase in anti-DNA antibody binding to double (■) and 
single (h) stranded DNA.
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Figure 5.6
Differential binding of anti-DNA isotypes against ROS-DNA. Binding of anti-IgG, IgM and IgA isotypes to double (q) and single (H)
stranded DNA.
dependent on metal ions and a reducing agent. There is evidence to suggest that metal ions, notably iron 
and copper, are bound to DNA (Mello Filho and Meneghini, 1984; Goldstein and Czapski, 1986; Ward, 
Blakely and Joner, 1985) and stabilise the association between DNA supercoils and the non-histone 
matrix (Dijkwel and Wenink, 1986).
The reaction between and metal ions is described in section 1.1.2.2 and the chelation of all assay 
reagents necessitates that the metal ions catalysing the production of OH- are bound to DNA. The 
results show that H^O  ^alone caused an increase in anti-DNA antibody binding and this is probably due 
to the reaction of with the reduced forms of metal ions bound to DNA. These become oxidised to 
produce OH- and then need to be reduced to further catalyse the production of OH-. Addition of AA to 
the reaction mixture caused a significant increase in the binding of anti-DNA antibodies to DNA and 
demonstrates the need for rejuvenation of metal ions to perpetuate the damaging Fenton reaction.
In sections 3.1 and 3.2 it was shown that concentrations of up to 200/iM H^O  ^caused an increase in 
DNA damage detected by the formation of 80HDG and TBA-reactive products respectively. Therefore, 
the reduction in linearity of polyclonal antibody binding to ROS-DNA seen beyond 50/xM H^O  ^may 
reflect either that further damage done to DNA does not cause additional changes in DNA conformation 
that are detected by polyclonal antibodies, or that continued alteration of sites damaged by 
concentrations of H^O  ^greater than 50;<M does not affect antibody binding further.
Inhibition of ROS-induced damage was effected by thiourea and desferrioxamine. Thiourea is a 
hydroxyl radical scavenger and can scavenge metal ions, particularly copper, whilst desferrioxamine is 
an iron ion chelator. The hydroxyl radical is highly reactive (see section 1.1.2.3) and can diffuse only 
1.5nm before reacting (Ward, Blakely and Joner, 1985). OH- produced by DNA-bound metal ions 
reacting with H^O  ^are more likely to react in close proximity to DNA than with a scavenger molecule 
in solution. This is reflected by the inability of mannitol, a hydroxyl radical scavenger to inhibit the 
reaction. Although the relative rate constant for scavenging OH- is 4.7 times greater for thiourea than 
mannitol (Halliwell and Gutteridge, 1989 pp 22-85), and thiourea may be more able to diffuse closer to 
DNA by virtue of its greater lipophilic nature, thiourea is most probably effective at inhibiting ROS- 
induced damage by binding to and chelating DNA-bound metal ions and preventing their participation
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in the Fenton reaction (reaction 6 - section 1.1.2.2). This is supported by the ability of desferrioxamine 
to effectively inhibit the ROS-induced changes to DNA as well.
The predominant isotype of anti-DNA antibodies is shown in figure 5.6 to be IgG. However, both IgG 
and IgA isotypes were sensitive to ROS-induced changes. There are many reports of the pathogenicity 
of anti-DNA antibodies (reviewed by Hahn, 1982) and positive associations between certain isotypes and 
disease manifestations. For example IgA anti-DNA antibodies have been shown to occur in patients 
with active nephritis (Gripenberg and Helve, 1986) and renal disease and disease activity in general are 
more closely related to high levels of circulating levels of IgG anti-DNA antibodies than to IgM 
antibodies (Rothfield and Stollar, 1967; Sontheimer and Gilliam, 1978). The IgG and IgA isotypes may 
recognise new epitopes exposed on ROS-denatured DNA following a change in conformation of the 
molecule. Results from chapter 3 show, using monoclonal antibodies (section 3.6) and strand break 
analysis (sections 3.3 and 3.4) that there is relaxation of the DNA molecule following damage and this 
may allow antibodies accessibility to previously hidden regions of DNA. This may have a role in the 
disease process, particularly in the formation of immune complexes with circulating anti-DNA 
antibodies reacting effectively with ROS-denatured DNA, released from cells.
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C H A P T E R  5.3: R O S - D N A  A S  A N  A N T IG E N  F O R  A N T I-D N A  A N T IB O D Y  M E A S U R E M E N T S  
5.3.1: Introduction
Although little is understood of the role of anti-DNA antibodies in the aetiopathogenesis of SLE (section 
1.2.4) the measurement of anti-DNA antibodies, to dsDNA in particular, is nevertheless used as a 
diagnostic marker for this disease (Aitcheson and Tan, 1982).
Several o ther inflammatory conditions, however, including RA, are associated with circulating 
antibodies to ssDNA and less commonly to dsDNA (Bell, Talal and Schur, 1975). Therefore, results 
obtained from anti-DNA antibody assays must be interpreted with caution (Swaak et al., 1981; Swaak 
and Smeenk, 1985; Eilat, 1986) and must be considered in the light of clinical observations.
At present, quantitative assays to determine circulating serum anti-DNA antibody levels rely on a 
radioimmunoassay (RIA) using radio-isotope-labelled DNA which, after complexing to antibody, is 
precipitated with ammonium sulphate or a co-precipitating antibody (Lewis, Stollar and Goldberg, 1973; 
Stokes, Cordwell and Thompson, 1982). RIA techniques show low binding to circulating antibodies in 
control sera, but patients with RA, Sjogren's syndrome and mixed connective tissue disease have levels 
that extend into the region shared by mildly active SLE patients (Notman, Kurata and Tan, 1975),
In section 5.1 the nature of circulating DNA has been described showing that the DNA has been 
damaged by ROS; the pattern of damage reflects that inflicted by which is produced during the 
inflammatory exacerbations of the disease. Although this DNA is complexed to anti-DNA antibodies, 
a single antibody combining site is large enough only to encompass both backbone regions of dsDNA 
over an extent of 2-3 base pairs (Stollar, 1973; Stollar, 1975), and there may be large regions of DNA 
unshielded by antibody protein. Therefore, it may be possible for ROS-DNA associated with immune 
complexes to act as an antigen for production of anti-DNA antibodies. This DNA may also be able to 
act as an immunogen before interacting with antibodies since the kinetics of this reaction are unknown.
The results in section 5.2 show that a control anti-DNA antibody positive serum sample had an 
increased binding to ROS-DNA when compared to Nat-DNA. In the following sections further serum 
samples from SLE patients and from patients with other connective tissue diseases have been
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investigated using the ELISA assay to compare the binding specificities of serum anti-DNA antibodies 
for Nat-DNA and ROS-DNA. A comparison of the results obtained by ELISA with those obtained by 
the conventional RIA currently used to measure serum anti-DNA antibodies was also undertaken, to 
determine whether ROS-modification of the dsDNA antigen could discriminate further between SLE, 
RA, and other connective tissue disorders.
5.3.2: Methods 
5.3.2.1: C lin ical samples
Forty-one patients (38 female, 3 male) with SLE, aged 22-55 years (median = 35) were studied. SLE 
patients were divided into an inactive group on the basis of having a stable clinical state, no new 
symptoms and low ESRs (15 female, age range 25-55, median = 32), or an active group with high 
ESRs, and new clinical symptoms in at least one major organ (15 female, age range 23-55, median = 
30).
They were also sub-divided into a dsDNA positive group, if they had ever had a positive result by RIA 
(24 female, 3 male, age range 22-55, median = 35), and into a dsDNA negative group if they had never 
had a positive result in this assay (14 female, age range 25-55, median = 37).
All SLE patients studied had a positive ANA result.
Twenty patients (15 female, 5 male) with classical or definite RA, aged 22-78 (median = 55), were 
used as a control connective tissue disease group. These were sub-divided as seropositive or 
seronegative for rheumatoid factor. All but one of these patients were ANA negative and dsDNA 
negative by RIA. The one ANA positive RA patient had a dsDNA binding titre of 20% by RIA.
A third disease control group were patients with connective tissue disease other than RA or SLE, who 
were ANA positive or ANA negative, and dsDNA negative by RIA. 23 patients had scleroderma and 
the 4 remaining patients had primary Raynauds. The diagnosis of these patients was based on standard 
clinical and serological criteria for these diseases.
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19 of these were ANA positive (17 female, 2 male, aged 30-79, median = 50) and 8 ANA negative (4 
male, 4 female, aged 34-57, median = 44).
Disease groups were compared with thirty-four healthy controls, (26 female, 8 male, aged 18-73, 
median = 44) who were not significantly different for age and sex.
To obtain sera from these patients, blood samples were allowed to clot at room temperature and the 
serum separated by centrifugation at 1000 x g for 10 minutes prior to storage at -20°C.
S.3.2.2: E L I S A  A ssay
The ELISA assays using Nat-DNA and ROS-DNA as antigen were performed as described in section 
5.2.2.3. Sera from patients and controls were diluted 1/100 in PBST and plated in triplicate. Standard 
seropositive and seronegative samples (prepared as in sections 5.2.3.1 and 5.2.3.3) were included on 
each plate.
5.3.2.3: Radioimmunoa.ssay
All sera from patients and control groups analysed for anti-dsDNA antibodies by the ELISA assay 
described in section 5 .3 .2 .2  were also analysed by the routine conventional RIA at the Regional 
Department o f Immunology, East Birmingham Hospital, using the method described by Stokes, 
Cordwell and Thompson (1982).
5.3.3: Results
Initial experiments investigated the sensitivity and specificity of the ROS-DNA ELISA compared with 
those of a Nat-DNA ELISA and the conventional RIA, in discriminating patients with SLE from those 
with RA, and from normal controls.
In the Nat-DNA ELISA, antibody binding to dsDNA clearly differed between the SLE and RA groups 
(figure 5.7). Binding of serum antibodies to native dsDNA is measured as the OD at 492nra produced 
from peroxidase-conjugated antibodies binding to IgG, IgA and IgM autoantibodies in total in the sera.
In SLE, antibody binding was significantly higher (median - 0.714 and range - 0.5-0.95) than RA 
(median - 0.483 and range - 0.33-0.62) (p<  0.001). However, there was a considerable overlap
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Figure 5.7
Anti-DNA antibody binding to Nat-DNA in patients with SLE and RA. Each point 
represents the OD at 492nm produced from the peroxidase-conjugated antibodies 
binding to total IgG, IgA and IgM autoantibodies in the sera.
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between the two groups, with 50% of RA patients having values above the lowest level of the range 
obtained for SLE.
When Nat-DNA was substituted by ROS-DNA as the coating antigen for the ELISA, a different pattern 
of antibody binding was observed (figure 5.8a). In SLE, denaturation of dsDNA with ROS induced a 
significant increase in serum antibody binding, the median and range increasing from 0.50 and 0.33- 
0.79 for Nat-DNA to 0.64 and 0.37-0.94 for ROS-DNA (p<0.01). Of the 15 patients' sera studied, 
only one sample showed decreased binding to ROS-DNA when compared to Nat-DNA and in another 
serum sample binding remained unchanged (figure 5.8a).
In contrast, only 53% of RA sera showed increased binding to ROS-DNA, 26% showed a decrease, and 
21 % remained unchanged. The median and range values for the binding of antibodies to Nat-DNA and 
ROS-DNA for the RA group were not significantly different from each other (figure 5.8b).
The levels of anti-DNA antibody binding in the ROS-DNA ELISA assay for SLE and RA patients, and a 
group of normal controls age and sex matched for the SLE patients are shown in figure 5.9. Values 
obtained for SLE were significantly higher than those of either the RA or control groups (p < 0.001 in 
both cases). In contrast to figure 5.7, taking a cut-off point of 0.25 above which all the SLE patients are 
placed, only 1 (5%) of the RA patients had levels of serum anti-DNA antibody binding in this region. 
This was the only RA patient who had a positive ANA result and positive dsDNA binding by RIA.
The binding of anti-DNA antibodies to ROS-DNA was further investigated by division of the SLE group 
into dsDNA positive or dsDNA negative patients as determined by the RIA. The percentage dsDNA 
binding of anti-dsDNA antibodies to calf thymus DNA in the RIA is shown in figure 5.10. All controls 
were negative for dsDNA binding by this assay, the cut-off point being 10% binding. Only one RA 
patient had a titre greater than this (20%). Of the SLE patients in the dsDNA positive group 8 out of 27 
(29.6%) were dsDNA negative by the RIA at the time of sampling.
Using a cut-off point of 0.25 in the ROS-DNA ELISA, all controls and all but one RA patient were 
negative. The ANA positive, dsDNA positive RA patient (by RIA) was also positive in the ROS-DNA 
ELISA (OD = 0.27). For the dsDNA negative group DNA binding values were significantly lower
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Optical density values obtained from the binding of sera from 15 SLE patients and 15 RA patients to Nat-DNA and ROS-DNA. Lines have
been drawn between the ODs of both antigens for each individual patient to illustrate the pattern of change.
Figure  5.9
Anti-ROS-denatured activity of IgG, IgM and IgA antibodies in sera from three 
groups: patients with SLE, patients with RA and a group of controls age matched for 
the SLE patients. Results show the medians and ranges of each of the groups, each 
point representing analysis of the sample in triplicate.
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Figure  5.10
Percentage binding of serum anti-DNA antibodies to radiolabelled DNA in a 
radioimmunoassay with a cut-off point of 10%. According to this, patients with SLE 
were divided into anti-dsDNA positive or negative. All controls and all but one RA 
patient were anti-dsDNA negative.
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than those of the dsDNA positive group (p<0.01) but were still significantly higher from those of 
either the RA (p<0.001) or control group (p<0.001) (figure 5.11).
More importantly, in contrast to the RIA, the ROS-DNA ELISA identified all SLE patients as positive 
for anti-DNA antibodies, with values clearly distinguishable from either the RA or normal control 
groups.
To assess the ability of the assay to reflect disease activity, 30 SLE patients were prospectively selected 
to have active or inactive disease and a comparison of the two groups was made by RIA and ROS-DNA 
ELISA.
The results obtained by RIA (figure 5.13) for the two groups of SLE patients, 20 RA patients subdivided 
as seropositive or seronegative, and 20 controls, 10 age and sex matched for RA and 10 age and sex 
matched for SLE show that all the controls were negative, having a dsDNA binding of < 10%, and the 
RA patient with a positive titre (see figure 5.10) was classified as seropositive for rheumatoid factor. 
This patient also had a consistently high dsDNA binding as measured by ELISA (figures 5.11 and 5.12). 
All other RA patients had negative titres.
The SLE patients with active disease had a range of dsDNA binding titres with 2 of the 15 patients 
(13%) having a negative result in this assay and all the patients with clinically inactive disease having 
DNA binding titres below 10%.
Figure 5.12 shows the results obtained by ROS-DNA ELISA. There was no significant difference 
between the normal control group and either of the RA groups or between the two RA groups. 
However, all three groups had significantly lower antibody binding than either active SLE (p< 0.001), 
or inactive SLE (p<0.001). In addition, within the total SLE group, patients with active disease had 
significantly higher antibody binding than those with inactive disease (p<0.001) (figure 5.12). 
Although there was overlap between these two SLE sub-groups, a cut-off point of 0.25 discriminated 
successfully >95% of patients with active or inactive disease.
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F igure  5.11
Anti-DNA antibody binding to ROS-DNA by ELISA as a reflection of disease 
activity as defined by the presence or absence of dsDNA antibodies in the RIA. The 
results show medians and ranges of dsDNA negative and dsDNA positive SLE patients 
as well as RA patients and controls.
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Figure  5.12
ROS-DNA ELISA to determine the differential binding of anti-DNA antibodies in 
serum from: patients with active and inactive SLE, patients with seropositive and 
seronegative RA and controls age and sex-matched for SLE ( • )  and RA (■) 
respectively. Each point represents the mean of triplicate serum samples per patient, 
and shows the median and ranges for each of the groups.
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Analysis of anti-DNA antibody binding determined by RIA in SLE patients 
classified as having either active disease with new clinical symptoms in a major organ, 
or inactive disease with a stable clinical state and no new symptoms. All SLE patients 
with inactive disease had a negative titre by this assay as did 26 % of the patients with 
clinically active disease. All the controls were negative and one RA patient had a 
fKDsitive titre.
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To assess the specificity of the ROS-DNA ELISA assay further, two additional groups of patients were 
studied: a group of ANA positive, dsDNA negative patients, with a diagnosis other than SLE, and a 
group of ANA negative patients with a diagnosis other than SLE or RA. These were compared with the 
SLE, RA and control groups mentioned above.
The results are shown in figure 5.14. Values obtained for anti-DNA antibody binding in the ANA 
positive group were significantly lower than those of either the dsDNA negative SLE group (p<0.01) or 
dsDNA positive SLE group (p <  0.001), Also, values for the ANA negative group were significantly 
higher than RA values (p<0.01). However, the distribution of DNA binding values clearly shows that 
there is no single cut-off point between these groups.
5.3.4: Discussion
Anti-dsDNA antibodies are highly specific for SLE and have been detected at high frequency in 
untreated patients with active disease (Tan, 1982). Several, but not all reports, have also identified a 
correlation between levels of anti-dsDNA antibodies and disease activity (Isenberg et al., 1986), 
especially in patients with renal involvement (Davis, Percy and Russell, 1977).
Many assays exist for measuring anti-DNA antibodies (Isenberg et al., 1987). This reflects problems of 
sensitivity and specificity in identifying particular disease groups with antibodies to dsDNA but not 
ssDNA or other anti-nuclear antibodies (ANAs).
Detection of anti-dsDNA antibodies is usually by RIA. This assay tends to detect high avidity anti- 
dsDNA antibodies which are thought to be associated with renal complications in SLE (Feltkamp, 
Aarden and Swaak, 1979). Alternatively, ELISA assays have been described which measure low avidity 
antibodies (Emlen, Pisetsky and Taylor, 1986). These require immobilisation of the DNA onto plastic 
and whilst ssDNA binds easily, dsDNA binds only poorly (Engvall, 1976). Several different methods 
have been used to enhance coating of DNA onto ELISA plates. These include irradiation of the plastic 
with UV light (Zouali and Stollar, 1986), precoating of the plates with a positively charged molecule 
such as protamine sulphate or poly-L-lysine to which the negatively charged DNA can more effectively 
(Eaton, Schnneider and Schur, 1983), or diluting the DNA in a positively charged coating buffer (eg. 
carbonate buffer, pH 9.6) which allows it to bind effectively to the negatively charged plastic.
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Figure 5.14
Measurement of anti-DNA antibody binding to ROS-DNA by ELISA in sera of 
patients with: ANA positive SLE, ANA negative RA, and ANA positive or negative 
patients with connective tissue disorders other than SLE or RA (mostly scleroderma). 
Results show the medians and ranges of each of the groups, each point representing 
analysis of serum samples in triplicate.
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Both ELISA and RIA require removal of contaminating ssDNA from the antigen preparation, 
particularly since other connective tissue disorders are more commonly associated with antibodies to 
ssDNA (Notman, Kurata and Tan, 1975). To eliminate this problem, closed circular DNA from 
plasmids is used in some assays (Emlen, Jarusiripipat and Burdick, 1990) and the results in general 
appear to be more specific for SLE patients.
Results from section 5.2 show that a control anti-DNA antibody positive serum sample had increased 
binding to ROS-denatured DNA when compared to Nat-DNA. Based on this property, sera from a large 
group of patients with SLE and other connective tissue disorders were analysed for binding to ROS- 
DNA, in order to investigate the sensitivity, specificity and possible clinical value of a ROS-DNA 
ELISA.
Using Nat-DNA as antigen in the ELISA assay there was a lack of discrimination between SLE and RA 
patients with 50% of the RA patients having DNA binding values within the SLE range. This is 
unlikely to be due to reactivity with ssDNA, since the dsDNA preparation was treated with SI nuclease 
prior to coating of the plates.
To investigate the binding of anti-DNA antibodies to ROS-DNA compared with Nat-DNA, sera from 
SLE and RA patients were initially studied. Whilst antibody binding increased significantly after ROS- 
denaturation of DNA in SLE, it did not show a consistent change in RA. This suggests that ROS-DNA 
may detect antibodies in SLE sera undetected by Nat-DNA and not present in RA.
The ROS-DNA ELISA was then used to measure anti-DNA antibody binding to SLE and RA patients 
and controls. There was a greater discrimination between the SLE and RA groups in this assay (figure 
5.9) compared to the Nat-DNA ELISA (figure 5.7). Both groups had levels of DNA binding 
significantly higher than the young normal controls, which were matched for age with SLE but not with 
RA. Investigation of DNA binding in young and elderly controls (figure 5.12) showed that levels 
increase with age; this is consistent with findings of other workers (Manoussakis et al., 1987). When 
the normal range of anti-DNA antibody binding was defined according to both young and elderly 
controls, all RA patients (with the exception of one who was dsDNA positive by RIA) were within the 
normal range.
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There was a significant difference in the DNA binding values obtained after division of the SLE group, 
either by disease activity or by the presence or absence of dsDNA antibodies in the sera by RIA. Both 
the active SLE group and the dsDNA positive group had higher levels of anti-DNA antibody binding in 
the ROS-DNA ELISA than the inactive and dsDNA negative groups. This supports the existing 
evidence (Aitcheson and Tan, 1982; Isenberg et al., 1986) that the presence of dsDNA antibodies in the 
serum correlates with disease activity.
Both in the ROS-DNA and Nat-DNA ELISAs, all SLE patients, including those classified as dsDNA 
negative by RIA, were positive for dsDNA binding. There was a significantly higher sensitivity of the 
ROS-DNA ELISA for detection of SLE patients compared to the RIA and an absolute specificity of 
discrimination between patients with SLE and those with RA. The only exception to this was an RA 
patient with a positive dsDNA binding titre by RIA who was also positive by ROS-DNA ELISA.
The increased sensitivity of the ROS-DNA ELISA assay may relate to the introducion of ROS-DNA as 
antigen. It is possible that this assay detects low affinity anti-dsDNA antibodies that exist in the serum 
of SLE patients with mild or inactive disease and are not detected by RIA.
In the ROS-DNA ELISA, taking a cut-off point of 0.25, all the SLE patients gave a positive result with 
the RA and controls lying below this. One RA patient consistently gave a positive result both by RIA 
and ELISA and will be monitored closely for manifestations of SLE. A prospective study of more than 
four hundred non-SLE patients with anti-dsDNA antibodies showed that =*85% of these developed SLE 
within five years (Swaak and Smeenk, 1985).
In the initial experiments, all but one RA patient and all normal controls were ANA negative whilst all 
SLE patients were ANA positive. Therefore to examine the specificity of the ROS-DNA ELISA 
further, it was necessary to determine its ability to differentiate between ANA positive and dsDNA 
positive patients. For this, a group of patients with other connective tissue disorders, predominantly 
scleroderma and primary Raynauds were studied and divided into ANA positive or ANA negative 
groups.
2 1 1
In the ANA negative group, anti-DNA antibody binding in the ROS-DNA ELISA was only slightly 
higher than in the ANA positive dsDNA negative, non-SLE group. Although DNA binding values were 
significantly lower than those of the dsDNA negative SLE group, they overlapped considerably with 
DNA binding values of both the dsDNA positive and negative SLE groups. This suggests that the ROS- 
DNA ELISA is less specific than the RIA in detecting ANA positive patients without the clinical 
diagnosis of SLE. This may be explained in several ways.
The low levels of serum anti-DNA antibodies for the control groups and the RA group show that the 
values obtained do not merely reflect the non-specific binding of a serum component to the coating 
antigen. The values are also unlikely to reflect binding to either protein or ssDNA since the DNA 
preparation was protein-free and treated with SI nuclease to remove any regions of ssDNA from it. 
Lack of binding to ssDNA is also supported by the low titres in the RA group which frequently have 
antibodies to ssDNA (Aitcheson et al., 1980).
This suggests that the assay measures a specific interaction between antibodies in the serum of ANA 
positive patients and the ROS-DNA antigen, whether these patients have SLE or not.
It is well documented that ELISA assays measure both low affinity antibodies that are not readily 
detected by RIA, as well as high affinity antibodies measured in both assays (Emlen, Pisetsky and 
Taylor, 1986). The positivity of the sera of SLE patients having negative dsDNA titres by RIA may 
reflect detection of low affinity anti-DNA antibodies in these patients by ELISA. The ELISA may also 
detect such antibodies in the ANA positive patients, again undetected by RIA.
Whilst this explains why low affinity antibodies may not be detected by RIA, this does not identify their 
antigen of recognition. Some of the ANA have been characterised and two of these, Ro and La, are 
peptides with associated RNA (Stephano, 1984; Gaither et al., 1987). From the results examining the 
antigenicity of ROS-DNA it is possible that low molecular weight fragments of DNA, with or without 
associated protein, could act as nuclear antigens. Compton, Steinberg and Sano (1984) showed that 
there is an increased accumulation of degraded fragments of nuclear DNA in SLE lymphocytes which 
they suggest may arise from excision repair of DNA. This would be consistent with the findings 
reported here regarding increased modification of base residues induced by ROS increasing DNA
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damage that is then abnormally processed leading to its accumulation in cells (section 4.2).
If ROS-DNA is an antigen for low affinity antibodies found in all ANA positive patients, the gradation of 
DNA binding for the SLE and ANA positive patients could represent differences in the levels of 
antibodies truly reactive with ROS-DNA or alternatively, it could represent the presence of antibodies 
reactive with different antigens but cross-reactive with ROS-DNA in some or all of the patients studied.
High affinity antibodies are most commonly associated with immune complexes (Winfield, Faiferman 
and Koffler, 1977) and low affinity antibodies may be less relevant to the pathogenesis of SLE. This is 
supported by their presence in ANA positive patients who do not develop SLE. However, the assay 
using ROS-DNA as antigen does have the capacity to reflect disease activity (figures 5.11 and 5.12) 
possibly because it detects high affinity antibodies associated with disease activity as well as low affinity 
antibodies. Therefore, the ROS-DNA ELISA may be useful for measuring disease fluctuations in the 
long-term monitoring of SLE patients.
It is possible that ROS-DNA may elicit anti-DNA antibody production in patients with connective tissue 
disease. However, from studies of the pathogenicity of anti-DNA antibodies it would appear that the 
progression of the immune repertoire to produce high affinity antibodies to either Nat-DNA or ROS- 
DNA or both is most relevant to the development of the severe disease manifestations of SLE such as 
glomerulonephritis. This is supported by isolation of high affinity anti-DNA antibodies from glomeruli 
of SLE patients with active kidney disease (Winfield, Faiferman and Koffler, 1977). Mechanisms that 
could be responsible for anti-DNA antibody production in inflammatory conditions are outlined in 
chapter 6.
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C H A P T E R  5.4: S T IM U L A T IO N  O F  P B M C  W IT H  R O S -D N A  
5.4.1: Introduction
The mechanism of anti-DNA antibody production in SLE is unknown and may involve the stimulation of 
autoreactive B cell c lones, may result from production o f antibodies to DNA, or may be the 
consequence of a circulating antigenic molecule producing antibodies cross-reactive with DNA (Isenberg 
and Shoenfeld, 1987).
Native DNA is a poor immunogen (Madaio et al., 1984); ROS-denaturation however, increases its 
binding to anti-DNA antibodies (sections 5.2 and 5.3) and elicits anti-DNA antibody production in 
animal models (Tan and Stoughton, 1969; Jansson, 1985).
In 1985, Mumford et al., investigated the ability of normal lymphocytes to produce autoantibodies. 
Following polyclonal activation with pokeweed mitogen, normal lymphocytes were stimulated to secrete 
autoantibodies of several antigenic specificities, rather than the restricted specificities seen in the various 
autoimmune diseases. This suggests that autoreactive B cell clones are not deleted but are more likely to 
be selectively recruited in autoimmune diseases.
Braude et al., (1988) showed that SLE lymphocytes in culture can spontaneously secrete anti-DNA 
antibodies, the levels of which can be increased by stimulation of the cells with DNA. Since ROS-DNA 
appears to be a better antigen for SLE anti-dsDNA antibodies (section 5.3) and has been shown to exist 
in the circulation associated with immune complexes (section 4.3), the ability of ROS-DNA to stimulate 
the production of anti-dsDNA antibodies from isolated PBMC was investigated in both SLE patients and 
in a group of normal controls in order to determine the importance of antigen driven anti-DNA antibody 
production versus polyclonal B-cell activation.
5.4.2: Methods
5.4.2.1: Clinical Samples
Twenty SLE patients (19 female, 1 male, age range 22-55, median = 33), five disease controls with RA 
(5 female, age range 35-60, median =  41), and five normal controls (4 female, 1 male, age range 22- 
51, median = 27) were studied.
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5.4.2.2; Cell Stimulation
PBMC were isolated from peripheral blood on Ficoll gradients as in section 2.3.3.1 and resuspended in 
RPMI-1640 to 1 X 10* cells/ml. Cells were plated in 2ml volumes in 24 well plates and cultured in a 
humidified atmosphere with 5 % CO^ at 37°C. To measure the spontaneous production of anti-DNA 
antibodies cells were cultured for 8 days and the supernatants harvested by centrifuging the samples at 
300 X g. To measure antigen-induced anti-DNA antibody production cells were incubated with Nat- 
DNA or ROS-DNA at 20/ig/mI for 6 days; they were then washed thoroughly (5 washes in RPMI-1640, 
300 X g, 5 minutes) to remove the DNA, replated, and cultured for a further 6 days before harvesting 
the supernatants as above.
Cells were also stimulated with the polyclonal B cell activator SPA at a concentration of lOO/ig/ml for 8 
days after which the supernatants were harvested.
The final culturing conditions stated were obtained from time-course experiments. Day 7 was found to 
be the period of maximum immunoglobulin production and cells were harvested on day 8. For cells 
cultured with DNA, exposure of 6 days was used as described by Braude et al., (1988). After washing, 
immunoglobulin production peaked at days 4 and 5 and cells were harvested on day 6. Other mitogens 
such as pokeweed mitogen and lipopolysaccharide were also used to stimulate the B cells but were not as 
effective as SPA.
The supernatants were analysed for the presence of immunoglobulins and anti-DNA antibodies.
5.4.2.3: E L I S A  Assay for Im m unoglobulin  Determination
Immunoglobulin levels in ti.ssue culture supernatants were mea.sured by ELISA as described in section 
2.3.2.1 using goat anti-human IgG, IgA and IgM as coating antigens at a dilution of l//g/ml in 0.05M 
carbonate buffer, pH 9.6. Supernatants were added neat or at doubling dilutions in PBST and the 
immunoglobulins detected using peroxidase-conjugated goat anti-human IgG, IgA or IgM (all at a 
working dilution of 1/1000 in PBSTj.
S.4.2.4: E L I S A  Assay for Anti-d sD N A  Antibodies
Measurement of anti-DNA antibodies in cell supernatants was as described in section 5.2.2.3 using
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ROS-DNA as antigen (section 5.2.2.1.2) and adding the supernatants neat onto the plate. Measurement 
of serum anti-DNA antibodies was also as in section 5.2.2.3 using a dilution of 1/100 for all samples.
5.4.3: Results
The predominant isotype of anti-DNA antibodies in SLE is IgG and it is antibodies of this class that 
have also been isolated from the glomerular basement membrane of SLE kidneys (Hahn, 1982).
Levels of IgG were measured in SLE, RA and control cells after culture of the PBMC in complete 
medium (section 2.1.6) for 8 days in the absence of any stimulating agents.
Fourteen SLE and 2 RA patients had levels of spontaneous IgG production of >lfrg/ml per 10'^  cells; 
this was used as the cut-off point in the assay for a positive response to cell stimulation. None of the 
normal control PMBC had detectable levels of spontaneous immunoglobulin production.
The 14 SLE and 2 RA patients with spontaneously produced immunoglobulins were stimulated with 
SPA, Nat-DNA and ROS-DNA and the levels of IgG and anti-DNA antibodies were measured. The 
normal PBMC were also stimulated since spontaneous immunoglobulin production is not typical of these 
cells as it is in the two autoimmune conditions, SLE and RA.
For the control PBMC levels of IgG in the culture supernatants were detectable following stimulation of 
the cells with all three agents when compared to the negligible levels in supernatants of unstimulated 
cells. There was however, no significant difference between the different stimuli (table 5.4). There 
was also a significant increase in the levels of anti-DNA antibodies detected by the ROS-DNA ELISA 
following stimulation not only by ROS-DNA but by Nat-DNA and SPA (table 5.4). Measurement of 
serum anti-DNA antibodies showed that both these controls had DNA binding values (figure 5.15) 
below the cut-off point of the ROS-DNA ELISA (section 5.3.3)
Results for the RA patients showed that the spontaneous level of immunoglobulin secretion was not 
significantly affected by any of the stimuli, and in none of the samples was any positive level of anti- 
DNA antibodies detected. There was again no detectable anti-DNA antibody binding to ROS-DNA in 
the sera from these patients (figure 5.15).
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Control SPA
100/xg/ml
Nat DNA
2 0/xg/ml
ROS DNA 
20/xg/ml
N1 IgG
(/ig /itil)
OD
a t 492nm
(anti-DNA a n tibo dy  
d e te rm in a tio n )
0.1310.01
0.29310.04
7.710.03
0.82710.03
7.410.03
0.84510.04
7.810.05
0.85410.08
N2 IgG
(Mg/ml)
OD
a t 492nm
(anti-DNA a n tib o d y  
d e te rm in a tio n )
0 .110.01
0.15910.01
6.110.04
0.87610.07
7.210.02
0.78510.06
7.210.06
0.78510.04
CNJ
Table 5.4
Concentrations of IgG (/xg/ml) and anti-DNA antibodies (OD at 492nm) in the supernatants of PBMC stimulated with SPA, Nat-DNA and ROS- 
DNA, from two normal controls.
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Figure 5.15
ROS-DNA ELISA of serum anti-DNA antibody binding of the 14 SLE patients and 
the 2 RA patients with spontaneous anti-DNA antibody production by PBMC in culture 
and the two normal controls with stimulated anti-DNA antibody production (see section 
5.4.3).
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Of the 14 SLE patients in which spontaneous immunoglobulin production was observed, all had positive 
OD values for anti-DNA antibodies in the serum (figure 5.15). Of the 6 patients in which this could not 
be detected 5 had never had detectable levels of dsDNA binding in the routine RIA (section 5.3.2.1). 
They had positive DNA binding values by the ROS-DNA ELISA but these were significantly lower 
(median = 0.64 compared with 0.93 p<0.01) than for the other 14 patients in which immunoglobulin 
production was detectable.
Measurement of anti-DNA antibodies in SLE supernatants showed that the level of anti-DNA antibodies 
was increased significantly in 6 patients by stimulation with ROS-DNA, in 4 of these 6 patients with 
Nat-DNA and in only 1 of these 6 patients with SPA. Figure 5.16 shows the means ± ISD for the 6 
SLE patients responsive to stimulation and the remaining 8 patients with levels of anti-DNA antibody 
production in the stimulated cultures not significantly different from the original level of spontaneous 
anti-DNA antibody production.
The fluctuations in IgG immunoglobulin levels (figure 5.17) did not always reflect the changes seen in 
anti-DNA antibody production and in 7 patients significant changes in immunoglobulin production were 
not accompanied by significant increases in anti-DNA antibody production, 13 out of 14 patients having 
increased levels of IgG in response to stimulation (figure 5.17).
5.4.4: Discussion
The results obtained for both the SLE and RA patients support the evidence that B cells from these 
patients spontaneously produce immunoglobulins in vitro. It cannot be determined if these cells were 
previously activated in vivo. However, the results of the stimulation experiments with RA PBMC also 
support the results of Mumford et al., (1985) and show that whilst patients with the autoimmune disease 
RA produce autoantibodies (to IgG in this case) they cannot be stim ulated to produce other 
autoantibodies such as anti-DNA antibodies. This is clearly not the case for PBMC isolated from 
normal controls. The normals had no spontaneous production of IgG immunoglobulin or anti-DNA 
antibodies but were stimulated with a polyclonal B cell stimulator (SPA) and ROS- and Nat-DNA to 
produce levels of the same order as levels produced by SLE PBMC.
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OD at 492nm
Responsive Non-Responsive
F igure  5.16
Spontaneous and SPA, Nat-DNA and ROS-DNA induced secretion of anti-DNA 
antibodies by PBMC from patients with SLE. Results shown are means ± ISD of 6 
patients whose cells after stimulation produced levels of anti-DNA antibodies above 
those secreted spontaneously (responsive) and of 8 patients whose cells did not respond 
to stimulation (non-responsive).
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IgG Concentration (ug/ml) 
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Responsive Non-Responsive
Figure  5.17
Optical densities representing levels of secreted IgG in ^g/mJ from PBMC of SLE 
patients stimulated with SPA, Nat-DNA or ROS-DNA as a comparison of the 
spontaneously produced levels of IgG. The results represent the means ±  ISD of 13 
patients responsive to stimulation (responsive) and of the 1 remaining patient where the 
level of spontaneous IgG production was not significantly increased by cell stimulation 
(non-responsi ve).
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Not all normal controls responded to the stimulation (this may reflect levels of immunoglobulin 
produced that were below the sensitivity of the assay) but this may also reflect differing susceptibilities 
of individuals to production of autoantibodies. The cause of immune dysfunction in SLE is unknown but 
there is a genetic predisposition to the disease (see section 1.2.2.2). The normals responsive to 
stimulation in this study may have genetic factors that favour disease susceptibility.
Stimulation of SLE PBMC by Nat-DNA and ROS-DNA to produce immunoglobulins of which anti- 
DNA antibodies are clearly a component, may be important in the pathogenesis of disease. The results 
show that ROS-DNA was most effective as a stimulating agent in this group of patients and may 
therefore influence the production of anti-DNA antibodies in the circulation which once produced appear 
to have increased binding to this altered form of DNA compared to Nat-DNA.
The results suggest that in the group of SLE patients studied the levels of immunoglobulins and anti- 
DNA antibodies produced are affected both by the B cell hyperactivity and by cell stimulation from 
circulating antigens. Although the initial antigen resonsible for anti-DNA antibody production, if it 
exists at all, is unknown, ROS-DNA by stimulating anti-DNA antibody production can perpetuate the 
response and increase the circulating anti-DNA antibody concentration. This in turn may lead to 
increased formation of immune complexes since the antibodies have been shown to have increased 
binding to the ROS-DNA, which may result in further deposition of complexes in tissues. This is a 
manifestation of the disease that can cause renal dysfunction and is associated with high avidity IgG 
antibodies bound to DNA.
Therefore, ROS-DNA may be involved in the perpetuation of anti-DNA antibody production by 
stimulating PBMC to produce antibodies which then bind to further molecules of ROS-DNA.
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GENERAL D ISCU SSIO N
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The aims of this thesis were:
a) to study the effects of reactive oxygen species (ROS) on the biomolecule DNA, and
b) to investigate the relevance of ROS-induced DNA damage in the inflammatory autoimmune 
condition, systemic lupus erythematosus (SLE), which is associated with the presence of anti-DNA 
antibodies.
Effects of ROS on DNA:
Initial experiments were designed to characterise extensively ROS-damaged DNA, using model systems 
to control generation of ROS, and specific methods to address the nature of damage to this biomolecule. 
The results of these experiments have been summarised in section 3.7, They show that ROS can cause 
damage to DNA at all levels of its structure, from individual bases and ribose moiety to the sugar- 
phosphate backbone. Damage to the sugar-phosphate backbone may cause strand breaks. It also relaxes 
the conformation of the molecule by reducing base stacking interactions, thus increasing the accessibility 
of ROS to internal regions of the structure where the bases are situated. Further conformational studies 
using circular dichroism and monoclonal antibodies supported this mechanism, showing that such 
damage may cause considerable distortion of the macromolecule, probably by relaxing its structure as 
stabilising hydrogen bonds become broken.
Measurement of ROS-induced DNA damage:
To assess the actual occurrence of ROS-mediated DNA damage and its relevance in vivo, a reliable 
assay was required. This was of particular importance since radical species, mainly OH-, are inherently 
difficult to detect and measure directly because of their high reactivity with all biological molecules. 
Further studies presented in sections 2.6 and 3.1 led to the development of a reliable assay for 
measurement of the ROS-induced DNA component 8-hydroxydeoxyguanosine (80HDG). In vitro, 
80HDG was shown to be generated in a hydroxyl radical-mediated reaction, and to be a reliable and 
stable marker o f oxidative damage to DNA. More importantly, it was shown to be detected with 
sensitivities relevant to in vivo biological situations. TTiis suggested that 80HDG in biological material 
could be used as a marker of oxidative DNA damage in vivo.
Role of oxidative DNA damage in the aetiopathogenesis of SLE:
ROS have been implicated in several disease processes. In this thesis work was restricted to the role of
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ROS in the aetiopathogenesis of SLE. This autoimmune disease is associated with inflammation and 
also with the presence of autoantibodies to DNA. The possibility arose therefore that:
a) ROS-mediated pathogenic mechanisms may be involved in SLE and
b) that ROS-induced changes to DNA may render it immunogenic and either initiate or facilitate the 
production of anti-DNA antibodies.
Measurement of DNA damage in vivo:
Damaged DNA bases are removed from DNA by excision repair mechanisms and released from the cell 
as a single base or as a small DNA fragment (Lindahl, 1982). These may then either react with 
enzymes which salvage the phosphate residue or are removed from the body unaltered and excreted in 
urine (Ames, 1988). This suggests that measurement of an adduct such as 80HDG in the urine, reflects 
the formation and subsequent repair of 80HDG and thus oxidative damage to DNA in vivo. The 
technique developed is quite advantageous, since it is non-invasive and with the use of an automated 
analytical system such as HPLC/ECD 80HDG can be detected sensitively, specifically and quickly in 
many samples. Furthermore, its sensitivity may be increased by the nature of urine formation itself, 
since DNA lesions are removed from all the cells of the body and concentrated in the relatively small 
volume of urine excreted. Although the method may be subject to artifacts such as adducts derived 
from DNA of ingested food material, this problem may to a great extent be overcome by collection of 
early morning samples which minimise contamination from such sources.
Inflammation-induced oxidative damage to DNA in vivo:
Studies in chapter 4 showed that rheumatoid arthritis (RA), a typical example of an autoimmune 
condition associated with active inflammation, is associated with significantly increased rates of 80HDG 
excretion compared with normal controls. Based on this, it is suggested that oxidative stress in 
inflammatory conditions causes increased DNA damage. When such damage is efficiently repaired by 
excision enzymes, as may be the case in RA, increased levels of 80HDG removed from cells are 
excreted in the urine, thus maintaining normal cellular function. This may reflect an enhancement of 
normal DNA repair processes to compensate for increased levels of damage.
In SLE, cells are likely to be subjected to oxidative stress of similar magnitude to that observed in RA. 
Furthermore, they appear to be as susceptible to ROS-induced damage as normal cells (chapter 4).
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What then is the explanation for the greatly reduced levels of 80HDG found in the urine of patients with 
SLE?
Studies in chapter 4 suggest that this may be due to:
(a) Aberrant removal of 80HDG, due to defective DNA repair.
(b) Accumulation of SOHDG-containing, damaged DNA in immune complexes.
Defective DNA repair in SLE cells:
Compared with normal, SLE cells appear to have a reduced ability to remove damaged DNA bases such 
as 80HDG. These accumulate in the cell and therefore may not be excreted in large quantities in the 
urine. This deficiency appears to manifest itself in vitro as an initial lack of excision repair immediately 
following the oxidative insult, after which .surviving cells have repair kinetics not significantly different 
from those of normal cells. Excessive DNA damage is known to cause energy depletion, resulting in cell 
death and lysis rather than repair of the lesions (Schraufstatter et a l., 1986). This could act as a 
protective mechanism against the consequences of DNA damage, since it may prevent replication of 
severely altered DNA which may form non-functional proteins. However, it may also result in the 
release o f DNA in the circulation: the consequences of this in the aetiopathogenesis of SLE are 
discussed later.
In addition to this, in situations of lower oxidant stress, deficient repair may have further serious 
pathogenic implications. 80HDG is a mutagenic base adduct causing mis-pairing at its site of 
incorporation (Kuchino et al., 1987; Shibutani, Takeshita and Grollman, 1991). Since this adduct does 
not appear to be adequately repaired in SLE, the mutagenic residues may be incorporated into the DNA 
and expressed. This may provide an explanation for the increased risk of malignancy in patients with 
SLE (Miller, 1967; Louie and Schwartz, 1978; Green, Dawson and Walker, 1978). Such a mechanism 
may be particularly relevant to patients with mildly active disease, where cells exposed to low level 
oxidative stress, may incur DNA damage not resulting in cell death. This could be investigated in 
epidemiological studies of SLE patients with consistently low disease activity or patients in long periods 
of clinical remission.
Rheumatoid arthritis is also associated with an increased risk of malignancy (Miller, 1967; Louie and
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Schwartz, 1978), which, however, does not appear to be due to an intrinsic defect of DNA repair 
mechanisms. Oxidative damage has been suggested to play a role in the aging process and the increased 
risk of malignancy towards the end of the life span (Ames, 1983; Cutler, 1984). This is believed to be 
related to the constant damage to cellular components that becomes less effectively repaired with age, 
resulting in eventual malfunctioning of the cell. It is possible that inflammation in RA, through 
increased ROS production, may cause an accelerated aging, such that malignancy appears to be more 
common. This could apply to other chronic inflammatory conditions as well.
Role of circulating ROS-daniaged DNA in SLE:
(a) Formation of circulating immune complexes:
Following cell lysis, damaged DNA may be released into the circulation and become bound by anti- 
DNA antibodies which bind native dsDNA, often with high affinity (Aarden, De Groot and Lakmaker, 
1976; Riley, Addis and Taylor, 1980). Evidence that such a mechanism may operate in SLE arises both 
from the detection of large DNA fragments in SLE sera (chapter 4.3.3), and from the analysis of DNA 
isolated from circulating immune complexes. Using both base residue modification and monoclonal 
antibody binding, it was shown that DNA from SLE circulating immune complexes displayed similar 
characteristics to DNA exposed to ROS in vitro (chapter 3.1 and 3.6). This suggests that it had been 
exposed to ROS and was considerably oxidised in vivo.
DNA fragments trapped in circulating immune complexes may not be degraded by serum nucleases, a 
process suggested to be impaired in SLE (Frost and Lachmann, 1968; Chitrabamrung, Rubin and Tan, 
1981). This may be a further explanation for the very low levels of adduct observed in urine from 
patien ts w ith SLE. It may also have im portant pathogenic im p lica tions, through the co 
nsequent deposition of immune complexes in tissues, such as glomeruli, and the resultant tissue damage 
(discussed in detail in chapter 1, section 1.2.5).
(b) Production of anti-DNA antibodies:
It is still highly controversial whether production of anti-DNA antibodies is due to antigen (DNA) driven 
resp)onses or due to polyclonal B cell activation. This has been discussed in detail in chapter 1, section 
1.2.4. Recent evidence tends to suggest that both mechanisms may contribute (Casali and Notkins, 
1989; Casali et al., 1989). There is, however, some evidence that ROS-altered DNA is more
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immunogenic than native dsDNA (Natali and Tan, 1971), and that antibodies elicited by ROS-DNA 
may cross-react with native dsDN A (Tan and Stoughton, 1969; Jansson, 1985). In view of this, three 
lines of evidence from the work described in this thesis suggest that ROS-DNA may be involved in anti- 
DNA antibody production in SLE;
Firstly, and possibly most directly, free ROS-DNA and to a lesser extent native dsDNA were shown to 
be able to initiate production of anti-DNA antibodies from normal peripheral blood mononuclear cells 
(PBMC) in vitro, and to enhance their production from already spontaneously anti-DNA producing SLE 
cells.
Secondly, this potentially immunogenic, ROS-DNA was shown to be present in the circulation of 
patients with SLE. It exists mainly as part of immune complexes, but theoretically it should be available 
in free (antigenic) form after its release from cells and before it combines with antibody. Even in 
complexed form, antigenic regions may still be exposed, in which case immune complexes themselves 
may elicit anti-DNA antibody production. Inadequate degradation of released ROS-DNA by serum 
nucleases, formation of immune complexes and impaired clearance of these complexes by the 
reticuloendothelial system in SLE, may all contribute to the persistence of DNA in the circulation, and 
thus initiate or potentiate the production of anti-DNA antibodies.
Lastly, anti-DNA antibodies from SLE sera were shown to bind better to ROS-DNA than native 
dsDNA, possibly indicating higher specificity or affinity. This may be of pathogenic significance, since 
high affinity antibodies appear to be particularly important in immune complex formation and deposition 
(Rothfield and Stollar, 1967). Low affinity antibodies on the other hand, may be equally important: 
these may dissociate from DNA more readily (Riley, Addis and Taylor, 1980), thus releasing free DNA 
to elicit or enhance further anti-DNA antibody production. Indeed, work in chapter 3.6 of this thesis 
showed that ROS may induce subtle changes to the DNA molecule which may affect the affinity of 
binding interactions between ROS-DNA and anti-DNA antibodies.
Clinical applications of the reactivity of anti-DNA antibodies with ROS-DNA:
Measurement of auto-antibodies in patients with connective tissue disorders is widely used to aid the 
diagnosis of particular conditions, but its value is limited by the lack of absolute specificity of any one
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autoantibody for a particular disorder. This is certainly true of anti-dsDNA antibodies and SLE. Whilst 
they are present in approximately 70% of SLE patients and appear to correlate with disease activity, 
they can also be found in other connective tissue disorders.
Serum anti-DNA antibodies from SLE patients showed increased reactivity with ROS-DNA when 
compared to native dsDNA (chapter 5.2 and 5.3), This suggested that an assay based on this property 
of ROS-DNA may be advantageous in terms of specificity and sensitivity compared with currently 
available, conventional anti-DNA antibody assays. An ELISA was therefore developed, to measure 
binding of serum anti-DNA antibodies to ROS-modified DNA.
Initial experiments using SLE, ANA negative RA and normal sera suggested that this ELISA detected 
anti-DNA antibodies with much higher sensitivity than the conventional RIA. All SLE patients studied, 
even those who were anti-dsDNA negative by RIA, had clearly detectable antibodies by ROS-DNA 
ELISA; the levels correlated well with disease activity. The increased sensitivity is most likely due to 
detection of both high and low affinity antibodies by ELISA. In contrast, RIA may detect only high 
affinity antibodies, the antibodies of lower affinity not forming stable precipitable antibody-antigen 
complexes (Casperson and Voss, 1980). This remarkable increase in sensitivity of detection, did not 
appear to be at the expense of specificity: SLE patients had clearly higher levels of anti-DNA antibodies 
than either patients with RA or normal controls.
Further analysis of the disease specificity of this assay was then attempted, by analysing an ANA 
positive group of patients, mostly with scleroderma. In this case, almost all of these patients were 
identified as anti-DNA antibody positive by the ROS-DNA ELISA, whilst they were negative by RIA. 
This obviously limits significantly the diagnostic value of this assay for SLE. It is however appropriate 
to speculate on the explanation and significance of this finding. These results are definitely not due to 
reactivity with either ssDNA or protein antigens (e.g. histones), since these were extracted prior to 
preparation of the ROS-DNA antigen. It is possible, that as in anti-dsDNA negative (by RIA) SLE, the 
antibodies detected in the ANA positive group of patients, are low affinity anti-DNA antibodies; these 
would not have been detected by RIA. More importantly, this would indicate that ROS-DNA is a 
nuclear antigen, detected in the initial ANA-screening method but not by RIA. To support this there is 
evidence to suggest that low molecular weight fragments of DNA are detected in the nuclei of cells
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during normal metabolism (Compton, Steinberg and Sano, 1984) and that there is an increased number of 
fragments produced in SLE cells (Sano et al., 1983; Compton, Steinberg and Sano, 1984). This in itself 
suggests that fragmentation of DNA by ROS is a normal metabolic process and antibodies to ROS-DNA 
may act to clear the damaged molecules. In addition, ultraviolet radiation of keratinocytes has been 
shown to induce antigens on the surface of the cell that were recognised by ANAs (Furukawa et al., 
1990). This suggests that ROS, produced during inflammation or periods of UV exposure, may also 
alter cell surface and internal components to increase ANA binding and this is supported by recent 
results of Sequi, Leigh and Isenberg (1991).
Increased damage to DNA in SLE and other inflammatory conditions may up-regulate the production of 
ANA and anti-DNA antibodies thus altering the fine balance of the immune system and producing 
excess numbers of antibodies with the potential to react with Nat- and ROS-DNA.
Figure 6.1 shows a schematic representation of how phagocyte-derived ROS may cause DNA damage. 
Initial activation of the phagocyte by bacterial stimuli or immune complexes generates 0^-‘ which 
dismutates to produce H^O^ (section 1.1.2.1). This can then diffuse into cells (Allan et al., 1988) 
causing lipid peroxidation upon interaction with the cell membrane (section 1.1.5.1). The products of 
lipid peroxidation themselves can interact with DNA to cause damage directly (Inouye, 1984), and can 
form clastogenic factors which extend the time and area over which ROS damage is inflicted (section 
1.1.5.4.6). Emerit et a l., (1980) have demonstrated increased levels of this clastogenic factor in SLE 
serum and this provides indirect evidence for the increased production and/or inadequate defences 
against ROS in SLE. In addition to lipid peroxidation, ROS will attack other cellular biomolecules, 
including proteins (section 1.1.5.2), carbohydrates (1.1.5.3) and DNA (1.1.5.4). Damage to DNA is 
particularly important since this molecule is central to cell differentiation and expression of constitutive 
proteins.
Since phagocytosis is a normal metabolic process, cellular defence mechanisms exist to degrade ROS 
with no significant detrimental effects to the cell (section 1.1.6). However, in chronic inflammatory 
diseases it can be envisaged that increased stimulation of phagocytes may initially increase damage to all 
cellular components, including DNA, thus exerting pressure on defence mechanisms to maintain normal
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Antibodies Raised to DNA
Figure 6.1
Hypothesis: schematic representation of the role of inflammation-derived ROS in DNA damage and the 
pathogenic consequences of this.
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cellular function. This may result in an increase in DNA excision repair activity, concomitantly 
increasing levels of oxidised products in extracellular fluids. These become concentrated, and are thus, 
measurable in urine.
This adaptation of cells to deal with increased oxidative stress, may be most relevant either to moderate 
inflammatory activity where levels of ROS do not increase dramatically, or to a gradual increase in ROS 
whereby the cell can adapt more efficiently by up-regulating defence mechanisms (as described in 
Brown et al., 1990).
In cases where levels of ROS rise suddenly, defence mechanisms may become over-whelmed resulting 
in inefficient repair of DNA. If the damage is sub-lethal, the cell will survive but may incorporate 
mutations into its genome (ROS may represent initiating or promoting factors in the multi-stage theory 
of mutagenesis). Support for this hypothesis is a notably increased risk of malignancy in chronic 
inflammatory conditions (Miller, 1967; Louie and Schwartz, 1978; Green, Dawson and Walker, 1978).
As an alternative, damage to DNA may generate a product irrepairable by the cell (Schraufstatter et al., 
1986). Cell death, and thus degradation of modified DNA would appear to be advantageous to 
maintenance of normal cell development. However, abnormalities of the immune system in chronic 
inflammatory disorders, SLE in particular, further complicate maintenance of normal cell metabolism.
SLE serum contains antibodies to DNA which combine with DNA, released from cells, to form immune 
complexes (see section 1.2.4 and 1.2.5). If DNA damage is increased, levels of DNA excretion are also 
increased which in turn can form immune complexes.
The role of released cellular DNA in the initiation of anti-DNA antibodies is unclear although the 
greater the damage to the DNA, the more immunogenic it is (Tan and Stoughton, 1969; Jansson, 1985). 
However, DNA/anti-DNA antibody immune complexes exacerbate the inflammatory response of SLE 
by contributing to further stimulation of phagocytic cells (Weiss and Ward, 1982; Ryan et al., 1990). 
This results in a positive feedback mechanism for ROS generation. Immune complexes also contribute 
to SLE disease manifestations by their deposition in tissues (section 1.2.5) which may also be a result of 
initial ROS production.
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Future Work
a) : Evaluation of DNA repair in RA PBMC
80HDG was excreted in significantly higher quantities in the urine of RA patients compared to control 
samples. This was thought to result from efficient repair of increased levels of ROS-induced DNA 
damage produced during inflammation.
Preliminary results from several patients with active RA suggest this to be the case; repair of 80HDG in 
oxidant-stressed RA PBMC did not differ significantly from PBMC of normal controls. However, 
further investigation of a larger number of RA patients is needed to confirm this finding.
b) : Immunoassays for detection of 80HDG
The measurement of 80HDG in urine has been shown to be a reliable indicator of DNA damage in vivo 
but there are problems of peak identification using HPLC/ECD as discussed in the introduction to 
chapter 4. To improve analysis of 80HDG in urine, an immunoassay using polyclonal antisera or 
monoclonal antibodies directed against 80HDG could be developed. This may have the sensitivity of 
the HPLC/ECD assay, and would diminish any doubts about specificity for 80HDG detection.
There are several references to both polyclonal and monoclonal antibodies raised against 80HDG 
although none have been used diagnostically (Kasai and Nishimura, 1986; Fraga et al., 1990).
For the production of antibodies, rabbits could be immunised with dG reacted with any of the model 
systems described in section 3.1 (using this information to maximise the yield obtained) and conjugated 
to albumin. It would then be neces.sary to screen and remove from the antisera antibodies reactive with 
dG and other ROS-induced products as well as the carrier molecule using well-established experimental 
procedures.
An antibody to 80HDG produced in this way could also be used as a fluorescent stain to detect 80HDG 
in tissues. This would require invasive procedures to obtain DNA but could be useful as a marker of 
accumulating DNA damage, potentially important in malignancy. For example, cigarette smoke can 
damage DNA to produce 80HDG (Leanderson and Tagesson, 1990) and there is a positive correlation 
between the number of aromatic hydrocarbon-DNA adducts in the lungs of smokers and the number of
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cigarettes smoked (Phillips et al., 1988). Analysis of 80HDG in lung tissue of smokers may enable the 
prediction of susceptibility to malignancy as a function of unrepaired DNA damage.
c) : ROS-DNA as an antigen
Results from the ROS-DNA ELISA have shown that sera from ANA positive patients react with ROS- 
DNA to give a positive result. The possibility that ROS-DNA is a nuclear antigen recognised in the 
ANA test could be clarified by extraction of nuclear antigens from cells (by isolation of nuclei from 
other cellular material), selective depletion of known antigens with antibodies to these, such as anti-Ro 
and anti-La antibodies found commonly in patients with scleroderma, and analysis of the remaining 
ethanol precipitable fraction with monoclonal antibody screening (shown to give a highly definitive 
pattern of ROS-damaged DNA).
ROS-DNA as antigen has also been shown to detect low affinity antibodies present in the serum of SLE 
patients with mildly active and inactive disease as well as high affinity antibodies more characteristic of 
active disease states. The ROS-DNA ELISA assay may therefore have potential for use in longitudinal 
studies to monitor any fluctuations of disease activity. This could determine if the assay could be used 
to predict periods of disease flair or remission.
d) : ROS-DNA as an immunogen
ROS-DNA and Nat-DNA stimulated normal and SLE PBMC in culture, to produce anti-DNA 
antibodies. Since anti-DNA antibodies are not a characteristic component of serum, this suggests that 
DNA released from cells during normal metabolism is quickly cleared from the circulation and does not 
induce anti-DNA antibody formation. However, it also suggests that when DNA excretion is increased, 
such as in active chronic hepatitis (Davis and Read, 1975), clearance mechanisms may be temporarily 
over-whelmed because anti-DNA antibodies do become detectable in serum from these patients. 
However, the rise in anti-DNA antibodies appears to be only transient. In SLE, regulation of anti-DNA 
antibody production clearly differs since the levels may and often do persist in the absence of an active 
inflammatory response. This may be due to a constant inability to clear DNA effectively or an 
overproduction of antibodies from polyclonal B cell activation. Both mechanisms however, would 
contribute to the formation and persistence of circulating immune complexes (section 1.2.5).
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Circulating inimune complexes may have a role in the production of anti-DNA antibodies. This could 
be investigated in a similar way to analysis of DNA-stimulated anti-DNA antibody production from SLE 
PBMC. This would require culturing of PBMC with immune complexes and measuring anti-DNA 
antibody production as in section 5.4.
Further, the epitopes and associated idiotypes of anti-DNA antibodies produced by ROS-DNA and Nat- 
DNA could be studied with available anti-idiotypic monoclonal antibodies. This would enable the 
pathogenicity of DNA-induced (antigen-driven) antibodies and any immune complex-induced antibodies 
to be determined. This may increase the understanding of the role of these antibodies and their initiating 
antigen in the manifestations of SLE.
e): Relevance of inflammatory status to DNA damage
The effects of ROS on DNA were effectively inhibited with scavengers of OH-, and metal ion chelators 
in particular, even for DNA-bound metal ion site-directed damage. Therefore, it is possible that in 
inflammatory conditions where ROS generation is increased, such treatment with antioxidants could be 
therapeutically beneficial.
This could be investigated in RA patients treated for active disease and followed over the months of 
treatment. Urinary 80HDG measured in these patients would determine whether or not, on suppression 
of the active inflammatory response, levels of 80HDG returned to normal with the corresponding 
decrease in inflammatory activity. Although treatment for RA does not involve conventional 
antioxidants, widely used dnigs act to reduce the levels of neutrophil- and macrophage-derived ROS, 
thus acting indirectly as antioxidants (Forrest and Brooks, 1988).
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